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Abstract 
The midbrain dopamine system plays a fundamental conserved role in regulating behaviour, and 
its dysfunction is associated with several neuropsychiatric disorders including addiction, 
schizophrenia, and Parkinson’s Disease. Midbrain dopamine neurons display considerable 
heterogeneity in their neurochemical, electrophysiological, and functional properties, and 
project to many cortical and subcortical structures. The majority of these neurons reside within 
the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA), but a less well-
known, and understudied, dopamine population are housed within the dorsal raphe nucleus 
(DRN) and ventrolateral periaqueductal grey (vlPAG). These neurons provide the majority of the 
dopaminergic input to the central extended amygdala and have been implicated in the sleep-
wake cycle and mediating the effects of opiates. However, their electrophysiological properties 
have not been examined. I have studied these neurons in mice using immunohistochemistry and 
electrophysiology in an acute brain slice preparation ex vivo. I found that they display similar 
properties to some VTA dopamine neurons, and noted co-expression of vasoactive intestinal 
peptide in a subset of this population. A characteristic feature of VTA dopamine neurons is the 
potentiation observed at glutamatergic synapses following a single dose of addictive drug or an 
acute stress experience. I investigated whether DRN/vlPAG dopamine neurons would show 
cocaine-induced plasticity and found that glutamatergic synapses were potentiated not only by 
a single dose of cocaine, but also by acute social isolation. This potentiation was associated with 
a change in AMPAR transmission, which is similar to that observed following cocaine in the VTA. 
I also investigated the hypothesis that this plasticity is a result of acute anxiety using behavioural 
analysis and administration of anxiolytic compounds. These findings suggest another form of 
salient stimulus which can induce plasticity in dopamine neurons, and have relevance to several 
neuropsychiatric diseases including those modelled by social isolation. 
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Chapter 1. Introduction 
The midbrain dopamine system plays a fundamental, conserved role in regulating behaviour. It 
is centrally involved in a range of mammalian functions including motor control, reward, 
motivation, neuroendocrine regulation, cognition, and emotional processing (Wise et al., 2004; 
Björklund and Dunnett, 2007a; Fields et al., 2007). Dysfunction of this system is consequently 
associated with a variety of disorders including Parkinson’s Disease, drug addiction, attention-
deficit hyperactivity disorder (ADHD), and schizophrenia (Sesack and Carr, 2002; Viggiano et al., 
2003; Liss and Roeper, 2007). 
1.1. Midbrain dopamine system: anatomical organisation 
Dopamine neurons form a continuous network extending throughout the mesencephalon and 
diencephalon in the mammalian brain, but can be conveniently divided into nine major groups, 
denoted A8-A16 (Dahlström and Fuxe, 1964; Felten and Sladek, 1983; Björklund and Lindvall, 
1984; Hökfelt et al., 1984). The best described of these are the A8 (retrorubal field), A9 
(substantia nigra, pars compacta; SNc) and A10 (ventral tegmental area; VTA) cell groups in the 
mesencephalon. This nomenclature has remained in use since these populations were originally 
described in the early 1960s, which allows for the fact that the dopaminergic cell groups are not 
generally confined to distinct anatomical structures, and also facilitates inter-species 
comparison, since the distribution of cell bodies within each group can vary significantly 
between species (Smeets and Gonzalez, 2000).  
1.1.1. VTA subnuclei 
The VTA itself can be anatomically divided into five distinct dopamine cell groups (Dahlström 
and Fuxe, 1964; Phillipson, 1979a; Oades and Halliday, 1987). Cytoarchitectural studies in rats 
and humans have defined these as: the paranigral nucleus (PN), interfascicular nucleus (IF), 
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parabrachial pigmented nucleus (PBP), caudal linear nucleus (CLi), and rostral linear nucleus 
(RLi) (Phillipson, 1979a; Swanson, 1982; Halliday and Tork, 1986; Oades and Halliday, 1987). In 
addition, a lesser known, and relatively understudied, population of dopamine neurons has also 
been described in the dorsal raphe nucleus (DRN) and ventrolateral periaqueductal grey (vlPAG; 
Fig. 1a). This population is often referred to as a dorsocaudal extension of the A10 group 
(A10dc; Lindvall and Björklund, 1974; Hökfelt et al., 1976; Ochi and Shimizu, 1978; Hökfelt et al., 
1984; Trulson et al., 1985; Descarries et al., 1986; Oades and Halliday, 1987; Arsenault et al., 
1988; Stratford and Wirtshafter, 1990; Charara and Parent, 1998), and has been reported in rats 
(Hökfelt et al., 1976; Ochi and Shimizu, 1978; Nagatsu et al., 1979; Hökfelt et al., 1984; Köhler 
and Goldstein, 1984; Descarries et al., 1986; Stratford and Wirtshafter, 1990), cats (Miachon et 
al., 1984), monkeys (Arsenault et al., 1988; Charara and Parent, 1998), and humans (Saper and 
Petito, 1982; Pearson et al., 1983). 
These neurons in the DRN/vlPAG have been confirmed as dopaminergic, as they express 
tyrosine hydroxylase (TH; the rate-limiting enzyme in dopamine synthesis; Levitt et al., 1965) 
and aromatic L-amino acid decarboxylase (AADC; the enzyme that catalyses conversion of L-
dihydroxyphenylalanine, the product of TH, to dopamine; Hökfelt et al., 1976; Hökfelt et al., 
1984; Köhler and Goldstein, 1984; Descarries et al., 1986; Stratford and Wirtshafter, 1990; Lu et 
al., 2006). However, they lack the enzyme dopamine-β-hydroxylase (DBH; expressed by 
noradrenergic neurons; Swanson and Hartman, 1975; Nagatsu et al., 1979; Miachon et al., 1984; 
Flores et al., 2004), and do not express 5-hydroxytryptamine (5-HT), suggesting they are 
dopaminergic and neurochemically distinct from the population of serotonin neurons in this 
region (Descarries et al., 1986; Stratford and Wirtshafter, 1990; Fu et al., 2010). Expression of 
the vesicular monoamine transporter (VMAT2) and the dopamine transporter (DAT), which are 
important in vesicular packaging and re-uptake of dopamine respectively, have yet to be 
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examined in this population. The DRN/vlPAG dopamine neurons reside in the midline, beginning 
in the ventral PAG, and extending to overlap with the rostral portion of the 5-HT neurons in the 
DRN, with only scattered dopaminergic neurons at more caudal levels, mostly occupying the 
region directly below the aqueduct of Sylvius (Hökfelt et al., 1984; Charara and Parent, 1998). 
There are few estimates of precise cell numbers in the DRN/vlPAG, and even those that exist set 
different boundaries, making accurate comparison difficult. Estimates restricted to the DRN 
suggest that there are around 1,000 dopamine neurons in the rat (Descarries et al., 1986), while 
in mice there are reported to be around 2,200 dopamine neurons in the DRN/vlPAG and RLi 
combined (Flores et al., 2004; Flores et al., 2006). This compares with around 40,000 and 11,000 
dopamine neurons in the VTA of rats and mice, respectively (Nelson et al., 1996; Nair-Roberts et 
al., 2008).  
In spite of their identification along with other midbrain dopamine groups, nearly 40 years ago, 
very little attention has been paid to this dopaminergic subpopulation in comparison with other 
components of the midbrain A10 group. This is most likely because they are less numerous than 
the dopamine neurons residing in the VTA, and because they are housed within a large 
serotonin population, which makes them difficult to target in vitro or in vivo. However, as I will 
describe, although these neurons appear similar to the VTA population in several respects, a few 
studies have indicated that they possess distinct anatomical and functional properties (e.g. 
Hasue and Shammah-Lagnado, 2002; Lu et al., 2006). The DRN/vlPAG population therefore 
represent an intriguing, understudied, dopaminergic group which warrant further investigation, 
particularly in light of the emerging functional heterogeneity of midbrain dopamine neurons.  
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1.1.2. Efferent projections of the midbrain dopamine neurons 
1.1.2.1. VTA and SNc 
Based on the major projection targets of the midbrain dopamine neurons, they have classically 
been divided into the nigrostriatal and mesocorticolimbic systems, originating in the SNc and 
VTA respectively. The nigrostriatal pathway projects to the dorsal striatum, (caudate-putamen in 
humans), while the mesocorticolimbic pathway projects to limbic structures including the 
ventral striatum (nucleus accumbens (NAc) and olfactory tubercle), amygdala, hippocampus, 
and hypothalamus, as well as limbic cortical regions including the prefrontal, orbitofrontal, 
cingulate, and entorhinal corticies (Anden et al., 1964; Anden et al., 1966; Ungerstedt, 1971; 
Fallon et al., 1978; Fallon and Moore, 1978a; Simon et al., 1979; Grecksch and Matties, 1981; 
Porrino and Goldman-Rakic, 1982; Albanese and Minciacchi, 1983; Björklund and Lindvall, 1984; 
Williams and Goldman-Rakic, 1998; Brinley-Reed and McDonald, 1999; Haber et al., 2000; Hasue 
and Shammah-Lagnado, 2002). 
However, while the projection pathways emanating from the midbrain are largely anatomically 
and functionally distinct (with very few collaterals), their cells of origin within the dopaminergic 
groups are partly intermixed (Fallon and Moore, 1978b; Fallon and Loughlin, 1982; Swanson, 
1982; Loughlin and Fallon, 1984). It has therefore been noted that more accurate terminology 
would be ‘mesostriatal’ rather than ‘nigrostriatal’ (Björklund and Dunnett, 2007b). The 
widespread nature of these projections allows dopamine to regulate neural processing and 
plasticity in many brain regions, and hence influence many forms of learning and behaviour. 
Furthermore, dense and complex arborization of dopaminergic terminals within target 
structures allows a single neuron to form synaptic contacts with a huge number of target cells 
(estimated as ∼370,000 per SNc dopamine neuron; Arbuthnott and Wickens, 2007; Matsuda et 
al., 2009). Additionally, each target cell receives input from ∼1000 dopaminergic terminals 
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(Doucet et al., 1986), so the activity of dopamine neurons can be highly influential in target 
regions. 
1.1.2.2. DRN/vlPAG 
Many regions receive dopaminergic input from the DRN/vlPAG population, including the NAc, 
caudate-putamen, central extended amygdala (central amygdaloid nucleus (CeA) and bed 
nucleus of the stria terminalis (BNST)), lateral septum, medial prefrontal cortex (mPFC), lateral 
habenula, hippocampus, midline and intralaminar thalamus, substantia innominata and 
horizontal limb of the diagonal band nucleus (HDB), ventrolateral preoptic nucleus (VLPO), 
perifornical region of the lateral hypothalamus, laterodorsal tegmental nucleus, and locus 
coeruleus (Pohle et al., 1984; Descarries et al., 1986; Ornstein et al., 1987; Grove, 1988; Semba 
et al., 1988; Yoshida et al., 1989; Stratford and Wirtshafter, 1990; Takada et al., 1990; Li et al., 
1993; Freeman et al., 2001; Hasue and Shammah-Lagnado, 2002; Lu et al., 2006; Shin et al., 
2008). There are also many TH-positive fibres with synaptic varicosities observed within the 
PAG, suggesting the presence of a local dopaminergic circuit (Buma et al., 1992; Peyron et al., 
1995; Flores et al., 2004), as well as evidence of a small projection to the VTA (Omelchenko and 
Sesack, 2010).  
Within the DRN/vlPAG, striatal-projecting neurons lie ventrally within the median subnucleus of 
the DRN, NAc-projecting neurons lie just below the aqueduct of Sylvius, and lateral septum and 
mPFC-projecting neurons are scattered more ventrally (Descarries et al., 1986; Yoshida et al., 
1989; Stratford and Wirtshafter, 1990). There is also a crude mediolateral topographical 
organization of the central extended amygdala projection (Hasue and Shammah-Lagnado, 
2002). This topographical organisation suggests there is very limited collateralization of 
DRN/vlPAG dopamine neurons, similar to those originating in the VTA (Hasue and Shammah-
Lagnado, 2002).  
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Illustration of the anatomical location of the DRN/vlPAG dopamine neurons and some of their 
major projections. (a) Sagittal view of the mouse brain indicating the rostro-caudal position of 
the DRN/vlPAG dopamine neurons, (b) corresponding coronal section, and (c) close up of the 
DRN/vlPAG showing the general distribution of the dopamine neurons (green dots). (d) 
Horizontal view of the mouse brain indicating some of the major projection targets of 
DRN/vlPAG dopamine neurons. Aq = aqueduct. Adapted from sagittal and coronal illustrations 
taken from the Mouse Brain Atlas in Stereotaxic Coordinates (Paxinos and Franklin, 2001) 
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1.1.3. Afferent inputs to midbrain dopamine neurons 
1.1.3.1. VTA and SNc 
The midbrain dopamine neurons receive afferent input from glutamatergic, GABAergic, 
cholinergic, serotonergic, orexigenic, and noradrenergic fibers, which influences their firing 
activity, and ultimately the release of dopamine in terminal projection sites (Grillner and 
Mercuri, 2002). The major excitatory drive to the midbrain dopamine neurons arises from 
glutamatergic neurons in the prefrontal cortex, subthalamic nucleus, laterodorsal- (LDTg) and 
pedunculopontine (PPTg) tegmental nuclei, lateral hypothamalus, superior colliculus, BNST, 
PAG, and lateral habenula (Herkenham and Nauta, 1979; Phillipson, 1979b; Kita and Kitai, 1987; 
Araki et al., 1988; Sesack and Pickel, 1992; Murase et al., 1993; Lavoie and Parent, 1994a,b; 
Charara et al., 1996; Tong et al., 1996a; Iribe et al., 1999; Lokwan et al., 2000; Fudge and Haber, 
2001; Georges and Aston-Jones, 2002; Comoli et al., 2003; Floresco et al., 2003; Geisler and 
Zahm, 2005; Omelchenko and Sesack, 2005; Lodge and Grace, 2006; Omelchenko and Sesack, 
2006; Geisler et al., 2007; Omelchenko and Sesack, 2007; May et al., 2009; Omenchenko et al., 
2009; Watabe-Uchida et al., 2012), as well as from local glutamatergic neurons within the VTA 
(Omelchenko and Sesack, 2009; Dobi et al., 2010). 
Inhibitory GABAergic afferents to the midbrain dopamine neurons originate in the dorsal 
striatum (targeting mostly SNc), ventral striatum (targeting mostly VTA), rostromedial tegmental 
nucleus (RMTg), ventral pallidum, and amygdala (Conrad and Pfaff, 1976; Walaas and Fonnum, 
1980; Price and Amaral, 1981; Zahm, 1989; Bolam and Smith, 1990; Zahm and Heimer, 1990; 
Smith and Bolam, 1990; Kalivas et al., 1993; Celada et al., 1999; Jhou et al., 2009; Kaufling et al., 
2009; Sesack and Grace, 2010; Watabe-Uchida et al., 2012). However, there is some 
disagreement over whether striatal neurons form functional GABAergic synapses onto midbrain 
dopamine neurons, which has yet to be resolved (Chuhma et al., 2011; Xia et al., 2011; Watabe-
22 
 
Uchida et al., 2012). Additionally, local GABAergic interneurons within the VTA and the 
neighbouring substantia nigra pars reticulata (SNr) provide inhibitory input to midbrain 
dopamine neurons (Di Chiara et al., 1979; Phillipson, 1979b; Grofova et al., 1982; Tepper et al., 
1995; Celada et al., 1999; Omelchenko and Sesack, 2009; Dobi et al., 2010).  
Midbrain dopamine neurons also receive serotonergic innervation from the DRN and median 
raphe nucleus, which is generally inhibitory (Herve et al., 1987; Wirtshafter et al., 1987; Corvaja 
et al., 1993; Broderick et al., 1997; Vertes et al., 1999; Gervais and Rouillard, 2000), cholinergic 
innervation from the PPTg (mainly to the SNpc) and LDTg (mainly to the VTA; Beninato and 
Spencer, 1987; Clarke et al., 1987; Cornwall et al., 1990; Bolam et al., 1991; Semba and Fibiger, 
1992; Oakman et al., 1995; Blaha et al., 1996; Yeomans and Baptista, 1997; Omelchenko and 
Sesack 2005; Mena-Segovia et al., 2008), excitatory noradrenergic afferents from the locus 
coeruleus (Phillipson, 1979b; Herve et al., 1982; Grenhoff et al., 1993; Grenhoff et al., 1995; 
Mejías-Aponte et al., 2009) and orexigenic afferents from the lateral hypothalamus (Geisler and 
Zahm, 2005). Several peptide neurotransmitters and neuromodulators also contribute to 
modulating the activity of midbrain dopamine neurons (Kalivas, 1985), while axodendritic 
synapses (Wilson et al., 1977; Bayer and Pickel, 1990) and somatodendritic release of dopamine 
(Bjorklund and Lindvall, 1975; Geffen et al., 1976; Cheramy et al., 1981; Jaffe et al., 1998) 
regulates their excitability via feedback inhibition (Lacey et al., 1987; Beckstead et al., 2004). 
1.1.3.2. DRN/vlPAG 
Tracing studies have identified afferent inputs to the DRN/vlPAG dopamine neurons from the 
LDTg, lateral hypothalamus, locus coeruleus, mPFC, VLPO, infralimbic cortex, and nucleus of the 
solitary tract (Kalen et al., 1988; Hurley et al., 1991; Herbert, 1992; Herbert and Saper, 1992; Lu 
et al., 2006). 
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1.1.4. Neural connectivity comparison between the VTA and DRN/vlPAG 
While many of the projection targets and afferent inputs of the DRN/vlPAG dopamine neurons 
overlap with those of the VTA, the relative composition of their dopaminergic efferents varies 
considerably. Retrograde tracing in rats revealed that the DRN/vlPAG dopaminergic projections 
to the NAc, lateral septum, mPFC, and lateral habenula are relatively sparse in comparison to 
the substantial input from the VTA (Stratford and Wirtshafter, 1990; Hasue and Shammah-
Lagnado, 2002). However, DRN/vlPAG dopamine neurons have been shown to constitute 
around 44% of the dopaminergic cells projecting to the lateral BNST and nearly 60% of those 
projecting to the CeA, compared with around 40% and 35% from the VTA to the BNST and CeA, 
respectively (Hasue and Shammah-Lagnado, 2002). More recently, one study examining 
restricted retrograde tracer injection into the dorsolateral (dl)BNST, suggested that around 66% 
of dopamine cells projecting to this region originate in the DRN/vlPAG (Meloni et al., 2006). 
Similarly, the vast majority of dopamine neurons innervating the ventrolateral (vl)BNST are 
located in the DRN/vlPAG (Shin et al., 2008), which highlights the importance of this population 
for the dopamine input to the central extended amygdala. Additionally, the DRN/vlPAG receives 
input from, and projects to, many regions involved in regulating the sleep-wake cycle, including 
the VLPO (Lu et al., 2006). However, the VTA lacks a VLPO projection (Chou et al., 2002), 
indicating another distinct feature of the DRN/vlPAG population.  
1.1.5. Comparison between rodent and primate DRN/vlPAG dopamine neurons 
Evidence from primates indicates that dopamine neurons in the DRN are less numerous than in 
rodents (Charara and Parent, 1998). Moreover, the primate amygdala (specifically the 
basolateral amygdala; BLA) and extended amygdala receives broad dopaminergic input, mostly 
from the SNc and retrorubal field, with a less prominent input from the VTA and almost none 
from the DRN/vlPAG dopamine neurons (Cho and Fudge, 2010). This clearly differs from the rat 
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projection system, in which the medial VTA and DRN/vlPAG are the major sources of dopamine 
to the BLA and central extended amygdala, respectively (Fallon et al., 1978; Swanson, 1982; 
Hasue and Shammah-Lagnado, 2002). However, this species difference should be treated with 
caution for two reasons: firstly, the BNST was not included in these primate tracing studies, and 
secondly, it has been previously noted that the midbrain dopamine system is considerably 
expanded in primates, including humans, and displays a different organisation (Björklund and 
Dunnett, 2007b). There are around 70,000 dopaminergic neurons within the A8-A10 groups in 
the rat midbrain, with around 55% of these residing within the VTA, and 35% in the SNc (Nair-
Roberts et al., 2008). This is increased to 160-320,000 dopaminergic neurons in the monkey, and 
400-600,000 in humans, with more than 70% located in the SNc, and just 15% in the VTA (Hirsch 
et al., 1992; Francois et al., 1999). However, this may partly be an artefact relating to the 
anatomical definition of the VTA in primates compared to rodents.  
1.2. Midbrain dopamine system: electrophysiological characteristics 
1.2.1. Electrophysiological identification of dopamine neurons 
Although the VTA is considered to be largely dopaminergic (Lacey et al., 1989; Yung et al., 1991; 
Johnson and North, 1992a), more recent estimates suggest that dopamine neurons only account 
for about 55-65% of neurons in this region, with the remainder consisting of mostly GABAergic 
neurons (35-45%) with a few glutamatergic neurons (2-3%; Kawano et al., 2006; Margolis et al., 
2006a; Olson and Nestler, 2007; Yamaguchi et al., 2007; Nair-Roberts et al., 2008). Early 
electrophysiological studies performed in the SNc developed criteria for identifying dopamine 
neurons based on their electrophysiological properties (Guyenet and Aghajanian, 1978; Grace 
and Bunney, 1980; Grace and Bunney, 1983; Grace and Onn, 1989; Lacey et al., 1989). 
Specifically, dopamine neurons exhibit slow regular firing, broad action potentials with a large 
afterhyperpolarisation, and a prominent hyperpolarisation-activated cation current (Ih; Grace 
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and Bunney, 1980; Grace and Bunney, 1983; Grace and Onn, 1989; Lacey et al., 1989; Yung et 
al., 1991; Johnson and North, 1992a). They are also hyperpolarised by a D2-receptor agonist but 
not by a μ-opioid agonist (Bunney et al., 1973a,b; Groves et al., 1975; Aghajanian and Bunney, 
1977; Lacey et al., 1987; Lacey et al., 1989; Johnson and North, 1992a,b; Chieng et al., 2011). In 
contrast, GABAergic neurons display high frequency firing, have short duration action potentials 
with a small afterpolarisation, do not exhibit an Ih, and are hyperpolarised by a μ-opioid agonist, 
but not by a D2-receptor agonist (Grace and Onn, 1989; Johnson and North, 1992a,b; Cameron 
et al., 1997; Steffensen et al., 1998; Chieng et al., 2011). 
However, while these properties are sufficient for accurately concluding dopaminergic identity 
in the SNc (e.g., Brown et al., 2009), dopamine neurons of the VTA exhibit considerable 
heterogeneity in their physiological and pharmacological properties (Neuhoff et al., 2002; Ford 
et al., 2006; Margolis et al., 2006a,b; Lammel et al., 2008; Margolis et al., 2008). This warrants 
greater caution when utilising these electrophysiological criteria to establish dopaminergic 
phenotype in this population. One frequently used dopaminergic marker is the presence of a 
large Ih (Lacey et al., 1989; Johnson and North, 1992a; Ungless et al., 2001; Gutlerner et al., 
2002; Saal et al., 2003; Borgland et al., 2004; Faleiro et al., 2004; Bellone and Lüscher, 2006; 
Hommel et al., 2006; Margolis et al., 2006a; Argilli et al., 2008; Stuber et al., 2008; Zweifel et al., 
2008). However, it has been shown that this does not reliably predict dopaminergic phenotype, 
because not only can some dopamine neurons lack a prominent Ih (Jones and Kauer, 1999; 
Neuhoff et al., 2002; Liss et al., 2005; Ford et al., 2006; Lammel et al., 2008; Chieng et al., 2011; 
Lammel et al., 2011), but many non-dopamine neurons can express a large Ih (Johnson and 
North, 1992a; Cameron et al., 1997; Jones and Kauer, 1999; Margolis et al., 2003; Ford et al., 
2006; Margolis et al., 2006a; Margolis et al., 2008; Zhang et al., 2010a, Chieng et al., 2011). 
Other properties, which have often been used to identify dopamine neurons, are also found in a 
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significant proportion of non-dopamine neurons, including response to a D2-receptor or μ-opioid 
agonist (Yim and Mogenson, 1980; Johnson and North, 1992a,b; Cameron et al., 1997; Margolis 
et al., 2003), and action potential shape, duration, and firing rate (Ungless et al., 2004; Margolis 
et al., 2006a; Luo et al., 2008; Chieng et al., 2011). Therefore, previous in vivo and ex vivo studies 
which employed these criteria, may have not only overrepresented certain dopamine 
subpopulations while neglecting others, but also included a proportion of non-dopamine 
neurons (Lammel et al., 2008; Margolis et al., 2008). 
Due to the variability in the electrophysiological properties of VTA dopamine neurons and the 
different neuronal types housed within this nucleus, many studies now utilise transgenic mice 
which express green fluorescent protein (GFP) selectively in dopamine neurons, in order to 
more efficiently target this population (e.g. Labouebe et al., 2007). Two mouse lines, which have 
been successfully employed in electrophysiology studies are Pitx3-GFP (Zhao et al., 2004) and 
TH-GFP mice (Matsushita et al., 2002). Pitx3 is a transcription factor required for the 
development and maintenance of midbrain dopamine neurons (van den Munckhof et al., 2003) 
and is expressed exclusively in this population (Smidt et al., 1997). Pitx3-directed GFP expression 
is therefore confined to midbrain dopamine neurons in Pitx3-GFP mice (Zhao et al., 2004). TH is 
required for neurotransmitter synthesis in all catecholaminergic neurons, and therefore, under 
the control of the TH promoter, GFP is expressed in dopaminergic, noradrenergic, and 
adrenergic cell groups in TH-GFP mice (Matsushita et al., 2002). The GFP signal in both these 
lines of transgenic mouse provides a useful guide for efficient targeting of dopaminergic 
neurons (discussed in more detail in 2.1.1).  
1.2.2. Projecting target-related heterogeneity in midbrain dopamine neurons 
Several studies have associated the variability in electrophysiological and neurochemical 
properties to axonal projection target (Ford et al., 2006; Margolis et al., 2006b; Lammel et al., 
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2008; Margolis et al., 2008), since VTA dopamine neurons almost exclusively project to a single 
forebrain structure (Deniau et al., 1980; Fallon, 1981; Swanson, 1982). However, it should be 
noted that these studies were performed in both mice and rats, and they reveal considerable 
inter-species differences in the properties of VTA dopamine neurons, as described below. 
1.2.2.1. Rat studies 
In rats, amygdala-projecting dopamine neurons exhibit the shortest action potential duration, 
followed by mPFC-projecting neurons and NAc-projecting neurons (Margolis et al., 2008). This 
correlates with D2-receptor inhibition, whereby amygdala-projecting dopamine neurons are 
unaffected by a D2-receptor agonist, while most mPFC- and NAc-projecting dopamine neurons 
respond with significant hyperpolarisation (Margolis et al., 2008). Additionally, a κ-opioid 
agonist selectively inhibits dopamine neurons projecting to the mPFC and amygdala, with no 
effect on NAc-projecting dopamine neurons or non-dopamine neurons (Margolis et al., 2006b; 
Margolis et al., 2008). A range of Ih amplitudes are present in both dopamine and non-dopamine 
neurons, but the absence of an Ih is thought to reliably predict a non-dopamine neuron 
(Margolis et al., 2006a). 
1.2.2.2. Mice studies 
In mice, it has been suggested that midbrain dopamine neurons consist of two anatomically and 
functionally distinct neuronal subtypes: ‘conventional’ dopamine neurons projecting to the NAc 
lateral shell and dorsolateral striatum, and ‘unconventional’ dopamine neurons projecting to the 
NAc medial shell, NAc core, mPFC, and BLA (Lammel et al., 2008). Conventional dopamine 
neurons have relatively short duration action potentials with a large afterhyperpolarisation, 
exhibit a prominent Ih, and have maximal firing rates of <10 Hz. In contrast, unconventional 
dopamine neurons have long duration action potentials with a small afterhyperpolarisation, 
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exhibit little or no Ih, and can maintain firing frequencies >10 Hz (Chiodo et al., 1984; Gariano et 
al., 1989; Neuhoff et al., 2002; Ford et al., 2006; Lammel et al., 2008). Interestingly, mPFC-
projecting dopamine neurons can be distinguished by their lack of D2-receptor inhibition 
(Lammel et al., 2008), while most NAc-projecting neurons, but few amygdala-projecting 
neurons, are inhibited by a κ-opioid agonist (Ford et al., 2006). 
Midbrain dopamine neurons also display quantitative molecular differences, with conventional 
and unconventional dopamine neurons exhibiting high and low DAT/TH ratios, respectively 
(Lammel et al., 2008). This is attributed mainly to significantly higher expression of DAT in 
conventional neurons, implying a greater capacity for dopamine re-uptake, relative to synthesis, 
which may impact on the decay kinetics of extracellular dopamine (Lammel et al., 2008).  
These studies highlight the neurochemical and electrophysiological heterogeneity of midbrain 
dopamine neurons, and also caution against generalising between different species in terms of 
projection-specific properties (Margolis et al., 2008). Furthermore, these findings indicate that 
the temporal profile of dopamine release in target regions may differ depending on the intrinsic 
properties of the dopamine neuron (Lammel et al., 2008). For example, excitation of mPFC-
projecting dopamine neurons, which can maintain high frequency firing, lack somatodendritic 
D2-receptor inhibition, and have a low DAT/TH ratio, is likely to result in a sustained dopamine 
release pattern in the mPFC (Lammel et al., 2008), which is consistent with in vivo studies 
(Yavich et al., 2007). 
1.2.3. Heterogeneity within DRN/vlPAG dopamine neurons 
Two major subtypes of dopamine neuron have been observed within the DRN/vlPAG, differing 
in their size, morphology, and anatomical distribution (Hökfelt et al., 1976; Stratford and 
Wirtshafter, 1990; Charara and Parent, 1998). Many small, rounded cells (10-15 μm in 
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diameter), with bipolar morphology, reside on the dorsal border of the rostral DRN, forming a 
thin band which lines the ventral surface of the aqueduct of Sylvius (Stratford and Wirtshafter, 
1990; Flores et al., 2004; Flores et al., 2006). Large (30-50 μm diameter) multipolar cells, 
exhibiting abundant arborisation, lie in the medial DRN, extending dorsocaudally from the 
ventro-rostral border of the DRN, (where the neurons are continuous with the dopamine 
neurons of the CLi (Stratford and Wirtshafter, 1990), and into the vlPAG (Flores et al., 2004).  
Interestingly, 6-hydroxydopamine (6-OHDA) treatment of this region selectively affects the large 
cells of the DRN/vlPAG (Flores et al., 2004). This corresponds to about an 80% reduction in the 
dopamine peak, as measured by in vitro voltammetry, suggesting that these large cells (although 
lower in number) contribute to the majority of the local dopamine release (Flores et al., 2004). 
Additionally, it has been noted that the small cells, located close to the aqueduct, show lower 
levels of TH immunoreactivity compared to other midbrain dopamine populations (Hökfelt et 
al., 1976; Rogers, 1992). These findings have led to the suggestion that the small periaqueductal 
cells are an extension of the periventricular dopamine system (Lindvall et al, 1974; Lindvall and 
Björklund, 1974; Moore and Bloom, 1978), which lacks DAT and is immune to 6-OHDA, whereas 
the larger dopamine neurons are an extension of the VTA, which expresses DAT and is therefore 
vulnerable to 6-OHDA (Kilty et al., 1991; Shimada et al., 1992; Fujita et al., 1993; Hasue and 
Shammah-Lagnado, 2002). 
1.2.4. Firing modes of midbrain dopamine neurons 
Midbrain dopamine neurons fire in two distinct modes: tonic and phasic (Grace and Bunney, 
1984a,b; Grace, 1991; Grace et al., 2007). Tonic, pacemaker-like firing (mean frequency ∼4 Hz) 
maintains steady, dopamine release in downstream target structures, which is essential for the 
normal functioning of these neural circuits (Grace and Bunney, 1984a; Sanghera et al., 1984; 
Schultz, 2007). Phasic firing refers to a rapid change in firing rate (for 100-500 ms), which results 
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in a substantial increase or decrease in dopamine release in target structures lasting for a few 
seconds (Grace, 1991; Floresco et al., 2001; Schultz, 2007; Schultz, 2008; Sombers et al., 2009). 
Phasic excitation in dopamine neurons manifests as ‘bursts’, which are short periods of high 
frequency firing (starting with an interspike interval (ISI) of <80 ms and finishing with an ISI >160 
ms; Grace and Bunney, 1984b).  
Synchronous phasic bursts in dopamine neurons can be initiated by an unexpected reward or 
reward-predicting cue (Schultz et al., 1997; Phillips et al., 2003; Cheer et al., 2007; Joshua et al., 
2009). This is thought to be functionally relevant for signalling salient information about the 
environment, and is believed to facilitate associative learning and motivation in a distinct 
manner from tonic activity (Grace, 1991; Overton and Clark, 1992; Berridge and Robinson, 1998; 
Schultz, 1998; Cooper, 2002; Grace et al., 2007; Lapish et al., 2007; Schultz, 2007). This is mainly 
attributable to the supralinear increase in extracellular dopamine resulting from burst firing 
(Gonon and Buda, 1985; Gonon, 1988; Bean and Roth, 1991; Chergui et al., 1994; Floresco et al., 
2003; Venton et al., 2003), which is thought to be important for influencing neural firing activity 
and modifying synaptic connections in the projection site (Surmeier et al., 2007; Robbins and 
Arnsten, 2009). It can also promote long-term plasticity and trigger re-wiring of neural circuits 
(Reynolds et al., 2001; Bromberg-Martin et al., 2010). By exploiting the temporal and spatial 
resolution offered by optogenetics, it has been confirmed that phasic bursting activity in VTA 
dopamine neurons is sufficient to establish behavioural conditioning (Tsai et al., 2009). 
Interestingly, however, phasic activation of VTA dopamine neurons in the absence of a reward 
does not drive ‘self-stimulation’-like behaviour, suggesting that activation of these dopamine 
neurons alone is not rewarding (Adamantidis et al., 2011). Phasic activation is, however, 
sufficient to re-activate previously extinguished reward-seeking behaviour, in the absence of a 
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reward or cues, which underscores its positive-reinforcing properties (Wise, 2004; Berridge, 
2007; Schultz, 2007; Koob and Volkow, 2010; Adamantidis et al., 2011). 
1.3. Functional diversity in the midbrain dopamine system 
1.3.1. Reward learning 
The traditional theory of midbrain dopamine neurons proposes that they encode positive 
motivational value (Berridge and Robinson, 1998; Schultz, 1998; Wise, 2004). This was originally 
based on findings that animals would repeatedly press a lever for self-stimulation in the VTA and 
its projection sites, or delivery of dopamine agonists into these regions (Olds and Milner, 1954; 
Phillips and Fibiger, 1978; Yokel and Wise, 1978; Carr and White, 1983; Gallistel and Karras, 
1984; Fiorino et al., 1993; Carlezon and Wise, 1996; McBride et al., 1999; Wise, 2004; Cheer et 
al., 2007). Reward-related stimuli increase dopamine release in the NAc, while aversive stimuli 
inhibit release (Roitman et al., 2008), and this correlates with an increase and decrease in 
dopamine neuron firing, respectively (Phillips and Olds, 1969; Schultz and Romo, 1987; Mantz et 
al., 1989; Mirenowicz and Schultz, 1996; Guarraci and Kapp, 1999; Ungless et al., 2004). 
Furthermore, reinforcing actions are potentiated by drugs which increase dopamine release, but 
attenuated by dopamine receptor antagonists (Fouriezos and Wise, 1976; Franklin, 1978; 
Gallistel and Karras, 1984; Wise, 2004).  
A defined role for the midbrain dopamine neurons in reward signalling was first clearly 
demonstrated through the pioneering work of Schultz et al., with the observation that 
dopamine neurons were phasically excited on presentation of an unexpected reward, or a 
reward-predicting cue, but were inhibited on reward omission (Schultz et al., 1997). This led to 
the hypothesis that dopamine neurons encode a reward-prediction-error signal, which is 
essential in reinforcement learning (Montague et al., 1996; Berridge and Robinson, 1998; 
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Schultz, 1998; Hyland et al., 2002; Bayer and Glimcher, 2005; Roesch et al., 2007; Schultz, 2007; 
D’Ardenne et al., 2008; Dayan and Niv, 2008; Schultz, 2010) and goal-directed behaviour (Wise, 
2004; Wise, 2005) by driving the formation of an appetitive associative memory (Montague et 
al., 1996; Schultz, 1998; Schultz, 2007). 
1.3.2. Aversive learning 
In an apparent contradiction to this established reward-coding role for dopamine neurons, 
many studies report that aversive stimuli can increase dopamine release in certain target sites 
(particularly the mPFC and NAc; Abercrombie et al., 1989; Kalivas and Duffy, 1995; Klitenick et 
al., 1996; Rougé-Pont et al., 1998; Bassareo et al., 2002; Giorgi et al., 2003; Joseph et al., 2003; 
Young, 2004; Amato et al., 2011; Budygin et al., 2012), while behavioural aversion is correlated 
with increased dopamine levels (Salamone, 1994; Joseph et al., 2003; Ventura et al., 2007; 
Anstrom et al., 2009; Barr et al., 2009; Fadok et al., 2009) and phasic activity in some putative 
dopamine neurons (Zweifel et al., 2009). Furthermore, there are inconsistencies in the literature 
regarding the response of putative dopamine neurons to aversive stimuli, with some studies 
reporting both inhibitions and excitations (Chiodo et al., 1980; Maeda and Mogenson, 1982; 
Trulson and Preussler, 1984; Schultz and Romo, 1987; Mantz et al., 1989; Gao et al., 1990; 
Mirenowicz and Schultz, 1996; Guarraci et al., 1999; Guarraci and Kapp, 1999; Coizet et al., 
2006; Wang and Tsien, 2011; Zweifel et al., 2011). This led to the alternative hypothesis that 
dopamine neurons signal salient, motivationally-relevant events (Berridge and Robinson, 1998; 
Redgrave et al., 1999; Horvitz, 2000; Di Chiara, 2002; Joseph et al., 2003; Kapur, 2003; Pezze and 
Feldon, 2004; Redgrave and Gurney, 2006; Anstrom et al., 2009). However, a role for dopamine 
in aversive signalling remained controversial, as these studies inferred dopaminergic identity 
using purely electrophysiological and pharmacological characteristics.  
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Subsequently, however, it was shown that a population of immunohistochemically-identified 
dopamine neurons in the ventral VTA of rats were phasically excited in response to noxious 
footshocks in vivo (Brischoux et al., 2009). Furthermore, a study in nonhuman primates, 
confirmed that some dorsolateral SNc putative dopamine neurons were excited by an 
unpredictable aversive stimulus, and also by cues predicting that aversive stimulus (Matsumoto 
and Hikosaka, 2009). These in vivo studies therefore presented a solution to the long-standing 
debate over information coding in dopamine neurons, by suggesting that there could be 
multiple anatomically and functionally distinct populations responding to different types of 
salient stimuli (Brischoux et al., 2009). 
1.3.3. Response to addictive drugs 
Midbrain dopamine neurons are known to be integral to the brain’s natural reward circuitry, 
and are activated by numerous naturally rewarding stimuli. In addition, it is widely documented 
that the mesolimbic dopamine system is critically involved in the response to drugs of abuse 
(Koob and Bloom, 1988; Self and Nestler, 1995; Wise, 2005). In spite of their diverse molecular 
targets, nearly all drugs of abuse, including cocaine, amphetamine, nicotine, ethanol, marijuana, 
and opiates, increase extracellular dopamine in the projection targets of the mesocorticolimbic 
system, most notably the NAc (Ungerstedt and Pycock, 1974; Heikkila et al., 1975; Adams, 1976; 
Plotsky et al., 1977; Di Chiara and Imperato, 1985; Di Chiara and Imperato, 1986; Imperato et al., 
1986a,b; Di Chiara and Imperato, 1988; Koob and Bloom, 1988; Self and Nestler, 1995; Bardo, 
1998; Koob et al., 1998; Volkow et al., 1999; Drevets et al., 2001; Boileau et al., 2003; Nestler, 
2005; Bossong et al., 2009; Brody et al., 2009), which is thought to mediate their rewarding or 
euphoric properties (Wise and Bozarth, 1987; Corrigall et al., 1992; McBride et al., 1999; 
Ikemoto and Wise, 2004). Contrastingly, drugs without addictive properties do not increase 
synaptic dopamine release (Di Chiara and Imperato, 1988). Furthermore, animals will self-
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administer addictive drugs into specific dopaminergic regions, but this is blocked by delivery of 
dopamine receptor antagonists, or lesion of dopaminergic terminals (De Wit and Wise, 1977; 
Gardner, 2000; Bressan and Crippa, 2005). Consistent with animal work, SPECT studies in 
humans have revealed that amphetamine-mediated dopamine release is correlated with 
positive emotional responses in subjects, described as ‘happiness’ and ‘energy’ (Abi-Dargham et 
al., 2003). The drug-induced rapid increase in dopamine release is thought to mimic the 
increased dopamine triggered by a naturally rewarding or salient stimulus (Schultz, 2010). In this 
way, addictive drugs are able to ‘hijack’ the brain’s natural reward circuitry to initiate 
maladaptive learning and behaviour (Hyman and Malenka, 2001; Jones and Bonci, 2005). 
Psychomotor stimulants, such as cocaine, are particularly dependent on dopamine to elicit their 
rewarding effects (DiChiara and Imperato, 1988). Cocaine elevates extracellular dopamine levels 
by inhibiting DAT (Heikkila et al., 1975; Ritz et al., 1987). DAT-deficient mice, however, still show 
cocaine-induced increase in dopamine levels and can still learn drug self-administration, which is 
thought to be due to blockade of dopamine re-uptake via serotonin and noradrenaline 
transporters (Rocha et al., 1998; Rocha, 2003). However, this is likely to be a compensatory 
mechanism in these knockout mice, since mice expressing a cocaine-insensitive form of DAT do 
not show cocaine-induced increase in extracellular dopamine, do not develop cocaine reward 
(Chen et al., 2006) or self-administration (Thomsen et al., 2009), and do not express cocaine-
induced synaptic plasticity (Brown et al., 2010). This suggests that blockade of DAT is cocaine’s 
principle mechanism of action. Contrastingly, amphetamine and methamphetamine increase 
dopamine release predominantly by reversing DAT and causing vesicular release of dopamine by 
acting as a substrate for VMAT2 (Ritz et al., 1987; Schuldiner et al., 1993; Pifl et al., 1995; Self and 
Nestler, 1995; Jones et al., 1998; Schmitz et al., 2001; Sulzer et al., 2005).  
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1.4. Functional studies on DRN/vlPAG dopamine neurons 
Very few studies have sought to identify a functional role for the DRN/vlPAG dopamine neurons.  
However, selective 6-OHDA lesions of this region have implicated this population in a number of 
distinct processes. 
1.4.1. Promoting arousal in the sleep-wake cycle 
The DRN/vlPAG dopamine neurons have been suggested to play a role in maintaining 
wakefulness in the sleep-wake cycle (Lu et al., 2006). These neurons were shown to express c-
Fos exclusively during wakefulness, and selective 6-OHDA lesion caused a 20% increase in total 
sleep (Lu et al., 2006), which is substantial when compared to the effect of lesions in other brain 
regions (Wenk et al., 1994; Hara et al., 2001). Contrastingly, the firing activity (Trulson et al., 
1981; Miller et al., 1983; Trulson and Preussler, 1984) and c-Fos expression (Lu et al., 2006) of 
VTA dopamine neurons does not correlate with the sleep-wake cycle. VTA dopamine neurons 
also lack a projection to the VLPO (a region which is critically involved in sleep regulation; Chou 
et al., 2002), and selective VTA lesion causes a decrease, not an increase, in total sleep time (Lai 
et al., 1999; Lu et al., 2006).  
These results indicate a distinct role for DRN/vlPAG dopamine neurons, based on both 
connectivity and function. This view, however, is still the subject of controversy, as conflicting 
results have been obtained for the VTA and DRN/vlPAG, and there is also evidence that 
midbrain dopamine neurons participate in the regulation of paradoxical/REM sleep (Monti and 
Monti, 2007). Specifically, Leger et al. did not observe a substantial increase in c-Fos expression 
in DRN/vlPAG or VTA dopamine neurons following a manipulation that increased wakefulness or 
paradoxical sleep deprivation (Leger et al., 2010). Additionally, others propose that VTA 
dopamine neurons switch to a prominent burst firing pattern during paradoxical sleep (Dahan et 
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al., 2007), which is associated with increased dopamine release in the NAc and mPFC (Lena et 
al., 2005).  
1.4.2. Opiate-induced antinociception and reward 
PAG dopamine neurons have been implicated in mediating the supraspinal nociceptive properties 
of opiates (Flores et al., 2004; Meyer et al., 2009). 6-OHDA treatment, which selectively affects 
large DRN/vlPAG dopamine neurons and depletes PAG dopamine by ∼80%, reduces opiate-
induced analgesia as measured using the hot-plate test (Flores et al., 2004). Infusion of a D1-, but 
not a D2-receptor antagonist into the PAG attenuates opiate-induced analgesia, suggesting that 
this antinociceptive effect is mediated by dopamine acting on local D1-receptors (Flores et al., 
2004). Furthermore, these effects are specific to the PAG, as a D1-receptor antagonist had no 
effect on antinociception when infused outside the PAG (Flores et al., 2004). Basal nociception, 
however, is unaffected by lesion of the PAG dopamine neurons, suggesting direct modulation of 
these neurons by exogenous opiates (Flores et al., 2004; Meyer et al., 2009). 
Another study examining the PAG dopamine neurons found that 6-OHDA lesion of these neurons 
(and the neighbouring RLi) significantly attenuated the rewarding and sensitizing properties of 
heroin, shown by a lack of conditioned place preference (CPP; a behavioural task in which an 
animal learns to associate a physical environment with a drug experience) or locomotor 
sensitisation on repeated exposure (Flores et al., 2006). Repeated heroin administration also 
upregulated TH levels in PAG dopamine neurons (Flores et al., 2006), similar to the VTA (Beitner-
Johnson and Nestler, 1991). In contrast to the effects of antinociception, a D2- but not a D1-
receptor antagonist in the PAG/RLi, blocked heroin-induced reward, suggesting a different 
mechanism of action for PAG-mediated reward-related behaviour (Flores et al., 2006). This 
function is reminiscent of the VTA, in terms of mediating the effects of addictive drugs, which 
suggests the possibility of some functional overlap between the two populations. 
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1.5. Drug addiction and neuroplasticity in the midbrain dopamine system 
1.5.1. The burden of drug addiction  
Drug addiction is a chronic neuropsychiatric disorder, characterised by compulsive drug use 
despite aversive consequences and a propensity to relapse during abstinence (Mendelson and 
Mello, 1996; American Psychiatric Association [DSM-IV], 2000). It represents a substantial global 
public health problem and a huge burden to society, with the total cost exceeding $600 billion 
annually in the United States, based on medical costs, criminal damage, incarceration, accidents, 
and loss of employment (Uhl and Grow, 2004; Volkow and Li, 2005; Robison and Nestler, 2011; 
Volkow et al., 2011). This includes ∼$280 billion for illegal drugs, ∼$185 billion for alcohol, and 
∼$158 billion for nicotine (Volkow and Li, 2005). More recently, European estimates in 2010 
covering addiction to alcohol, opioid drugs, and cannabis, suggest a total annual cost of €65,684 
million across 30 European countries (Gustavsson et al., 2011). Although the economic cost is 
astounding, it does not reflect the huge emotional cost of drug addiction on the individual, their 
family, friends, and wider society. Moreover, these figures do not include the cost of non-drug 
addictions, such as pathological gambling and food addiction, which have recently been 
recognised as addictive disorders, with similar neurobiological substrates, and physiological and 
behavioural manifestations to those of addictive drugs (Potenza, 2008; Frascella et al., 2010; 
Grant et al., 2010; Holden, 2010; Kenny, 2011). The huge social and economic burden of drug 
addiction is not least attributable to the high proportion of the population that are classified as 
drug dependent or abusing psychoactive substances, estimated at 9.1% of the total population 
over 12 years old in the US (Wright et al., 2007). 
The high relapse rate among drug abusers is a major clinical problem, and represents the main 
challenge to the management and treatment of drug addiction (Aguilar et al., 2009). Intense 
craving and relapse is frequently observed in addicts, even after decades of abstinence, often 
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triggered by exposure to drug-related environmental stimuli or stress (O'Brien, 1997; el-Guebaly 
and Hodgins, 1998; De Wit, 2000). While there are a number of types of anti-craving medication 
currently in use (e.g., naltrexone for alcoholism, bupropion for nicotine, and methadone for 
heroin; van den Brink and van Ree, 2003) these treatments are limited in their efficacy and have 
significant side-effects. Additionally, at present, there are no effective medications available for 
the treatment of psychostimulant addiction (Gorelick and Gardner, 2004; Vocci and Ling, 2005; 
Karila et al., 2008). The substantial disruption to normal behaviour in addicted individuals is due 
to the impact of chronic drug intake on multiple neuronal circuits, and is suggestive of long-term 
changes in neural circuitry (Nestler, 2004). This emphasises the definition of addiction as a 
chronic relapsing disease (Volkow et al., 2011), and highlights the need for a deeper 
understanding of the underlying neural actions of addictive drugs, in order to identify novel 
targets for treating addictive disorders (O’Brien and Gardner, 2005; Robison and Nestler, 2011). 
1.5.2. Drug-induced synaptic plasticity 
Synapses represent the fundamental information-processing unit in the brain and are diverse in 
shape and properties. Synaptic dysfunction is implicated in nearly all neuropsychiatric disorders, 
therefore examining the role of synapses in disease is an essential focus for research and drug 
development (Sudhof and Malenka, 2008).  
Synapses can display activity-dependent plasticity, which is revealed as strengthening (long-
term potentiation; LTP) or weakening (long-term depression; LTD) of a synaptic connection 
(Sudhof and Malenka, 2008). This plasticity is a ubiquitous, basic property of excitatory synapses 
in the brain, which is essential for learning and memory as well as other brain functions 
(Malenka and Bear, 2004). Drugs of abuse are able to hijack synaptic plasticity mechanisms in 
the reward circuitry of the brain, and this is thought to create powerful and enduring memories 
relating to the drug experience, which forms the neural basis of addiction (Hyman et al., 2006; 
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Kauer and Malenka, 2007). Numerous and complex neuroadaptations occur in response to 
drugs of abuse, but glutamatergic synapses onto dopamine neurons in the VTA have been 
particularly intensively studied (Kauer, 2004; Thomas et al., 2008).  
Glutamatergic afferents are the major source of fast excitatory input to VTA dopamine neurons, 
via glutamate acting on postsynaptic ionotrophic α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA) and N-methyl-D-aspartic acid (NMDA) receptors located on neuronal cell 
bodies and dendrites (Mereu et al., 1991; Albin et al., 1992; Martin et al., 1993; Wang and 
French, 1993a,b; Wang and French, 1995; Paquet et al., 1997). Activation of AMPA or NMDARs 
in the VTA increases neuronal firing (Grace and Bunney, 1984b; Johnson et al., 1992; Suaud-
Chagny et al., 1992; Chergui et al., 1993; Murase et al., 1993; Wang and French, 1993a,b) and 
therefore increases dopamine release in target regions (Grenhoff et al., 1988; Suaud-Chagny et 
al., 1992; Karreman et al., 1996; Westerink et al., 1996; Westerink et al., 1998, Floresco et al., 
2003). AMPARs are permeable to Na+ and K+ ions, and contribute to the majority of excitatory 
current when the postsynaptic neuron is near its resting membrane potential. In contrast, 
NMDARs are also permeable to Ca2+ and are voltage-dependent, requiring sufficient 
depolarisation of the postsynaptic membrane to remove the Mg2+ ion which blocks the ion pore 
at rest (Mayer et al., 1984; Nowak et al., 1984). NMDAR activation is particularly important in 
the switch from tonic to phasic burst firing in vivo (Grenhoff et al., 1988; Svensson and Tung, 
1989; Charléty et al., 1991; Johnson et al., 1992; Chergui et al., 1993; Tong et al., 1996b; White, 
1996; Overton and Clark, 1997; Lokwan et al., 2000; Mathon et al., 2003; Kuznetsov et al., 2006; 
Lodge and Grace, 2006; Zweifel et al., 2009), which results in a significant increase in dopamine 
release (Forster and Blaha, 2000; Sombers et al., 2009). NMDARs are also thought to be crucially 
involved in some forms of synaptic plasticity (Malenka and Nicoll, 1999) including those that 
occur in response to drugs of abuse (Kauer, 2004).  
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1.5.3. Cocaine-induced plasticity at glutamatergic synapses in the VTA 
Following a single dose of cocaine, there is potentiation of AMPAR transmission at glutamatergic 
synapses onto VTA dopamine neurons (Ungless et al., 2001). This occurs within 2-3 hours of 
drug exposure (Argilli et al., 2008) and is prevented by co-administration of an NMDAR 
antagonist (Ungless et al., 2001), which is reminiscent of NMDAR-dependent LTP (Nicoll et al., 
1988; Malenka 1991; Malenka and Nicoll, 1993; Bonci and Malenka, 1999; Liu et al., 2005; Luu 
and Malenka, 2008). The potentiation persists for at least 5, but no more than 10, days following 
an acute drug dose (Ungless et al., 2001), even after multiple noncontingent injections (Borgland 
et al., 2004). Importantly, LTP-like potentiation at these glutamatergic synapses can also be 
induced by other addictive drugs including nicotine, alcohol, amphetamine, benzodiazepines, 
and morphine (Saal et al., 2003; Faleiro et al., 2004; Heikkinen et al., 2009; Tan et al., 2010), but 
not by non-addictive psychoactive compounds, such as fluoxetine or carbamazepine, suggesting 
that this synaptic potentiation is related to the addictive qualities of the drug (Saal et al., 2003). 
Additionally, acute stress, such as cold water swim or formalin injection, has been shown to 
potentiate these synapses (Saal et al., 2003; Lammel et al., 2011).  
Recently, it was demonstrated by Lammel et al. that this potentiation is projection-specific. In 
particular, cocaine-induced potentiation only occurs at synapses onto dopamine neurons 
projecting to the NAc lateral and medial shell, but not those projecting to the dorsal striatum or 
mPFC (Lammel et al., 2011). Contrastingly, an aversive stimulus selectively potentiates synapses 
onto mPFC- and NAc lateral shell-projecting dopamine neurons, without affecting those 
projecting to the NAc medial shell or dorsal striatum (Lammel et al., 2011). Furthermore, 
dopamine neurons projecting to the NAc medial shell, showed more enduring cocaine-induced 
potentiation, lasting for at least 21 days after the single cocaine dose (Lammel et al., 2011). This 
selective synaptic modification indicates that separate subsets of dopamine neurons, integrated 
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into distinct neural circuits, are involved in processing different types of motivationally-relevant 
cue.  
1.5.3.1. Induction 
Initially, cocaine transiently enhances NMDAR transmission due to increased extracellular 
dopamine acting on postsynaptic D5-receptors and activating the PKA pathway, which causes 
increased insertion of NMDARs onto the postsynaptic membrane (Schilstrom et al., 2006; Argilli 
et al., 2008). The activation of postsynaptic NMDARs, and subsequent Ca2+ entry, is then 
essential to activate appropriate downstream signalling cascades in the dopamine neuron, 
which involves several protein kinases and results in protein synthesis (Bellone and Lüscher, 
2006; Argilli et al., 2008). Activation of VTA dopamine neurons alone is sufficient to induce this 
plasticity, when paired with spontaneous activity, as demonstrated by bath application of 
cocaine to VTA slices (Argilli et al., 2008) and selective optogenetic stimulation of burst firing in 
dopamine neurons (Brown et al., 2010). 
This strengthening of AMPAR transmission is indicative of synapses in a potentiated state, which 
does not only occlude further induction of activity-dependent LTP (Ungless et al., 2001; Liu et 
al., 2005; Argilli et al., 2008; Luu and Malenka, 2008), but actually changes the rules governing 
induction of plasticity at these synapses (Mameli et al., 2011). Specifically, a spike-timing 
dependent protocol, which involves depolarisation of dopamine neurons, is no longer able to 
induce NMDAR-dependent LTP in slices from cocaine-treated animals (Ungless et al., 2001; 
Argilli et al., 2008; Luu and Malenka, 2008). However, a protocol combining afferent stimulation 
with hyperpolarisation of the dopamine neuron elicits significant LTP in cocaine-treated, but not 
saline-treated mice (Mameli et al., 2011).  
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1.5.3.2. Postsynaptic expression 
Cocaine-induced AMPAR potentiation is associated with increased insertion of GluR2-lacking 
AMPARs, which display a characteristic inwardly rectifying I-V relationship (i.e. passing less 
current at positive potentials than at the corresponding negative potentials; Bellone and 
Lüscher, 2006; Isaac et al., 2007; Liu and Zukin, 2007; Mameli et al., 2007; Argilli et al., 2008; 
Brown et al., 2010; Good and Lupica, 2010). AMPARs which lack the GluR2 subunit have greater 
single channel conductance than GluR2-containing AMPARs (Liu and Zukin, 2007) and are Ca2+-
permeable, which allows entry of Ca2+ into the neuron, and initiation of Ca2+-dependent 
intracellular signalling cascades (Kauer and Malenka, 2007). AMPAR trafficking in response to 
cocaine is thought to result in an exchange of GluR2-containing receptors for GluR2-lacking 
receptors, without a significant change in receptor number (Lüscher and Malenka, 2011), and 
hence causes a rapid change in the quality of synaptic transmission at these synapses. However, 
not all studies have reported this drug-induced change in AMPAR rectification (e.g., Faleiro et 
al., 2004; Dong et al., 2004), which may be due to methodological differences.  
Cocaine-induced synaptic potentiation was first clearly demonstrated by an increase in the ratio 
of evoked postsynaptic AMPAR- to NMDAR-mediated current, known as the AMPAR:NMDAR 
ratio (Ungless et al., 2001). Since bath application of exogenous AMPA, but not NMDA, 
increased the evoked current in animals that had received cocaine, this was interpreted solely as 
a change in AMPAR transmission (Ungless et al., 2001). However, by measuring unitary EPSCs 
from single synapses, using 2-photon laser photolysis of caged glutamate, it has recently been 
demonstrated that there is a concomitant reduction in NMDAR-transmission (Mameli et al., 
2011). This occurs at the same synapses which show an increase in the rectification of the 
AMPAR current, suggesting synapse-specific modulation by cocaine (Mameli et al., 2011). A 
reduction in NMDAR-mediated current would account for the observation that there is an 
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increase in the AMPAR:NMDAR ratio in dopamine neurons from cocaine-treated animals, even 
though AMPARs lacking the GluR2 subunit pass relatively little current at positive potentials. 
1.5.3.3. Reversal 
It has been demonstrated that activation of metabotropic (m)GluR1-receptors in the VTA can 
induce LTD (Bellone and Lüscher, 2005), which is necessary for the reversal of cocaine-induced 
potentiation about a week following exposure (Bellone and Lüscher, 2006; Mameli et al., 2009). 
This mGluR-dependent LTD requires GluR2-lacking AMPARs at the synapse, and causes 
replacement of these AMPARs with GluR2-containing receptors, thereby de-potentiating the 
synapse back to its basal state (Bellone and Lüscher, 2006; Mameli et al., 2007; Good and 
Lupica, 2010).  
1.5.4. Other reward-related stimuli induce plasticity at glutamatergic synapses in the VTA 
Interestingly, natural reward-related learning has also been shown to induce NMDAR-
dependent potentiation of AMPAR transmission in VTA dopamine neurons (Stuber et al., 2008), 
which is similarly persistent to that of an acute dose of cocaine (Chen et al., 2008; Stuber et al., 
2008). This supports the notion that addictive drugs hijack the neural circuitry that processes 
motivationally-relevant cues (Bowers et al., 2010). Conversely, however, voluntary cocaine self-
administration, rather than passive administration, can induce LTP-like potentiation at 
glutamatergic synapses that persists for up to 3 months following the final drug exposure (Chen 
et al., 2008). This potentiation, therefore, is possibly mediated not just by the pharmacological 
actions of the drug, but also by an active learning mechanism related to cocaine intake in 
animals which show learned associative behaviour (Chen et al., 2008; Bowers et al., 2010). 
Furthermore, potentiation following self-administration persists even after drug-seeking 
behaviour is extinguished (Chen et al., 2008), but this is not a feature of potentiation in response 
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to natural rewards, which is extinguished following acquisition of these behaviours (Pan et al., 
2008). This resilient cocaine-induced synaptic potentiation may underlie the enduring ‘memory’ 
associated with drug use, which can facilitate reinstatement of drug-seeking behaviour, often 
seen following long periods of abstinence (Nestler, 2001). It may also promote maladaptive 
behaviour, through aberrant assignment of value to drug-related cues, encouraging behaviours 
associated with drug-use, and attenuating response and behaviours related to other salient 
stimuli (Kalivas and O’Brien, 2008). 
1.5.5. Importance of drug-induced plasticity in VTA dopamine neurons 
Drug-induced synaptic plasticity in the VTA may represent a transient, early neuroadaptation in 
the response to addictive drugs, but it is thought to be important for CPP and behavioural 
sensitization (Kalivas and Alesdatter, 1993; Wolf and Jeziorski, 1993; Vezina and Queen, 2000; 
Harris and Aston-Jones, 2003; Borgland et al., 2004). Given the importance of glutamatergic 
afferents onto dopamine neurons in the control over phasic burst firing, strengthening this 
excitatory input will have consequences for the firing activity of dopamine neurons, and hence 
dopamine release in target regions. Consistent with this, cocaine-induced potentiation is essential 
for the induction of plasticity at glutamatergic synapses in the downstream NAc, which is known to 
express more enduring drug-induced plasticity following chronic exposure (Boudreau and Wolf, 
2005; Kourrich et al., 2007; Conrad et al., 2008; Mameli et al., 2009). These changes are thought to 
be critical in mediating the long-term behavioural changes seen in drug addiction (Kauer and 
Malenka, 2007; Thomas et al., 2008) and may underlie the development of persistent memories 
associated with the reinforcing properties of the drug experience (Hyman et al., 2006; Kauer and 
Malenka, 2007). Hence, drug-induced strengthening of glutamatergic synapses onto VTA 
dopamine neurons is an early critical step, which may ultimately trigger remodelling of the brain 
reward circuitry and the development of addiction (Mameli et al., 2009). 
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While the mesocorticolimbic dopamine system is essential for the induction of addiction, many 
chronic aspects of addiction are thought to be dopamine-independent (Wolf, 1998). 
Nevertheless, understanding the early stages in the process of addiction is important for 
developing targeted therapeutic interventions. Furthermore, dopamine is also thought to play a 
key role in drug-induced relapse (Kalivas and McFarland, 2003; Phillips et al., 2003), which is an 
important stage in the treatment of drug addiction. Several pharmacological agents, which 
manipulate dopamine transmission, either by acting on dopamine receptors or the dopamine 
transporter, have yielded promising results in treating psychostimulant addiction (Xi and 
Gardner, 2008). This indicates that the dopamine system could be a key target for 
pharmacotherapies to treat addiction-related behaviours, and highlights the importance of fully 
understanding this system and the changes it undergoes following exposure to drugs of abuse.  
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1.6. Project overview 
Midbrain dopamine neurons display considerable heterogeneity with regard to their molecular, 
electrophysiological, and functional properties. Only relatively recently, with much wider sampling 
of the VTA population, have these differences clearly been revealed. The DRN/vlPAG dopamine 
neurons are an understudied component of the midbrain dopamine system. This is likely to be 
because of their small size and number, relative to the VTA population, and also because they are 
housed within a large serotonergic population. This has hindered the targeting of these neurons in 
vitro and in vivo, and therefore no studies have reported their electrophysiological properties. 
However, these neurons provide the majority of the dopaminergic input to the central amygdala 
and BNST, and they have been implicated in promoting arousal and mediating the effects of 
opiates. Therefore, they are likely to be an important functional subgroup. I sought to characterise 
the neurochemical and electrophysiological properties of the DRN/vlPAG dopamine neurons, and 
examine the ability of cocaine to induce synaptic plasticity.  
To overcome the difficulty in targeting these neurons, I utilised two lines of transgenic mice 
expressing GFP in dopamine neurons: TH-GFP and Pitx3-GFP. In chapter 2 I have described the 
neurochemical features of the DRN/vlPAG dopamine neurons using immunohistochemistry, and 
compared the suitability of the GFP signal in TH-GFP and Pitx3-GFP mice for designating this 
population. I found that the majority of GFP+ neurons are TH+ in both mouse models, and 
additionally noted co-expression of vasoactive intestinal peptide (VIP) in the small periaqueductal 
subset of dopamine neurons. In chapter 3 I explored the electrophysiological properties of these 
dopamine neurons, using whole-cell patch-clamp in an acute brain slice preparation ex vivo. I 
focused, in particular, on their firing characteristics in current clamp, and their response to 
depolarisation and hyperpolarisation. The DRN/vlPAG dopamine neurons displayed similar 
properties to ‘unconventional’ VTA dopamine neurons, and post-hoc identification of recorded 
47 
 
neurons revealed that VIP+ neurons fire in a more irregular pattern and exhibit a larger Ih than VIP- 
neurons. Importantly, however, I found no differences between identified TH+ and TH- GFP+ 
neurons, or between neurons recorded in TH-GFP and Pitx3-GFP mice. I next recorded 
spontaneous and evoked synaptic currents, which are described in chapter 4. Specifically, I 
compared glutamatergic and GABAergic currents in DRN/vlPAG dopamine neurons identified as 
VIP+ or VIP- and TH+ and TH-. In chapter 5, I studied the effect of a single dose of cocaine on the 
AMPAR:NMDAR ratio. Unexpectedly, I found that a single dose of cocaine, or just 24 hours of 
social isolation, causes an increase in the AMPAR:NMDAR ratio in DRN/vlPAG dopamine neurons. I 
examined the characteristics of this plasticity in chapter 6, focusing particularly on changes in 
AMPAR transmission. I found that both cocaine- and social isolation-induced plasticity appear to 
be associated with a change in the AMPAR subunit composition, similar to cocaine-induced 
plasticity in the VTA. Finally, in chapter 7, I addressed the hypothesis that this may be a form of 
anxiety-induced plasticity, by assaying behaviour in the open field test and examining the effect of 
diazepam on synaptic strength. I also tested whether diazepam or ketamine could prevent social 
isolation-induced potentiation in DRN/vlPAG dopamine neurons. These findings are discussed in 
chapter 8, in relation to the functional implications of this plasticity for downstream projection 
targets, the significance of VIP co-expression, the clinical relevance of the results, and future 
experiments that would complement this work. 
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Chapter 2. Characterisation of DRN/vlPAG dopamine neurons: 
immunohistochemistry 
 
2.1. Introduction 
Dopamine neurons in the DRN/vlPAG are scattered in amongst many other neuronal types 
(Kohler and Steinbusch, 1982; Jacobs and Azmitia, 1992; Fu et al., 2010). They are also not the 
most abundant population, with estimates suggesting that around two-thirds of all neurons in 
the DRN are serotonergic (Molliver, 1987; Jacobs and Azmitia, 1992). This suggests that 
unguided patching within this region is unlikely to yield a high number of dopaminergic neurons. 
Indeed, in spite of wide sampling in the DRN/vlPAG (e.g. Allers and Sharp, 2003), only one 
confirmed dopamine neuron has been recorded in vivo (Schweimer and Ungless, 2010). 
Therefore utilising mice which express Green Fluorescent Protein (GFP; Chalfie et al., 1994) 
selectively in dopamine neurons is likely to be the most efficient method for targeting the 
dopaminergic population in the DRN/vlPAG. GFP mice are now frequently used in an attempt to 
improve the efficiency of electrophysiological recordings, and they have proved useful for 
targeted electrophysiological recordings in the VTA (e.g. Labouebe et al., 2007; Mameli et al., 
2009). 
2.1.1. GFP mouse models 
Two lines of transgenic mice, in particular – Pitx3-GFP and TH-GFP – have been generated to 
selectively express GFP in dopamine neurons, and have both been successfully used to conduct 
targeted recordings from the VTA in brain slices (e.g., Labouebe et al., 2007; Zhang et al., 2010). 
This suggests that they may also be suitable for targeting the DRN/vlPAG population. 
Preliminary work by Antonios Dougalis (a former postdoc in Mark Ungless’s laboratory) in Pitx3-
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GFP mice found that the GFP signal is relatively weak, and he showed with a small sample of 
recorded DRN/vlPAG neurons that most, but not all, GFP+ neurons were TH+. This indicated that 
a more extensive quantitative and qualitative analysis was required to determine the suitability 
of Pitx3-GFP mice for targeting these dopamine neurons, along with the use of TH-GFP mice for 
comparison. 
2.1.1.1. Pitx3-GFP mice 
In Pitx3-GFP mice, GFP is inserted into the Pitx3 locus, resulting in Pitx3-directed GFP expression 
(Zhao et al., 2004). Pitx3 is a paired-like homeobox transcription factor which is functionally 
required for dopamine neuron development and maintenance (Semina et al., 2000; Rieger et al., 
2001; Hwang et al., 2003; Nunes et al., 2003; van den Munckhof et al., 2003), and is expressed 
exclusively in midbrain dopamine neurons (Smidt et al., 1997). In Pitx3-GFP mice there is almost 
complete overlap between GFP and TH expression in the VTA and SNc (Zhao et al., 2004). Not 
only are the vast majority of GFP+ cells TH+ (99% in the SNc, 95% in the VTA), but also nearly all 
TH+ cells in this region are GFP+ (98% in the SNc and 95% in the VTA; Zhao et al., 2004), 
indicating high expression efficiency. It is noted that Pitx3 (Smidt et al., 1997), and therefore 
Pitx3-directed GFP expression (Zhao et al., 2004), is restricted to dopaminergic neurons of the 
ventral midbrain (VTA and SNc), and is not expressed by other dopaminergic populations. The 
DRN/vlPAG was not examined by Zhao et al. and therefore it remains to be established whether 
Pitx3 is expressed throughout this population, and whether the Pitx3-GFP mouse line is an 
appropriate tool for the purposes of this study.  
2.1.1.2. TH-GFP mice 
In TH-GFP mice, GFP is under the control of the TH promoter (Sawamoto et al., 2001; 
Matsushita et al., 2002). As TH is the rate-limiting enzyme in catecholamine synthesis (Levitt et 
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al., 1965) this results in GFP expression in midbrain and non-midbrain dopamine populations, as 
well as noradrenergic and adrenergic cell groups in the hindbrain and posterior hindbrain 
(Sawamoto et al., 2001; Matsushita et al., 2002). Although the proportions are slightly lower 
than in Pitx3-GFP mice, the majority of GFP+ cells in the midbrain are TH+ in these mice (93% in 
the SNc, 92% in the VTA; Matsushita et al., 2002). Similarly, most TH+ neurons express GFP (94% 
in the SNc, 85% in the VTA; Matsushita et al., 2002), demonstrating high expression efficiency in 
these transgenic mice. However, as in Pitx3-GFP mice, the overlap in the DRN/vlPAG population 
has not been specifically examined. 
Even though both of these mouse models display impressive overlap between GFP and TH in the 
VTA/SNc, and have both been used to target dopamine neurons in these regions in brain slices 
(e.g., Mameli et al., 2009; Zhang et al., 2010), it is unknown whether this also applies to 
dopamine neurons in the DRN/vlPAG. This will be essential for accurate targeting of this 
dopamine population, and so quantification of GFP/TH co-expression in the DRN/vlPAG is 
required. 
2.1.2. Molecular markers of dopamine neurons 
2.1.2.1. TH expression 
The most consistently used marker for identifying midbrain dopamine neurons is the presence 
of TH, the rate-limiting enzyme in catecholamine synthesis (Levitt et al., 1965). In the VTA/SNc, 
TH-expressing neurons lack the enzyme dopamine-β-hydroxylase (DBH), so cannot synthesise 
noradrenaline, and therefore the presence of TH can reliably identify dopamine neurons in this 
region. DRN/vlPAG dopamine neurons are similarly TH+ and DBH-, indicating their dopaminergic 
rather than noradrenergic phenotype (Swanson and Hartman, 1975; Nagatsu et al., 1979; 
Miachon et al., 1984; Flores et al., 2004). In some brain regions, however, there are reports of 
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TH+ neurons which do not appear to produce catecholamines (Meredith et al., 1999; Weihe et 
al., 2006). Conversely, the absence of TH is not always a definitive indicator of a non-dopamine 
neuron, as TH levels can be dynamically regulated within neurons (Liu and Baker, 1999; 
Chevalier et al., 2008; Akiba et al., 2009), while certain intracellular solutions can cause ‘wash-
out’ of intracellular contents during recordings, preventing detection of TH (Margolis et al., 
2010; Zhang et al., 2010). Additionally, it has been suggested that TH is efficiently transported to 
the terminals of some dopamine neurons, rendering TH levels in the somatodendritic regions 
undetectable with immunohistochemistry (Frain and Leviel, 1998). Therefore TH expression 
should be interpreted with caution, but it is currently the best indicator of dopaminergic 
phenotype in the ventral midbrain (Björklund and Dunnett, 2007b).  
2.1.2.2. AADC and DAT expression 
In order to assess the suitability of these GFP mouse models, the primary marker I have used is 
TH expression in the DRN/vlPAG. However, in addition to this I have examined two other 
molecular markers of dopamine neurons: the enzyme aromatic L-amino acid decarboxylase 
(AADC) and the plasma membrane dopamine transporter (DAT).  
Although TH is the rate-limiting enzyme in dopamine synthesis, AADC is required to catalyse the 
conversion of L-DOPA (the product of the TH reaction) into dopamine. Therefore the presence 
of both proteins indicates that the neuron is fully capable of enzymatically producing dopamine. 
This is important (as mentioned above), since in some regions TH+/AADC- neurons can be 
found, which are not thought to be enzymatically capable of producing dopamine. However, as 
AADC is also required to convert 5-hydroxytryptophan into serotonin, it is not useful as a 
selective marker in regions with a serotonergic population, such as the DRN/vlPAG.  
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DAT mediates uptake of dopamine back into the cell, and its expression is restricted to 
dopamine neurons, particularly those in the ventral midbrain (Augood et al., 1993). DAT 
expression has been used to identify dopamine neurons in brain slices (e.g. Good and Lupica, 
2010). However, the expression pattern of DAT has been shown to vary significantly between 
different subpopulations of VTA dopamine neurons (Lammel et al., 2008). Dopamine neurons 
projecting to the NAc core, NAc medial shell, BLA, and mPFC show significantly lower DAT/TH 
ratio than NAc lateral shell-projecting neurons, which is attributed to lower levels of DAT in 
these neurons (Lammel et al., 2008). Moreover, only 33% of these neurons with a low ratio 
showed levels of DAT that were significantly higher than background (Lammel et al., 2008). This 
suggests that even though DAT has been previously used to identify dopamine neurons and, 
when quantified, it can be a useful indicator of the dopamine uptake capacity of the neuron 
(Lammel et al., 2008), it is likely to yield a considerable number of false negatives if used as a 
dopaminergic marker alone. 
In summary, TH is the most widely accepted molecular marker for dopamine neurons, and (as 
long as it is used in a region that does not contain noradrenergic neurons) provides a selective 
indicator of dopaminergic identity. Other dopaminergic markers, can provide additional useful 
information about the neurons, but are not necessarily the most appropriate indicators of 
neurotransmitter content. For this reason I have used a combination of immunohistochemistry 
for TH, AADC, and DAT, along with markers for other cell types in the DRN/vlPAG, in order to 
provide a well-rounded characterisation of these dopamine neurons, and establish the 
suitability of GFP mice for targeting this population. 
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2.2. Materials and methods 
2.2.1. Animals and breeding 
Male heterozygous TH-GFP (B6.Cg-Tg(TH-GFP)21-31/C57B6; Matsushita et al., 2002) and Pitx3-
GFP (Zhao et al., 2004) mice, aged 1-4 months, were housed under a 12 hour light/dark schedule 
with food and water available ad libitum. TH-GFP mice were originally obtained from Kazuto 
Kobayashi (Department of Molecular Genetics, Fukushima Medical University, Japan) and Pitx3-
GFP mice from Meng Li (MRC Clinical Sciences Centre, Imperial College London, UK). All 
breeding and experimental procedures were conducted in accordance with the Animals 
(Scientific Procedures) Act of 1986 (United Kingdom, UK). TH-GFP mice were bred from 
heterozygous x wildtype (C57BL/6) breeding pairs, generating both heterozygous and wildtype 
offspring. The genotype of TH-GFP mice was confirmed by PCR using primers 5’-
CCTGTGACAGTGGATGCAATTG-3’, 5’-CTTGTACAGCTCGTCCATGCCGAG-3’, 5’-
TGAGCGAGCTCATCAAGATAATCAGGT-3’, and 5’-GTTAGCATTGAGCTGCAAGCGCCGTCT-3’, which 
yielded an internal control fragment of 550 bp in wildtype mice, and an additional fragment of 
1,660 bp in heterozygous mice. Pitx3-GFP mice were produced from homozygous x wildtype 
(C57BL/6) breeding pairs, whose offspring were all heterozygous and therefore did not require 
genotyping. 
2.2.2. Perfusion-fixation and cryostat sectioning 
Mice were given a lethal intraperitoneal (IP) injection of ketamine (KETASET, Willows Francis, 
UK) and xylazine (ROMPUN, Bayer, Germany), then transcardially perfused with 50 ml 
phosphate buffered saline (PBS; 0.1 M, pH 7.4) followed by 80 ml of 4% weight/volume (w/v) 
paraformaldehyde (PFA; Sigma, UK) in PBS. Brains were subsequently removed and post-fixed 
for 1-5 hours in 4% PFA, at 4 °C, then cryoprotected for 24 hours in 30% sucrose in PBS, at 4 °C. 
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They were then embedded in Optimal Cutting Temperature (OCT) medium and frozen in 
isopentane at -50 °C before cryostat sectioning (Leica CM1800, Leica Microsystems, Germany). 
Coronal sections (30 µm thickness) were prepared from the region containing the DRN/vlPAG, 
and also the VTA for comparison. 
2.2.3. Brain slice preparation and fixation 
Mice were sacrificed by isoflurane anaesthesia followed by decapitation. The brain was then 
rapidly removed out of the cranial cavity and submersed in ice-cold (0-4 °C) artificial 
cerebrospinal fluid (aCSF, composition in mM, NaCl 120, KCl 3.5, NaH2PO4 1.25, NaHCO3 26, 
Glucose 10, MgCl2 1, CaCl2 2) fully equilibrated with carbogen gas (95% oxygen, 5% carbon 
dioxide). Two or three coronal brain slices (220 µm thickness) encompassing the DRN/vlPAG 
were obtained using a vibratome (Leica VT1000S, Leica Microsystems, Germany) and 
immediately transferred to 4% PFA for 1 hour at room temperature. 
2.2.4. Immunohistochemistry 
Free-floating 30 µm sections, or 220 µm brain slices, were washed in PBS to remove OCT 
medium or fixative respectively, then blocked in PBS containing 0.2% Triton X-100 (PBS-T) with 
6% normal donkey serum (NDS; Jackson ImmunoResearch, USA) for 30-60 min at room 
temperature. They were then incubated overnight at room temperature in 0.2% PBS-T with 2% 
NDS and appropriate primary antibodies: anti-TH monoclonal chicken antibody (1:1000, Abcam, 
USA), anti-serotonin (5-HT) polyclonal rabbit antibody (1:1000, Immunostar, USA), anti-DAT 
rabbit polyclonal antibody (1:500, Millipore, MA, USA), anti-AADC rabbit antibody (1:1000, 
Millipore, USA), anti-VIP (vasoactive intestinal polypeptide) rabbit antibody (1:500, Immunostar, 
USA). Sections or brain slices were then washed in 0.2% PBS-T and incubated for 1.5-2 hours at 
room temperature in 0.2% PBS-T containing 2% NDS and corresponding secondary antibodies: 
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Alexa 633-conjugated anti-chicken (1:1000, Invitrogen, USA), Cy3-conjugated anti-rabbit 
(1:1000, Jackson ImmunoResearch, USA). Lastly, sections or brain slices were rinsed with 0.2% 
PBS-T, followed by PBS alone, and then mounted onto glass microscope slides. Once dry, 
coverslips were placed over the sections using VectaShield mounting medium (Vector 
Laboratories, USA), for visualisation using confocal microscopy. 
2.2.5. Confocal microscopy 
A Leica SP5 II confocal laser scanning microscope (Leica Microsystems, Germany) was used to 
view the sections, and images were captured using Leica Application Suite software (Leica 
Microsystems, Germany). Sections were viewed through a 20x / 0.7 numerical aperture dry HC 
Plan-Apochromat CS DIC objective, with 1.5x digital zoom applied during image capture (30x 
total magnification). GFP was excited by a 488 nm line of an Argon laser, Cy3 by a 561 nm line of 
a DPSS laser, and AlexaFluor633 by a 633 nm line of a HeNe laser. The pinhole size was set to 1 
Airy unit and an optical slice thickness of 2 μm was used. The signal-to-noise ratio was improved 
by averaging at least six scans for each z-section. Images were taken at a resolution of 1024 x 
1024 and were processed with general brightness and contrast curve adjustments in Adobe 
Photoshop CS5 (Adobe Systems Incorporated).  
2.2.6. Cell counting and statistics 
To quantify overlap between GFP and TH in 30 µm sections, 9 sections containing the 
DRN/vlPAG were counted (3 each from 3 animals) from TH-GFP and Pitx3-GFP mice. For 220 µm 
brain slices, 6 brain slices were counted (1 each from 6 animals) from TH-GFP and Pitx3-GFP 
mice. Overlap between GFP and AADC was quantified in 30 µm sections from TH-GFP mice by 
counts from 9 sections (3 each from 3 animals). Statistical comparisons on the proportion of 
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double-labelled neurons were performed using a chi-squared test in Prism 5.04 (Graphpad, CA, 
USA). 
2.3. Results 
2.3.1. Co-expression of GFP and TH in Pitx3-GFP and TH-GFP mice 
The pattern of expression of TH+ neurons within the DRN/vlPAG of both mouse models was 
identical to that described in previously reports (Hökfelt et al., 1984; Hasue and Shammah-
Lagnado, 2002; Flores et al., 2004; Flores et al., 2006; Lu et al., 2006). I observed both large 
multipolar and small rounded neurons in this region, with the large neurons generally located 
more ventrally and laterally, compared to the small rounded neurons, which were mostly found 
in the midline and close to the ventral surface of the aqueduct of Sylvius. Rostrally, the 
DRN/vlPAG TH+ neurons were continuous with the TH+ neurons of the rostral and caudal linear 
nuclei (RLi and CLi), and extended caudally throughout the vlPAG/DRN, generally in the medial 
portion of this nucleus and ventral to the aqueduct of Sylvius, but with some larger neurons 
residing more laterally, and some smaller neurons spreading up the lateral surface of the 
aqueduct. Most caudally in the DRN, the number of large ventral TH+ neurons diminished, and 
only small periaqueductal neurons remained. 
2.3.1.1. Perfused-fixed sections 
In 30 µm sections from perfused-fixed TH-GFP and Pitx3-GFP mice, the majority of DRN/vlPAG 
GFP+ neurons were TH+ (Fig. 1a,b). I quantified this with cell counts from 9 sections (3 animals, 
3 sections per animal) for each GFP mouse model. This revealed that both models had similar 
proportions of GFP+/TH+ cells (TH-GFP: 74%, 606/823 cells; Pitx3-GFP: 71%, 274/386 cells; chi-
squared = 0.93, p = 0.33). The GFP+/TH- neurons were typically small periaqueductal neurons in 
both Pitx3-GFP and TH-GFP mice. However, given that the GFP signal in TH-GFP mice is under 
57 
 
the control of the TH promoter, it is likely that these small, periaqueductal GFP+/TH- neurons 
are dopaminergic, but TH may be below the detection threshold for immunohistochemistry. 
Consistent with this, lower TH levels in the small, periaqueductal dopamine neurons has been 
previously reported (Hökfelt et al., 1976; Rogers, 1992). Additionally, I observed no TH 
immunostaining if either primary or secondary antibodies were omitted. 
The GFP signal was considerably stronger in TH-GFP compared to Pitx3-GFP mice, with 
significantly higher laser power required during microscopy to visualise the neurons in Pitx3-GFP 
mice. Additionally, although GFP expression in TH-GFP mice was relatively uniform throughout 
the DRN/vlPAG population, in Pitx3-GFP mice expression was particularly strong in small, 
periaqueductal neurons, with weaker, and sometimes absent, expression in the large, more 
ventral and laterally located TH+ neurons. Specifically, in Pitx3-GFP mice, cell counting revealed 
that 40% of TH+ neurons in the DRN/vlPAG were GFP- (183/457 cells) compared with just 10% in 
TH-GFP mice (70/676 cells; chi-squared = 138.6, p < 0.0001). As in the case of the GFP+/TH- 
neurons, this could be a detection issue, particularly given the weaker GFP signal observed in 
Pitx3-GFP mice. However, this does indicate that the GFP expression efficiency is higher in TH-
GFP mice, compared to Pitx3-GFP mice, and the GFP signal appears to be more evenly spread 
across the dopamine population. GFP and TH showed a high rate of co-expression in the VTA 
(Fig. 1c,d) of both mouse models, as previously described (Matsushita et al., 2002; Zhao et al., 
2004), with few GFP+/TH- neurons, or TH+/GFP- neurons. 
2.3.1.2. Brain slices 
I examined the overlap between GFP and TH in 220 µm brain slices containing the DRN/vlPAG. 
These were prepared in the same way as brain slices made for ex vivo electrophysiology, in 
order to confirm that the GFP signal is strong enough in this preparation for visually-guided 
patching, and that TH is still detectable in this region using immunohistochemistry. GFP and TH 
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showed a similar pattern of co-expression in brain slices compared to perfused-fixed sections, in 
both Pitx3-GFP and TH-GFP mice (Fig. 1e,f). Interestingly, a higher proportion of GFP+ neurons in 
the DRN/vlPAG co-expressed TH in brain slices compared to perfused-fixed sections: 83% in TH-
GFP mice (403/485 cells) and 76% in Pitx3-GFP mice (247/325 cells; total counts from 6 brain 
slices for each mouse model, 1 section per animal from 6 animals). This could either be because 
the GFP+/TH- neurons are less likely to survive brainslicing, or because their low levels of TH 
(undetectable in perfusion-fixed sections) are at detection level in brain slices. Similarly, there 
was a lower proportion of TH+/GFP- neurons in both mouse lines, with 9% in TH-GFP (942/445 
cells) and 36% in Pitx3-GFP mice (140/387 cells). This could also be due to the improved ability 
to detect a weak GFP signal in the large TH+ neurons in brain slices, compared to perfused-fixed 
sections.  
In summary, these results indicate that the GFP signal in both mouse models can be used as an 
effective means to target dopamine neurons in the DRN/vlPAG, with TH-GFP mice providing a 
stronger, and perhaps more uniformly spread, GFP signal. 
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Figure 1. Colocalisation of GFP with tyrosine hydroxylase (TH). Examples of 30 µm perfused-
fixed sections from (a,c) a TH-GFP and (b,d) a Pitx3-GFP mouse showing the overlap between 
GFP and TH in the DRN/vlPAG and VTA. Examples of 220 µm brain slices from (e) a TH-GFP and 
(f) a Pitx3-GFP mouse showing the overlap between GFP and TH in the DRN/vlPAG. The GFP 
signal is shown in green and TH in magenta, with selected double-labelled neurons indicated by 
the white arrows. Images shown are single 2 µm thick optical sections captured on a confocal 
microscope through a 20x objective with 1.5x digital zoom applied during image capture. The 
red dotted box marks the region of 3x zoom. Scale bars = 30 µm. 
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2.3.2. Co-expression of GFP with other dopaminergic molecular markers 
2.3.2.1. DAT 
In 30 µm sections from both TH-GFP and Pitx3-GFP mice, DAT was expressed in most large, 
multipolar GFP+ neurons, generally localised to the cell membrane and along neuronal 
processes (Fig. 2a,b). It was not usually observed in the small periaqueductal neurons, which is 
consistent with the observation that the large multipolar dopamine neurons are sensitive to 6-
OHDA, whereas the small periaqueductal neurons are relatively spared following administration 
of this neurotoxin (Flores et al., 2004; Flores et al.,2006; Lu et al., 2006). DAT staining was also 
present in TH+ neurons of the VTA (Fig. 2c,d), suggesting that the lack of expression in small 
periaqueductal DRN/vlPAG neurons, and the generally weaker staining in this region, was not a 
result of the antibody used. 
2.3.2.2. AADC 
I found that in sections from perfused-fixed TH-GFP mice, 72% of GFP+ neurons in the 
DRN/vlPAG co-expressed the enzyme AADC (Fig. 2e,f; TH-GFP mice: 510/704 cells; 3 animals, 3 
sections per animal counted). This is a similar proportion to those which were TH+, suggesting 
that these enzymes are immunohistochemically-detectable in a similar number of GFP+ 
neurons. In addition, as with TH expression, the GFP+/AADC- neurons were generally small 
periaqueductal neurons. AADC is also required for synthesis of 5-HT, therefore I also observed 
many large AADC+, GFP- neurons in the DRN/vlPAG located more ventrally, which are likely to 
be serotonergic (Fig. 2e,f). I also found almost complete co-expression of GFP and AADC in the 
VTA (Fig. 2g,h), confirming the specificity of this antibody. Furthermore, omission of either DAT 
or AADC primary or secondary antibodies resulted in no detectable immunostaining.  
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Figure 2. Colocalisation of GFP with other dopaminergic markers. Examples sections of the 
DRN/vlPAG from (a) a TH-GFP and (b) a Pitx3-GFP mouse showing co-expression of DAT in some 
GFP+ neurons. Example sections of the VTA from (c) a TH-GFP and (d) a Pitx3-GFP mouse 
showing DAT co-expression in the majority of GFP+ neurons. Example sections from (e,g) a TH-
GFP and (f,h) a Pitx3-GFP mouse showing that most GFP+ neurons co-express AADC in the 
DRN/vlPAG and VTA. The GFP signal is shown in green and DAT or AADC in magenta, with 
selected double-labelled neurons indicated by the white arrows. Images shown are single 2 µm 
thick optical sections captured on a confocal microscope through a 20x objective with 1.5x 
digital zoom applied during image capture. The red dotted box marks the region of 3x zoom. 
Scale bars = 30 µm. 
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2.3.3. Co-expression of GFP and TH with other cell types in the DRN/vlPAG 
2.3.3.1. 5-HT 
Consistent with previous reports, numerous large 5-HT+ neurons were present in the DRN, 
overlapping with TH+ neurons mainly in the rostral DRN/vlPAG. 5-HT+ neurons were most 
abundant at the more caudal levels of the DRN, occupying the majority of the medial and 
ventral portion of the nucleus, with many cells also located in the lateral wings. More rostrally, 
5-HT+ neurons were scattered ventrally, overlapping with the large TH+ neurons in this region, 
but less with the small periaqueductal neurons. I found no co-expression of GFP or TH with 5-
HT, at any level of the DRN/vlPAG (Fig. 3a), as previously reported (Fu et al., 2010), and staining 
was absent in the VTA (Fig. 3b). 
2.3.3.2. Vasoactive intestinal peptide (VIP) 
Through studying the immunohistochemical work in the DRN detailed in Fu et al. (2010) I 
noticed that there was a striking similarity between the expression pattern of GFP close to the 
aqueduct and that of the neuropeptide transmitter vasoactive intestinal peptide (VIP; Fu et al., 
2010). I therefore used an antibody against VIP to determine whether this neuropeptide was co-
localised with GFP and TH. I found that all VIP+ neurons in the DRN/vlPAG were GFP+, in both 
mouse models (Fig. 3c), with the majority also co-expressing TH (TH-GFP: 75%, 246/330 cells, 
Pitx3-GFP: 76% 171/224 cells; 3 animals, 3 sections per animal counted). Interestingly, I 
observed increased colocalisation of VIP and TH in 220 µm brain slices (TH-GFP: 87%, 248/286 
cells; Pitx3-GFP: 88%, 203/231 cells), similar to that noted for GFP and TH described previously.  
The distribution of these VIP+ neurons matched that of the small, rounded GFP+ neurons (i.e. 
around the ventral and lateral surface of the aqueduct, and spreading ventrally in midline), and 
was identical to previous descriptions of the expression pattern of this neuropeptide (Sims et al., 
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1980; Marley et al., 1981; Hökfelt et al., 1982; Moss and Basbaum, 1983; Petit et al., 1995; Fu et 
al., 2010). Additionally, I noted co-expression in some GFP+/TH+ neurons in the CLi, but found 
no VIP+ cells in the VTA (Fig. 3d), which suggests that this neuropeptide co-expression is specific 
to more caudal dopaminergic populations. VIP+ neurons constituted 40% of GFP+ neurons in 
TH-GFP mice (330/823 cells) and 58% of GFP+ neurons in Pitx3-GFP mice (224/386 cells; chi 
squared = 34.0, p < 0.0001). This is consistent with the observation that the GFP signal was 
somewhat biased towards the small periaqueductal neurons in Pitx3-GFP mice, with weaker, or 
sometimes absent, expression in the larger more ventral neurons, which are typically VIP-. This 
indicates that GFP-guided patching in Pitx3-GFP mice may yield a slightly greater proportion of 
VIP+ neurons than patching in TH-GFP mice, although both cell types are present.  
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Figure 3. Colocalisation of GFP with markers for other cell types. Example sections of (a) the 
DRN/vlPAG and (b) the VTA, from a TH-GFP mouse, showing 5-HT+ neurons in the DRN/vlPAG, 
but no co-expression with GFP. The GFP signal is shown in green and 5-HT in blue, with selected 
GFP+ neurons indicated by the white arrows. Example sections from (c) the DRN/vlPAG and (d) 
the VTA showing co-expression of VIP in the small periaqueductal GFP+/TH+ neurons, but not in 
the large ventral/lateral neurons of the DRN/vlPAG, or in the VTA. The GFP signal is shown in 
green, TH in magenta, and VIP in red, with selected triple-labelled neurons indicated by the 
white arrows. Images shown are single 2 µm thick optical sections captured on a confocal 
microscope through a 20x objective with 1.5x digital zoom applied during image capture. The 
red dotted box marks the region of 3x zoom. Scale bars = 30 µm. 
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2.4. Conclusion 
I have used immunohistochemistry to examine the expression of GFP and TH in the DRN/vlPAG 
of two lines of transgenic mice, which were generated to selectively express GFP in dopamine 
neurons. Quantification of GFP/TH co-expression in 30 µm sections indicated that TH colocalises 
with the large majority of GFP+ neurons in the DRN/vlPAG of both mouse models, but with 
somewhat lower co-expression than that reported for the VTA (Matsushita et al., 2002; Zhao et 
al., 2004). Furthermore, I found a higher degree of co-expression in 220 µm brain slices, which is 
the primary means by which I will be examining these dopamine neurons. The reason for this is 
not clear. However, it has been observed that TH can be transported out to neuronal terminals 
(Frain and Leviel, 1998), so the severing of these processes during brain slice preparation may 
result in increased accumulation of TH in the soma, resulting in levels detectable with 
immunohistochemistry. 
The GFP signal in TH-GFP mice was more evenly distributed throughout the TH+ population in 
the DRN/vlPAG, whereas there was some bias towards GFP expression in the small, 
periaqueductal TH+ neurons in Pitx3-GFP mice. However, this might be a result of the weak GFP 
expression in this mouse line, because improved overlap was observed in brain slices compared 
to sections. As long as care is taken to sample widely throughout this region, both small 
periaqueductal and large ventral GFP+/TH+ neurons can be located in both mouse models. 
Therefore, although colocalisation of TH and GFP in the DRN/vlPAG was not complete (which is 
a common feature of most GFP mouse models), these results suggest that the GFP signal in 
these transgenic mice can be used to target dopamine neurons in this region for 
electrophysiological recordings, in combination with post-hoc immunohistochemistry. 
Analysis of other dopaminergic molecular markers revealed that AADC colocalised with GFP to a 
similar extent as TH in 30 µm sections. Serotonergic neurons in this region also express AADC, and 
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the signal intensity was often much stronger in these neurons (possibly due to their larger size), 
which often obscured the signal in smaller GFP+ neurons. AADC is not, therefore, the most useful 
indicator of dopaminergic phenotype in this region, although it does suggest that these TH+ 
neurons are enzymatically capable of producing dopamine. DAT expression was generally weaker 
in the DRN/vlPAG dopamine neurons, compared to the VTA, and on the whole was only expressed 
by the large multipolar neurons, with very little observed in the small, rounded neurons. This is 
consistent with previous reports indicating that these two cell types differ in their sensitivity to the 
neurotoxin 6-OHDA, which selectively lesions the large, ventral neurons (Flores et al., 2004; Flores 
et al., 2006; Lu et al., 2006). Based on the pattern of DAT expression I observed, this is likely to be 
due to the lack of the transporter in the small, periaqueductal neurons, which would prevent 
uptake of this neurotoxin (Jonsson and Sachs, 1971; Kostrzewa and Jacobowitz, 1974; Glinka et al., 
1997). Additionally, this may have implications for the decay kinetics of extracellular dopamine, 
since DAT-mediated reuptake is one method of regulating extracellular dopamine levels (Horn, 
1990; Giros et al., 1996), although diffusion of dopamine also plays a major role in this process 
(Cragg and Rice, 2004). 
Previous immunohistochemical studies have confirmed that TH+ neurons in the DRN/vlPAG are 
DBH- (and therefore do not synthesise noradrenaline; Nagatsu et al., 1979; Miachon et al., 1984; 
Lu et al., 2006), and also do not co-express 5-HT (Fu et al., 2010) suggesting that they are a 
distinct population. These findings confirm that 5-HT is not co-expressed in TH+ neurons in this 
region, nor in GFP+ neurons in either mouse model. Furthermore, I have shown that the two cell 
types previously described in the DRN/vlPAG can be distinguished based on the expression of 
VIP. The presence of VIP+ neurons within the DRN/vlPAG has been reported (Sims et al., 1980; 
Marley et al., 1981; Hökfelt et al., 1982; Moss and Basbaum, 1983; Smith et al., 1994), and it has 
been shown that these neurons are neither serotonergic, nor GABAergic (Fu et al., 2010). It has 
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also been previously noted that peptide histidine isoleucine (PHI; a related peptide)/VIP and CCK 
are co-expressed with a limited number of TH+ neurons in periventricular regions and around 
the aqueduct (Seroogy et al., 1988a), but the data presented here suggests significant co-
expression of VIP with DRN/vlPAG dopamine neurons, which may delineate a distinct 
subpopulation. The functional significance of this co-expression remains to be determined, 
although the presumed co-release of dopamine and VIP may have implications for downstream 
projection targets. 
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Chapter 3. Characterisation of DRN/vlPAG dopamine neurons:  
electrophysiology 
 
3.1. Introduction 
The electrophysiological properties of VTA/SNc dopamine neurons have been widely 
documented both in vivo and ex vivo. Electrophysiology has been proposed to be sufficient for 
reliably identifying SNc, and the majority of VTA, dopamine neurons in vivo, by employing 
criteria including action potential waveform, firing rate, and pattern (Ungless and Grace, 2012). 
Ex vivo, however, different criteria can be utilised, partly because most afferent inputs are 
severed in the slice preparation, resulting in a more regular firing pattern (Grace and Onn, 
1989), and additional currents can be assayed using the whole-cell configuration. As discussed in 
chapter 1, there is some inter-species variation in the expression of many of these classically-
used electrophysiological markers, but for the purposes of this study I will focus on the 
properties reported in mice. 
3.1.1. Electrophysiological markers of dopamine neurons 
One frequently used indicator of dopaminergic phenotype is the presence of a prominent 
hyperpolarisation-activated cation current (Ih; Lacey et al., 1989; Johnson and North, 1992a; 
Ungless et al., 2001; Gutlerner et al., 2002; Saal et al., 2003; Borgland et al., 2004; Faleiro et al., 
2004; Bellone and Lüscher, 2006; Margolis et al., 2006a; Argilli et al., 2008; Stuber et al., 2008; 
Zweifel et al., 2008; McCutcheon et al., 2012). However, considerable variation has been 
observed across the VTA dopamine population in terms of the size of the Ih, and it is even absent 
in certain subpopulations (Johnson and North, 1992a; Neuhoff et al., 2002; Liss et al., 2005; Ford 
et al., 2006; Sarti et al., 2007; Lammel et al., 2008; Zhang et al., 2010; Lammel et al., 2011). 
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Other characteristic features of dopamine neuron electrophysiology include their broad action 
potential width, slow firing rate, and prominent afterhyperpolarisation (Sanghera et al., 1984; 
Trulson and Trulson, 1987; Johnson and North, 1992a). However, similar to the Ih, it has been 
shown that dopamine neurons in fact exhibit a broader range of these measures than previously 
thought (Lammel et al., 2008), which emphasises the heterogeneity of this population. Equally, 
the spike-frequency adaptation seen in response to depolarisation, thought to be a consistent 
property of midbrain dopamine neurons, has been shown to vary in different dopamine neuron 
subpopulations (Zhang et al., 2010; Lammel et al., 2011). 
3.1.2. Projection-specific electrophysiological properties 
Differences in the Ih and action potential properties have been associated with projection target 
(Ford et al., 2006; Lammel et al., 2008). Specifically, VTA and SNc dopamine neurons projecting 
to the NAc lateral shell and dorsolateral striatum exhibit a large Ih, low frequency firing, (∼1-3 
Hz), short duration action potential (∼3 ms), large afterhyperpolarisation, and do not sustain 
firing above ∼10 Hz in response to depolarisation (Lammel et al., 2008). In contrast, VTA 
dopamine neurons projecting to the NAc core, NAc medial shell, BLA, and mPFC exhibit a 
considerably smaller Ih (or lack this current), fire, on average, at higher frequencies (∼5 Hz), 
possess a wider action potential (∼4.5-7 ms), smaller afterhyperpolarisation, and display 
significantly higher maximal firing frequencies in response to depolarisation (∼20-30 Hz; 
Lammel et al., 2008; Lammel et al., 2011). Therefore, while ‘classic’ dopamine properties may be 
found in certain subpopulations, there is considerable variability across the whole dopamine 
population.  
Preliminary work, conducted by Antonios Dougalis, in Pitx3-GFP mice suggested that GFP+ 
neurons in the DRN/vlPAG exhibit similar electrophysiological properties to VTA dopamine 
neurons, but distinct from those of putative serotonergic neurons within the same nucleus 
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(Dougalis et al., 2012). I have therefore examined these same properties, but instead focused on 
comparing DRN/vlPAG GFP+ neurons from TH-GFP and Pitx3-GFP mice, as well as 
neurochemically-identified TH+ or TH-, and VIP+ or VIP- neurons. The electrophysiological 
properties assayed include those which have frequently been attributed to midbrain dopamine 
neurons, including action potential waveform, firing pattern, and the Ih.  
3.2. Materials and methods 
3.2.1. Brain slice preparation 
Coronal 220 µm brain slices containing the DRN/vlPAG were prepared from TH-GFP and Pitx3-
GFP mice (aged 1-2.5 months) at 10.00 am, as described in chapter 2. The slices were 
transferred to a custom-made holding bath containing artificial cerebrospinal fluid (aCSF; 
composition in mM, NaCl 120, KCl 3.5, NaH2PO4 1.25, NaHCO3 26, Glucose 10, MgCl2 1, CaCl2 2), 
saturated with carbogen gas (95% oxygen, 5% carbon dioxide), at room temperature. Slices 
were allowed to recover in the holding bath for at least one hour before being transferred to 
the recording chamber for electrophysiology. Once in the recording chamber, slices were 
continuously perfused at a rate of 2-4 ml/min with fully oxygenated aCSF at 32 °C. Neurons were 
visualised under an upright microscope (BXWI 51; Olympus, Tokyo, Japan), equipped with infra-
red (IR) differential interference contrast (DIC) optics and a charge coupled device (CCD) video 
camera (Hamamatsu Photonics, Germany), through a 40x immersion objective. GFP+ neurons 
were identified in the slice, prior to recording (Fig. 4a), using brief fluorescence illumination (X-
cite 120Q, EXFO, UK) through a GFP excitation filter. PatchVision software (Scientifica, UK) was 
used to view IR-DIC and fluorescence images on a standard desktop computer. 
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3.2.2. Whole-cell patch-clamp electrophysiology 
Whole-cell patch-clamp recordings were made using a Multiclamp 700B amplifier (Molecular 
Devices, CA, USA) and Clampex 10.2 software (Molecular Devices, CA, USA). Records were low-
pass filtered at 1 kHz and digitised at 3-5 kHz. Electrodes were pulled from thin-walled 
borosilicate glass capillary tubing (GC150F-10, Harvard Apparatus, UK) using a two-stage vertical 
puller (model PC-10, Narashige). They had resistances of 5-7 MΩ when filled with internal 
solution (composition in mM: potassium gluconate 140, NaCl 5, MgCl2  1, EGTA 1, HEPES 10, Mg-
ATP 2, Li-GTP 0.5, and 0.1% neurobiotin, with pH 7.3 and osmolarity 280-290 mosmol/l.) Series 
resistance (Rs; typical values 15-30 MΩ, compensated by 60-70% in the majority of experiments) 
and input resistance (Rin) were monitored frequently throughout experiments, via a 10 mV, 250 
ms hyperpolarizing step in voltage-clamp or a 10-100 pA current injection in current-clamp. 
Recordings were terminated if Rs exceeded 35 MΩ, if Rin changed more than 20% after achieving 
whole-cell configuration, or if there were any large changes in holding current or noise 
characteristics. Membrane capacitance (Cm) was measured in pClamp (Molecular Devices, CA, 
USA), from the change in membrane charge taken from the integrated capacity transients, using 
a 10 mV, 250 ms step in voltage-clamp at -50 mV. All values quoted here have not been 
corrected for liquid junction potential (estimated as 12.8 mV using the pClamp calculator; 
Neher, 1992). 
3.2.2.1. Current-clamp recordings 
Once whole-cell configuration had been achieved, neurons were recorded in current-clamp 
mode for at least 1-2 min, in order to establish their resting membrane potential (Vm) and action 
potential firing properties. In spontaneously active neurons, the basal action potential firing 
frequency and inter-spike interval (ISI) were determined across the initial 60-120 s of activity. 
The coefficient of variation of the ISI (CV-ISI) was calculated by dividing the standard deviation 
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of the ISI by the mean ISI. Average action potential waveforms were produced using Spike2 
software (Cambridge Electronic Design, UK), from which the action potential threshold (defined 
as a rate of change in membrane potential > 10 mV/ms), amplitude (threshold to peak), width 
(at the level of the threshold), afterhyperpolarisation (AHP) maximum (absolute membrane 
potential at the peak of the AHP), and AHP repolarisation rate (over the first 10 ms following the 
AHP peak) were calculated. Depolarising current steps, (20-100 pA, 5 s duration) were delivered 
every 20 s and the instantaneous and steady-state firing frequencies were calculated over the 
first 100 ms and last 2 s of the current step, respectively. Hyperpolarising current steps (120 pA, 
1 s duration), were delivered every 10 s to activate the Ih. 
3.2.2.2. Voltage-clamp recordings 
Neurons were held at -50 mV in voltage-clamp mode, and a series of 10 mV incremental 
hyperpolarising steps (1 s duration) were delivered up to -120 mV, in order to activate the Ih. 
The amplitude of the Ih was measured as the difference between the peak instantaneous and 
the steady-state current (see Fig. 7b), with the final step to -120 mV producing near complete 
activation of the Ih. The instantaneous current values from this protocol were also used to 
calculate the Rin of the neuron. The peak of the residual current, following termination of the -
120 mV step, was also measured. 
3.2.3. Immunohistochemistry and confocal microscopy 
Following recording, slices were transferred to 4% PFA at room temperature for 1 hour, washed 
in PBS to remove fixative, and blocked in 0.2% Triton PBS-T with 6% NDS (Jackson 
ImmunoResearch, USA) for 30-60 min at room temperature. They were then incubated 
overnight at room temperature in 0.2% PBS-T with 2% NDS and primary antibodies: anti-TH 
monoclonal chicken antibody (1:1000, Abcam, USA) and anti-VIP rabbit antibody (1:500, 
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Immunostar, USA). Brain slices were washed in 0.2% PBS-T and incubated for 1.5-2 hours at 
room temperature in 0.2% PBS-T containing 2% NDS and secondary antibodies: Alexa 633-
conjugated anti-chicken (1:1000, Invitrogen, USA), Cy3-conjugated anti-rabbit (1:1000, Jackson 
ImmunoResearch, USA), and AMCA-conjugated streptavidin (1:1000, Jackson ImmunoResearch, 
USA) to reveal neurobiotin labelling. Lastly, brain slices were rinsed with 0.2% PBS-T, followed 
by PBS alone, and then mounted onto glass microscope slides. Once dry, coverslips were placed 
over the sections using VectaShield mounting medium (Vector Laboratories, USA), for 
visualisation using confocal microscopy. 
A Leica SP5 II confocal laser scanning microscope (Leica Microsystems, Germany) was used to 
view the brain slices, and images were captured using Leica Application Suite software (Leica 
Microsystems, Germany). Slices were viewed through a 20x / 0.7 numerical aperture dry HC 
Plan-Apochromat CS DIC objective, with 2x digital zoom applied during image capture (40x total 
magnification). AMCA was excited by a 405 nm line of a diode laser, GFP by a 488 nm line of an 
Argon laser, Cy3 by a 561 nm line of a DPSS laser, and AlexaFluor633 by a 633 nm line of a HeNe 
laser. The pinhole size was set to 1 Airy unit and an optical slice thickness of 2 μm was used. The 
signal-to-noise ratio was improved by averaging at least six scans for each z-section. Images 
were taken at a resolution of 1024 x 1024 and were processed with general brightness and 
contrast curve adjustments in Adobe Photoshop CS5 (Adobe Systems Incorporated).  
3.2.4. Analysis and statistics 
Recordings were analysed using Clampfit 10.2 (Molecular Devices, CA, USA) unless otherwise 
stated, and values are reported as mean ± standard error of the mean (SEM). Statistical analysis 
was performed using Prism 5.04 (Graphpad, CA, USA). Unpaired t-tests (non-directional), one-
way ANOVA with Newman-Keuls post-hoc tests, two-way ANOVA with Bonferroni post-hoc 
tests, and chi-squared tests were employed where appropriate. 
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3.3. Results 
3.3.1. Single-cell labelling in brain slices 
In these experiments a total of 78 GFP+ neurons were recorded and analysed in the DRN/vlPAG, 
with 59 of these successfully processed with immunohistochemistry for TH. This revealed that a 
similar proportion of recorded GFP+ neurons were TH+ in each mouse line, with 83.3% in TH-
GFP mice (30/36 cells) and 82.6% in Pitx3-GFP mice (19/23 cells; chi-squared = 0.005, p = 0.94). 
These proportions are also consistent with those I obtained when quantifying the overlap 
between GFP and TH in non-recorded cells in brain slices (chapter 2). Additionally, of the 
neurobiotin-filled GFP+ neurons processed for VIP immunolabelling (Fig. 4b), 40.5% were VIP+ in 
TH-GFP mice (15/37 cells) and 52.2% in Pitx3-GFP mice (12/23 cells; chi-squared = 0.78, p = 
0.38). This is again consistent with my counts in brain slices, which suggests that a slightly higher 
proportion of GFP+ neurons co-express VIP in Pitx3-GFP compared with TH-GFP mice.  
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Figure 4. Whole-cell patch-clamp electrophysiology in an ex vivo brain slice preparation. (a)  GFP 
signal, DIC image, and diagrammatic illustration of a neuron targeted with a recording electrode. 
Brain slices were subsequently processed with immunohistochemistry to reveal the 
neurochemical identity of the recorded neuron. (b) Examples of neurobiotin-filled neurons 
confirmed as TH+/VIP+ (upper panels) and TH+/VIP- (lower panels). Neurobiotin is shown in 
blue, TH in green, and VIP in magenta. Images shown are single 2 µm thick optical sections 
captured on a confocal microscope through a 20x objective with 2x digital zoom applied during 
image capture. Scale bars = 30 µm. 
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3.3.2. Action potential properties 
In current-clamp recordings I found that the majority of GFP+ neurons in the DRN/vlPAG fired 
spontaneous action potentials (TH-GFP: 71.4%, Pitx3-GFP: 73.7%; Table 1), with an average 
firing frequency of ∼4 Hz, which is within the range of values reported for VTA dopamine 
neurons (e.g. Johnson and North, 1992a; Neuhoff et al., 2002; Wolfart et al., 2001; Ford et al., 
2006; Lammel et al., 2008; Zhang et al., 2010; Chieng et al., 2011). Neither the proportion of 
spontaneously active cells, nor the average firing frequency differed between TH-GFP and Pitx3-
GFP mice (TH-GFP: 25/35 active; 4.2 ± 0.6 Hz; Pitx3-GFP: 14/19 active, 3.9 ± 0.6 Hz; chi-squared 
= 0.03, p = 0.86; t37 = 0.36, p = 0.72), or between TH+ and TH- neurons (TH+: 27/38 firing; 4.3 ± 
0.6 Hz; TH-: 5/7 firing, 3.6 ± 1.1 Hz; chi-squared = 0.0004, p = 0.98; t30 = 0.45, p = 0.67; Table 1).  
The firing pattern, as indicated by the CV-ISI, was somewhat higher in DRN/vlPAG GFP+ neurons 
(0.48 ± 0.07, n = 39) than values typically reported in the VTA suggesting greater variability in 
the ISI between action potentials, which results in a more irregular firing pattern. There were no 
differences between neurons recorded in TH-GFP and Pitx3-GFP mice (TH-GFP: 0.47 ± 0.06, n = 
25; Pitx3-GFP: 0.48 ± 0.14, n = 14; t37 = 0.08, p = 0.93), or between TH+ and TH- (TH+: 0.48 ± 
0.09, n = 27; TH-: 0.55 ± 0.20, n = 5; t30 = 0.31, p = 0.76) neurons in terms of firing pattern. 
However, I did observe that firing in VIP+ neurons was more irregular than in VIP- neurons, as 
shown by a greater CV-ISI (VIP+: 0.67 ± 0.13, n = 15; VIP- 0.33 ± 0.07, n = 18; t31 = 2.24 p < 0.05; 
Fig. 5a,c, Table 1). This was independent of a difference in the proportion of active cells (VIP+: 
68%, 15/22 cells, VIP-: 75%, 18/24 cells, chi-squared = 0.26, p = 0.61) or the firing frequency 
(VIP+: 3.7 ± 0.8 Hz, n = 15; VIP-: 4.5 ± 0.65 Hz, n = 18; t31 = 0.80, p = 0.43). Differences in the CV-
ISI could be a result of differences in the synaptic inputs of these neurons, or differences in their 
intrinsic excitability due to ion channel expression (Overton and Clark, 1997).  
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An average action potential waveform was generated and analysed for each cell, with the 
different properties shown in Table 1. DRN/vlPAG GFP+ neurons generally fired broad action 
potentials (4.2 ± 0.2 ms, n = 39), with a relatively depolarised threshold (-26.0 ± 1.1 mV), and a 
prominent afterhyperpolarisation (-51.0 ± 1.1 mV, n = 39), which is within the range of most VTA 
dopamine neurons (e.g. Lammel et al., 2008). I found no differences in waveform properties 
between neurons recorded in TH-GFP and Pitx3-GFP mice, between TH+ and TH- neurons, or 
between VIP+ and VIP- neurons (Fig. 5b, Table 1).  
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Property TH-GFP Pitx3-GFP TH+ TH- VIP+ VIP- 
Current-clamp       
Resting potential 
(mV) 
-45.94 ± 1.64 -41.47 ± 2.20 -44.37 ± 1.61 -43.11 ± 2.22 -44.32 ± 2.04 -43.87 ± 1.88 
% spontaneously 
active 
71.4% (25/35) 73.7% (14/19) 71.1% (27/38) 71.4% (5/7) 68.1% (15/22) 75.0% (18/24) 
Firing rate (Hz) 4.2 ± 0.6 3.9 ± 0.6 4.3 ± 0.6 3.6 ± 1.1 3.7 ± 0.8 4.6 ± 0.7 
CV-ISI 0.47 ± 0.6 0.48 ± 0.14 0.48 ± 0.09 0.55 ± 0.20 0.67 ± 0.14 0.33 ± 0.07* 
AP threshold 
(mV) 
-27.04 ± 1.93 -23.27 ± 1.96 -24.33 ± 1.35 -26.42 ± 0.80 -23.31 ± 1.98 -25.86 ± 1.27 
AP amplitude 
(mV) 
56.57 ± 1.69 58.39 ± 1.74 57.88 ± 1.55 58.66 ± 4.22 57.14 ± 2.31 58.76 ± 1.82 
AP width (ms) 3.94 ± 0.21 4.34 ± 0.21 4.03 ± 0.16 4.04 ± 0.52 4.03 ± 0.25 4.03 ± 0.19 
TTP-AHP (ms) 17.01 ± 0.842 17.93 ± 0.69 17.59 ± 0.77 15.69 ± 0.60 16.67 ± 0.72 17.84 ± 1.09 
AHP maximum 
(mV) 
-53.03 ± 1.85 -49.00 ± 2.06 -50.76 ± 1.47 -50.50 ± 1.52 -50.65 ± 2.10 -50.79 ± 1.54 
Repolarisation 
rate (mV/ms) 
0.132 ± 0.010 0.106 ± 0.009 0.121 ± 0.010 0.125 ± 0.014 0.137 ± 0.013 0.110 ± 0.011 
n 35, 25 firing 19, 14 firing 38, 27 firing 7, 5 firing 22,15 firing 24, 18 firing 
Voltage-clamp       
Capacitance (pF) 12.01 ± 0.53 12.25 ± 0.97 12.39 ± 0.66 12.46 ± 0.96 10.87 ± 0.56 13.66 ± 0.88* 
Holding current 
at -50mV (pA) 
-12.78 ± 3.67 -9.49 ± 7.81 -6.87 ± 4.59 -22.96 ± 9.05 -13.41 ± 5.75 -7.14 ± 5.75 
Input resistance 
(MΩ) 
1640.46 ± 
256.63 
1531.50 ± 
264.64 
1750.96 ± 
267.75 
1015.50 ± 
130.60 
1745.16 ± 
410.70 
1522.59 ± 
226.69 
Ih amplitude (pA) 12.07 ± 1.64 10.98 ± 2.10 10.89 ± 1.66 15.53 ± 4.50 19.12 ± 2.80 5.74 ± 0.74* 
Ih residual 
amplitude (pA) 
192.25 ± 22.25 137.60 ± 22.66 177.05 ± 19.00 130.46 ± 24.69 164.28 ± 25.12 172.95 ± 21.08 
n 52 26 49 10 27 33 
 
Table 1: Electrophysiological properties of identified TH+, TH-, VIP+, and VIP- neurons in the 
DRN/vlPAG of TH-GFP and Pitx3-GFP mice. Values quoted are mean ± standard error of the 
mean (SEM). Statistically significant comparisons (p < 0.05) are shown in bold and marked with 
an *. The mean age for each experimental group was 7.5 weeks (VIP+), 7.0 weeks (VIP-), 7.2 
weeks (TH+), 8.0 weeks (TH-), 8.5 weeks (TH-GFP), and 5.6 weeks (Pitx3-GFP). 
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Figure 5. VIP+ and VIP- neurons displayed similar firing properties, apart from a greater CV-ISI in 
VIP+ neurons. Representative examples of (a) spontaneous firing activity and (b) average action 
potential waveform for an identified VIP+ and VIP- neuron. (c) Bar charts showing the mean (+ 
SEM) firing frequency, CV-ISI, and action potential (AP) width for VIP+ and VIP- neurons. * 
indicates p < 0.05. 
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3.3.3. Response to depolarisation and hyperpolarisation 
3.3.3.1. Depolarisation 
The response to depolarisation was assessed by applying positive steps in current-clamp, in 20 
pA increments up to 100 pA (Fig. 6a). DRN/vlPAG GFP+ neurons fired rapidly throughout the 
pulse, with a higher discharge rate immediately following onset of the pulse (instantaneous 
firing frequency) compared to the end of the pulse (steady state firing frequency), i.e. 
demonstrating spike-frequency adaptation. In response to the larger depolarisations (≥60 pA), 
some neurons began to enter depolarisation block during steady-state firing, with the majority 
(80%, 24/30 cells) showing depolarisation block during the final 100 pA step.  
There was no difference in the firing response observed between TH-GFP and Pitx3-GFP mice (n 
= 24 and 10; instantaneous: interaction between mouse model and depolarising step, F4,160 = 
0.02, p = 0.9995; main effect of group, F1,160 = 0.30, p = 0.86; main effect of pulse amplitude, 
F4,160 = 10.35, p < 0.0001; steady-state: interaction between mouse model and depolarising step, 
F4,160 = 0.17, p = 0.95; main effect of group, F1,160 = 0.14, p = 0.71; main effect of pulse amplitude, 
F4,160 = 14.08, p < 0.0001), or between TH+ and TH- neurons (n = 26 and 6; instantaneous: 
interaction between cell type and depolarising step, F4,150 = 0.15, p = 0.96; main effect of group, 
F1,150 = 0.02, p = 0.88; main effect of pulse amplitude, F4,150 = 7.70, p < 0.0001; steady-state: 
interaction between cell type and depolarising step, F4,150 = 0.54, p = 0.71; main effect of group, 
F1,150 = 1.02, p = 0.31; main effect of pulse amplitude, F4,150 = 9.20, p < 0.0001). However, 
identified VIP+ neurons tended to fire at lower instantaneous frequencies, with each current 
injection, compared to VIP- neurons, which was confirmed by a main effect of cell type in a two-
way ANOVA (VIP+: n = 13, VIP-: n = 20; interaction between cell type and depolarising step, F4,155 
= 0.83, p = 0.51; main effect of group, F1,155 = 11.81, p < 0.001; main effect of pulse amplitude, 
F4,155 = 11.26, p < 0.0001; Fig. 6b). The sustained firing frequency, however, did not differ 
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between VIP+ and VIP- neurons (interaction between cell type and depolarising step, F4,155 = 
0.07, p = 0.99; main effect of group, F1,155 = 0.30, p = 0.59; main effect of pulse amplitude, F4,155 = 
14.28, p < 0.0001; Fig. 6c), suggesting that this difference is limited to the firing rates achievable 
immediately after the onset of the current injection. 
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Figure 6. VIP+ neurons fired at lower instantaneous frequencies in response to depolarisation 
than VIP- neurons, but showed similar steady-state frequencies. (a) Representative examples of 
the firing response to depolarising steps, showing spike-frequency adaptation leading to 
depolarisation block, in an identified VIP+ and VIP- neuron. Graphs showing the mean (± SEM; b) 
instantaneous and (c) steady-state firing frequency in VIP+ and VIP- neurons. A two-way ANOVA 
revealed a significant main effect of cell type (p < 0.05) for the instantaneous, but not the 
steady-state, frequencies. 
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3.3.3.2. Hyperpolarisation 
The Ih was activated in DRN/vlPAG GFP+ neurons by hyperpolarising steps delivered in both 
voltage- and current-clamp (Fig. 7a,b). Most GFP+ neurons exhibited a clear Ih (11.70 ± 1.24 pA, 
n = 78) that was within the range of many VTA dopamine neurons, but considerably smaller 
than SNc dopamine neurons (Liss et al., 2005; Neuhoff et al., 2002; Ford et al., 2006; Lammel et 
al., 2008; Zhang et al., 2010; Chieng et al., 2011; Lammel et al., 2011). The Ih amplitude was not 
significantly different between TH-GFP and Pitx3-GFP mice (TH-GFP: 12.07 ± 1.64 pA, n = 48; 
Pitx3-GFP: 10.98 ± 2.1 pA n = 24; t70 = 0.39, p = 0.70), or between identified TH+ and TH- 
neurons (TH+: 10.89 ± 1.66 pA, n = 46; TH-: 15.53 ± 4.50 pA, n = 10; t54 = 1.13, p = 0.26, Table 1). 
However, on average, the Ih was significantly larger in VIP+ compared to VIP- neurons (VIP+: 
19.12 ± 2.80 pA, n = 25; VIP-: 5.74 ± 0.74 pA, n = 32; t55 = 5.14, p < 0.0001; Fig 7c). This 
difference could be observed with hyperpolarising steps ≥ -40 mV, in response to which VIP- 
neurons displayed very little or no Ih, in contrast to the overall larger current with each step in 
VIP+ neurons (Fig. 7d). This could also be seen in current-clamp by the lack of a prominent Ih sag 
in VIP- neurons, compared to VIP+ neurons (Fig. 7a).  
Following removal of the hyperpolarising step, a large outward residual current was observed in 
voltage-clamp, which mediated the delayed repolarisation seen in current-clamp. This is thought 
to represent the IA, an outward potassium current, and is observed in VTA dopamine neurons, 
but not SNc dopamine neurons (Neuhoff et al., 2002; Ford et al., 2006; Lammel et al., 2008; 
Lammel et al., 2011), The size of this current did not differ significantly between TH-GFP and 
Pitx3-GFP mice (TH-GFP: 192.25 ± 22.25 pA, n = 48; Pitx3-GFP: 137.60 ± 22.66 pA, n = 24; t70 = 
1.55 p = 0.13), TH+ and TH- neurons (TH+: 177.05 ± 19.00 pA, n = 46; TH-: 130.46 ± 24.69 pA, n = 
10; t54 = 1.10, p = 0.28), or between VIP+ and VIP- neurons (VIP+: 164.28 ± 25.12 pA, n = 25; VIP-: 
172.95 ± 21.08 pA, n = 32; t55 = 0.27, p = 0.79; Table 1). 
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Hyperpolarising steps in voltage-clamp were also used to calculate the Rin, by measuring the 
instantaneous current (i.e. the inward leak current, mediated by background conductances), 
that occurs immediately after applying the step (Fig. 7b). When measured closest to the resting 
potential of the cell (i.e., a -10 mV step from holding potential of -50 mV), the Rin of DRN/vlPAG 
GFP+ cells was calculated as 1603 ± 190 MΩ (n = 55). This is considerably larger than values 
reported for the VTA (∼200-400 MΩ; Ford et al., 2006; Zhang et al., 2010), although not too 
dissimilar from NAc medial shell-projecting dopamine neurons (Lammel et al., 2011). This 
difference is likely to be due to the noticeably smaller size of the DRN/vlPAG dopamine neurons 
(as indicated by their smaller capacitance (Cm), ∼12 pA) compared to the VTA (typically ∼20-30 
pA; Neuhoff et al., 2002; Ford et al., 2006). Neither Rin, (TH-GFP: 1640.46 ± 256.63 MΩ n = 36; 
Pitx3-GFP: 1531.50 ± 264.64 MΩ, n = 19, t53 = 0.27, p = 0.79) nor Cm was significantly different 
between TH-GFP and Pitx3-GFP mice (TH-GFP: 12.01 ± 0.53 pF, n = 52; Pitx3-GFP: 12.25 ± 0.97 
pF, n = 26; t76 = 0.23, p = 0.82 (Cm)) or between TH+ and TH- neurons (TH+: 1750.96 ± 267.75 
MΩ, n = 37, 12.39 ± 0.66 pF, n = 49; TH-: 1015.50 ± 130.60 MΩ, n = 8, 12.46 ± 0.96, n = 10; t43 = 
1.26, p = 0.22 (Rin), t57 = 0.05, p = 0.96 (Cm); Table 1). However, VIP+ neurons had, on average, 
significantly smaller whole-cell capacitance compared with VIP- neurons (VIP+: 10.87 ± 0.56 pF, 
n = 27; VIP-: 13.66 ± 0.88 pF, n = 33; t58 = 2.55, p < 0.05), which is consistent with their observed 
smaller size, but this did not significantly affect the mean Rin (VIP+: 1745.16 ± 410.70 MΩ, n = 
21; VIP-: 1522.59 ± 226.69 MΩ, n = 24; t43 = 0.49, p = 0.63).  
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Figure 7. The average hyperpolarisation-activated cation current (Ih) was larger in identified VIP+ 
compared to VIP- neurons. Representative examples of the Ih measured in (a) current-clamp and 
(b) voltage-clamp from an identified VIP+ and VIP- neuron. (c) Bar chart showing mean (+ SEM) 
Ih amplitude and (d) graphs showing the mean (± SEM) instantaneous current and Ih at each 
hyperpolarising step in VIP+ and VIP- neurons. * indicates p < 0.05. 
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3.4. Conclusion 
In this chapter, I have examined the basic electrophysiological properties of DRN/vlPAG 
dopamine neurons using whole-cell patch-clamp in acute brain slices, in combination with 
single-cell labelling and immunohistochemistry. Specifically, I analysed passive membrane 
properties, action potential firing, and the response to depolarisation/hyperpolarisation, which 
are well-documented characteristics of dopamine neurons in the VTA/SNc. Given that the basic 
features of unlabelled GFP+ DRN/vlPAG neurons in Pitx3-GFP mice had already been studied in 
comparison with putative serotonergic neurons (Dougalis et al., 2012), I focused on comparing 
GFP+ neurons in TH-GFP and Pitx3-GFP mice, as well as immunohistochemically identified 
TH+/TH- and VIP+/VIP- neurons, in order to provide a more thorough electrophysiological 
characterisation of this population. 
I have shown that DRN/vlPAG dopamine neurons exhibit firing rates and patterns, and an Ih 
amplitude, that are similar to those displayed by some VTA dopamine neurons. Specifically, the 
range of firing rates and action potential widths in DRN/vlPAG dopamine neurons overlaps with 
the values cited for midbrain dopamine neurons projecting to the NAc core, NAc medial shell, 
BLA, and mPFC (which are calbindin-positive; Neuhoff et al., 2002), but not those projecting to 
the NAc lateral shell or dorsal striatum (Lammel et al., 2008; Lammel et al., 2011). Additionally, I 
noted some differences between DRN/vlPAG dopamine neurons expressing VIP, and those 
lacking this neuropeptide. In particular, VIP+ neurons fired in a more irregular manner than VIP- 
neurons, fired at lower maximal frequencies in response to depolarisation, and expressed a 
significantly larger Ih. The more irregular firing pattern may be a result of intrinsic neuronal 
differences in channel expression or function, and/or extrinsic differences in synaptic input. 
However, the differences in maximal firing frequency and Ih, are most likely to result from 
intrinsic differences in ion channel expression or function.  
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Given that, in the VTA, different maximal firing frequencies and Ih amplitudes are associated 
with dopamine neurons projecting to distinct target structures (Lammel et al., 2008; Lammel et 
al., 2011), it is tempting to speculate that these properties may also distinguish projection target 
in the DRN/vlPAG. Consistent with this, the VIP projection from the DRN/vlPAG is restricted to 
the dorsolateral BNST (Eiden et al., 1985; Petit et al., 1995; Kozicz et al., 1998), in comparison 
with the multiple targets innervated by the rest of the DRN/vlPAG population. Therefore VIP 
may serve as a useful marker of this projection. However, VIP is not the first neuropeptide to be 
colocalised to dopamine neurons, either in the DRN/vlPAG (Seroogy et al., 1988a) or the VTA 
(Seroogy et al., 1988b; Seroogy et al., 1989; Jayaraman et al., 1990; Seroogy et al., 1994), and its 
functional significance remains to be determined. 
Importantly, these results indicate that there are no significant differences, in any of the 
measures examined, between neurons recorded in TH-GFP and Pitx3-GFP mice. Therefore, even 
though a slightly greater proportion of VIP+ neurons may be sampled in Pitx3-GFP mice, this 
does not significantly affect the average properties of the sample. In addition, there were no 
significant differences between recorded GFP+ neurons that were TH+ and TH-. This is further 
evidence to support the view that these TH- neurons are dopaminergic, and may just express 
very low levels of TH, which are undetectable with standard immunohistochemical methods, or 
have experienced ‘wash-out’ of intracellular contents (Zhang et al., 2010). There is debate over 
whether this occurs very frequently with potassium gluconate-based internal solutions 
(Margolis et al., 2010), but these DRN/vlPAG dopamine neurons are considerably smaller than 
those in the VTA, which may suggest that wash-out would occur more rapidly in this population. 
91 
 
Chapter 4. Synaptic physiology of DRN/vlPAG dopamine neurons 
4.1. Introduction 
VTA dopamine neurons are highly innervated by glutamatergic and GABAergic afferents 
originating in many cortical and subcortical regions (Kalivas and Alesdatter, 1993; Carr and 
Sesack, 1999; Geisler et al., 2007; Jhou et al., 2009; Omelchenko and Sesack, 2009). The balance 
between this excitatory and inhibitory input is crucial in governing the neuronal firing pattern, 
which shapes dopamine release in target structures (White, 1996; Mathon et al., 2003; Marinelli 
et al., 2006; Morikawa and Paladini, 2011). Furthermore, diversity in the origin of these 
afferents allows dopamine neurons to integrate information arising from a wide range of brain 
regions, which are sensitive to different environmental stimuli (Morikawa and Paladini, 2011). 
DRN/vlPAG dopamine neurons also receive both glutamatergic and GABAergic afferents, and 
their activity is likely to be modulated by these inputs in a similar manner to VTA dopamine 
neurons.  
4.1.1. Excitatory and inhibitory transmission in midbrain dopamine neurons 
Fast excitatory transmission onto dopamine neurons is mediated mainly by glutamate activating 
ionotrophic AMPARs and NMDARs on the postsynaptic membrane, which results in 
depolarisation and an increase in neuronal firing (Christoffersen and Meltzer, 1995; Morikawa et 
al., 2003). However, NMDARs appear to be unique in their ability to generate burst firing in 
dopamine neurons, which cannot be initiated by AMPARs alone (Charlety et al., 1991; Overton 
and Clark, 1992; Chergui et al., 1993; Chergui et al., 1994; Christoffersen and Meltzer, 1995; 
Tong et al., 1996b; Deister et al., 2009; Zweifel et al., 2009). Additionally, metabotrophic 
glutamate receptors (mGluRs) can hyperpolarise dopamine neurons via mobilisation of 
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intracellular Ca2+, and the subsequent opening of Ca2+-sensitive K+ (SK) channels (Fiorillo and 
Williams, 1998; Morikawa et al., 2003). The major inhibitory input to dopamine neurons arises 
from GABA acting on postsynaptic ionotrophic GABAA or metabotropic GABAB receptors, which 
can suppress burst ﬁring (Bolam and Smith, 1990; Johnson and North, 1992a; Paladini et al., 
1999; Erhardt et al., 2002; Brazhnik et al., 2008). Conversely, there is evidence that removal of 
this input (i.e., disinhibition) may contribute to the generation of phasic bursting in dopamine 
neurons in vivo (Paladini and Tepper, 1999; Jhou et al., 2009; Matsumoto and Hikosaka, 2007; 
Tepper and Lee, 2007; Lobb et al., 2010; Tan et al., 2010; Lobb et al., 2011). The nature of these 
glutamatergic and GABAergic synapses allows the firing pattern of dopamine neurons to be 
controlled on the order of milliseconds, which is essential for the tight association of 
environmental stimuli with behaviour.  
4.1.2. Plasticity at synapses onto dopamine neurons 
Excitatory and inhibitory inputs to dopamine neurons are important not only for short-term 
changes in neuronal firing and neurotransmitter release, but also long-term changes in neuronal 
activity. This is due to the ability of these synapses to exhibit plasticity, i.e. activity-dependent 
modulation of synaptic strength, which serves to strengthen (long-term potentiation; LTP) or 
weaken (long-term depression; LTD) the synaptic connection. Both glutamatergic and GABAergic 
synapses onto dopamine neurons have been shown to express several forms of LTP and LTD. 
These differ in the conditions for, and mechanism of, induction and expression, and can be 
mimicked in brain slices with specific stimulation protocols (Bonci and Malenka, 1999; Overton 
et al., 1999; Jones et al., 2000; Thomas et al., 2000; Liu et al., 2005; Bellone and Lüscher, 2006; 
Luu and Malenka, 2008; Nugent et al., 2008; Pan et al., 2008; Harnett et al., 2009; Mameli et al., 
2011).  
93 
 
One important, well-characterised, form of plasticity is that which occurs at glutamatergic 
synapses onto VTA dopamine neurons in response to an acute dose of addictive drug (Ungless 
et al., 2001; Saal et al., 2003; Borgland et al., 2004; Dong et al., 2004; Faleiro et al., 2004; Liu et 
al., 2005; Bellone and Lüscher, 2006; Argilli et al., 2008; Engblom et al., 2008; Heikkinen et al., 
2009). This potentiation has recently been shown to occur only at a subset of dopamine neurons 
projecting to the NAc lateral and medial shell, but not those projecting to the mPFC or dorsal 
striatum (Lammel et al., 2011). The DRN/vlPAG dopamine neurons have not been studied in 
relation to this form of plasticity or any others, but given that they have been implicated in 
drug-related learning (Flores et al., 2006), it is possible that they may show synaptic 
modifications in response to addictive drugs.  
I ultimately wanted to test this directly, but it was first necessary to assay some basal measures 
of synaptic strength at these dopamine neurons, as these have not been previously reported. 
Recordings by Antonios Dougalis, from unlabelled GFP+ neurons in Pitx3-GFP mice, had shown 
that it was possible to measure spontaneous and evoked synaptic currents within the coronal 
brain slice preparation of the DRN/vlPAG (Dougalis et al., 2012). This was used for comparison 
with putative serotonergic neurons, but I wanted to broaden this analysis by examining synaptic 
currents in identified VIP+/VIP- dopamine neurons of the DRN/vlPAG. In order to directly 
compare to this previous work (Dougalis et al., 2012), I employed the same measures of synaptic 
strength: glutamatergic and GABAergic spontaneous synaptic currents and evoked paired-pulse 
ratios. I also assayed the AMPAR:NMDAR ratio, as this is a sensitive measure of synaptic 
strength and is frequently used to reveal changes following drug exposure. Additionally, I 
examined evoked glutamatergic currents in the VTA for comparison with the DRN/vlPAG 
dopamine neurons.  
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4.2. Materials and methods 
4.2.1. Brain slice preparation 
Coronal 220 µm brain slices containing the DRN/vlPAG were prepared and maintained as 
described in chapter 3. Additionally, in separate animals, horizontal 220 µm brain slices were 
prepared, which contained the VTA. Recordings were made from GFP+ cells in the region medial 
to the medial terminal nucleus of the accessory optic tract (MT) to target the VTA.  
4.2.2. Electrophysiology 
Whole-cell patch-clamp recordings were performed as described in chapter 3. In the recording 
chamber brain slices were continuously perfused at a rate of 2-4 ml/min with fully oxygenated 
aCSF (composition in mM, NaCl 120, KCl 3.5, NaH2PO4 1.25, NaHCO3 26, Glucose 10, MgCl2 1, 
CaCl2 2) at 32 °C. A potassium gluconate-based internal solution (composition in mM: potassium 
gluconate 140, NaCl 5, MgCl2  1, EGTA 1, HEPES 10, Mg-ATP 2, Li-GTP 0.5, and 0.1% neurobiotin, 
with pH 7.3 and osmolarity 280-290 mosmol/l) was used for recording spontaneous 
postsynaptic currents and paired-pulse ratios when comparing VIP+ and VIP- neurons of the 
DRN/vlPAG (Fig. 8 and 9). A cesium-based internal solution (composition in mM: CsCH3SO3 130, 
NaCl 2.8, HEPES 20, EGTA 0.4, TEA-Cl 5, MgATP 2, Li-GTP 0.5, and 0.1% neurobiotin; pH 7.3, 
osmolarity 280-290 mosmol/l) was used to record the AMPAR:NMDAR ratio at +40 mV, and for 
all protocols comparing DRN/vlPAG with VTA dopamine neurons (Fig. 10 and 11). The values 
cited here have not been corrected for liquid junction potential (estimated as 12.8 mV for the 
potassium-gluconate solution and 9.8 mV for the cesium-based solution using the pClamp 
calculator; Neher, 1992). 
95 
 
Following recording, brain slices were fixed in 4% PFA and processed with 
immunohistochemistry (as described in chapter 3) to reveal TH and VIP staining in recorded 
cells. 
4.2.2.1. Spontaneous postsynaptic currents 
Synaptic currents were recorded in voltage-clamp mode, using the potassium gluconate-based 
internal solution. The neuron was held at either -70 mV or 0 mV to selectively monitor 
spontaneous excitatory postsynaptic currents (sEPSCs) or inhibitory postsynaptic currents 
(sIPSCs), respectively. Spontaneous activity was recorded for 3-5 min at each holding potential, 
and the data was analysed using MiniAnalysis 6.0.7 (Synaptosoft, Fort Lee, NJ). The detection 
threshold was set at 7 pA for sEPSCs at -70 mV, and 15 pA for sIPSCs at 0 mV, which was suitable 
to distinguish events from the baseline noise. Events were subsequently verified by eye to 
confirm the presence of a fast rise time (<3 ms) and an exponential decay.  
4.2.2.2. Evoked currents 
In order to evoke postsynaptic currents, a bipolar stimulating electrode (FHC, USA) was placed 
100-300 µm ventrolateral (in coronal slices) or rostral (in horizontal slices) to the recorded 
neuron, and used to stimulate afferents at 0.03 Hz. Stimulus intensity was controlled using an 
ISO-flex stimulus isolator (AMPI, Jerusalem, Israel) and adjusted to evoke monosynaptic events, 
typically using a stimulus intensity of 10-40 V, 500 μs duration. At least 12 stable sweeps were 
recorded for each protocol, with averaged responses calculated and analysed using Clampfit 
10.2 (Molecular Devices, CA, USA). 
To measure the paired-pulse ratio (PPR) the potassium gluconate-based internal solution was 
used and neurons were held at -70 mV or 0 mV to evoke EPSCs or IPSCs, respectively. Two 
afferent stimuli were delivered with an inter-stimulus interval of 50 ms, and the PPR was 
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calculated by dividing the average peak amplitude of the PSC generated by the second stimulus 
by the average peak amplitude generated by the first.  
To determine the AMPAR:NMDAR ratio the cesium-based internal solution was used and the 
neuron was voltage-clamped at +40 mV. Picrotoxin (100 µm) was also included in the aCSF to 
block GABAA receptor-mediated synaptic currents. A stable mixed AMPAR- and NMDAR-
mediated EPSC was recorded, following which the NMDAR antagonist d-AP5 (50 µM) was 
applied to the slice, and the pure AMPAR current recorded. This was then digitally subtracted 
from the mixed current, using ClampFit 10.2, to give the pure NMDAR current. The 
AMPAR:NMDAR ratio was calculated by dividing the peak amplitude of the average AMPAR-
mediated EPSC by the peak amplitude of the NMDAR-mediated EPSC (Hsia et al., 1998).  
The decay kinetics of the AMPAR-mediated and NMDAR-mediated current recorded at +40 mV 
were determined by fitting the decay phase of the current with an exponential curve using Spike 
2 (Cambridge Electronic Design, UK). The AMPAR current was fitted with a single exponential 
function and the NMDAR-mediated current was fitted with a double exponential function (as 
shown in Fig. 10d). The following formula was used to calculate the weighted decay time 
constant (τW) of the NMDAR-mediated current: 
 τW = [(A1 x τ1) + ( A2 x τ2)]/[(A1 + A2)] 
A1 and A2 are the amplitudes, and τ1 and τ2 the decay time constants of the fast and slow 
components, respectively (Lammel et al., 2011).  
4.2.2.3. NMDA application 
The neuron was voltage-clamped at +40 mV, using the cesium-based internal solution, and once 
the holding current had stabilised NMDA (10 µM) was applied to the slice for 30 s. The holding 
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current was sampled every 10 s before, during and after the drug washed on to the slice, and 
the amplitude of the response calculated by subtracting the baseline current from the peak 
current following NMDA application.  
4.2.3. Statistics 
Unpaired t-tests (non-directional) were used for statistical comparison with Prism 5.04 
(Graphpad, CA, USA). Values are reported as mean ± standard error of the mean (SEM). 
4.2.4. Drugs 
Picrotoxin, NBQX, and NMDA were obtained from Sigma-Aldrich (Sigma, UK) and d-AP5 from 
Tocris Bioscience (Tocris, UK). Stock solutions of picrotoxin (400 mM) and NBQX (11.9 mM) were 
prepared in dimethylsulphoxide (DMSO), and NMDA (6.8 mM) and d-AP5 (50 mM) were 
prepared in dH20. They were then divided into aliquots and stored at -20 °C. Individual aliquots 
were defrosted immediately before recording, and added to the aCSF to give a final DMSO 
concentration of <0.045%.  
4.3. Results 
4.3.1. Glutamatergic and GABAergic currents in DRN/vlPAG dopamine neurons 
Synaptic physiology was sampled in 48 neurons from TH-GFP mice (aged 1-2months), 38 of 
which were successfully labelled and processed with immunohistochemistry for TH and VIP. 97% 
of these neurons (37/38 cells) were confirmed TH+, with 45% (17/38 cells) VIP+, and 55% (21/38 
cells) VIP-, in line with my previous proportions of recorded and non-recorded neurons in TH-
GFP brain slices. The mean age for each experimental group was 5.2 weeks (VIP+) and 5.0 weeks 
(VIP-). 
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4.3.1.1. Glutamatergic currents 
Spontaneous events (sEPSCs) recorded at -70 mV were blocked with the AMPAR antagonist 
NBQX (5 µM, n = 6), indicating that they are AMPAR-mediated glutamatergic events. The 
average amplitude of sEPSCs was smaller in VIP+ compared to VIP- neurons (VIP+: 15.0 ± 1.6 pA, 
n = 9; VIP-: 21.5 ± 1.5 pA, n = 17; t24 = 2.73, p < 0.05), as was the frequency of events (VIP+: 0.46 
± 0.19 Hz, n = 9, VIP-: 1.43 ± 0.25 Hz, n = 17; t24 = 2.62, p < 0.05; Fig. 8a)  
Postsynaptic currents were evoked in the slice by means of a bipolar stimulating electrode 
placed on the brain slice, ventrolateral to the recorded neuron. When afferent fibres are 
stimulated twice in quick succession, the paired-pulse ratio (PPR) can be measured, which is the 
amplitude ratio of the second postsynaptic response to the first (Zucker and Regehr, 2002). The 
degree of facilitation or depression of the response is one method used to assess the probability 
of neurotransmitter release (Pr) at the synapse (Katz and Miledi, 1968; Citri and Malenka, 2008; 
Branco and Staras, 2009). Synapses with a high Pr tend to depress their response to the second 
stimulus whereas synapses with a low Pr normally exhibit an increase in their response to the 
second stimulus (Dobrunz and Stevens, 1997). Paired-pulse recordings made at -70 mV, to 
stimulate AMPAR-mediated currents, showed that VIP+ neurons exhibited slight paired-pulse 
depression (i.e., exhibiting a PPR less than 1; PPR: 0.97, n = 8), whereas VIP- neurons tended 
towards facilitation (PPR: 1.35, n = 10; t16 = 2.28, p < 0.05; Fig. 8b). Differences in the PPR are 
often interpreted as presynaptic differences in the Pr, although there are alternative 
explanations involving postsynaptic alterations (e.g. Savtchouk and Liu, 2011). 
I recorded AMPAR:NMDAR ratios at +40 mV using a cesium-based internal solution and with 
picrotoxin present in the aCSF. This ratio is a frequently used measure of the relative 
contribution of glutamatergic receptors at a synapse, and it allows comparisons between cells 
since it is independent of factors such as the position of the stimulating electrode and the 
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number of afferent fibres stimulated (Kauer and Malenka, 2007; Thomas et al., 2008). The 
average AMPAR:NMDAR ratio was 1.23 ± 0.13 (n = 15) for GFP+ DRN/vlPAG neurons, and was 
not significantly different between identified VIP+ and VIP- neurons (VIP+: 1.16 ± 0.19, n = 6; 
VIP-: 1.34 ± 0.15, n = 8; t12 = 0.75, p = 0.47; Fig. 8c). 
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Figure 8. Spontaneous and evoked glutamatergic currents in VIP+ and VIP- neurons. Bar charts 
(mean + SEM) and representative examples from an identified VIP+ and VIP- neuron showing (a) 
sEPSC amplitude and frequency, (b) the PPR, and (c) the AMPAR:NMDAR ratio. * indicates p < 
0.05. 
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4.3.1.2. GABAergic currents 
Spontaneous events recorded at 0 mV (sIPSCs) were abolished by the GABAA-receptor 
antagonist picrotoxin (100 µM, n = 5) indicating that they are GABAA-mediated inhibitory events. 
There was considerable variability in the frequency of events in VIP+ neurons, ranging from 0.05 
Hz to 3.15 Hz (standard deviation: 1.18). There appeared to be a bimodal distribution with 7/9 
cells displaying a frequency of <0.5 and 2/9 cells displaying a frequency of >2 Hz. More data 
would be useful to determine whether there are two distinct groups within the VIP+ population, 
which differ in the nature of their GABAergic input. In contrast, I only observed low sIPSC 
frequency in VIP- neurons (<0.3 Hz; standard deviation: 0.05). The average frequency was 
therefore quite different between VIP+ and VIP- (VIP+: 0.74 ± 0.39 Hz, n = 9; VIP-: 0.09 ± 0.01 Hz, 
n = 13; Fig. 9a), but this did not reach statistical significance (t20 = 2.00, p = 0.06) probably due to 
the high variability in VIP+ neurons. The average amplitude of sIPSCs was similar between VIP+ 
and VIP- neurons (VIP+: 25.5 ± 2.8 pA, n = 9, VIP-: 22.1 ± 0.9 pA, n = 13; t20 = 1.31, p = 0.20), but 
again there was greater variability within the VIP+ population (standard deviation - VIP+: 8.5pA, 
VIP-: 3.3pA). Interestingly, less GABAergic input onto VIP- neurons may explain the more regular 
firing observed in this subpopulation in chapter 3 (Fig. 5). Reducing GABAA-mediated inhibition 
has been shown to reduce the CV-ISI, and hence improves spike timing (Caillard, 2011). 
Therefore less GABAA-mediated inhibition may underlie the smaller CV-ISI in VIP- compared to 
VIP+ neurons. 
Paired-pulse stimulation at 0 mV, to evoke GABAergic currents, produced paired-pulse 
facilitation in both VIP+ (PPR: 1.61 ± 0.28, n = 6) and VIP- neurons (PPR: 1.64 ± 0.25, n = 9), with 
no significant difference between the two cell types (t13 = 0.07, p = 0.95, Fig. 9b). 
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Figure 9. Spontaneous and evoked GABAergic currents in VIP+ and VIP- neurons. Bar charts 
(mean + SEM) and representative examples from an identified VIP+ and VIP- neuron showing (a) 
sEPSC amplitude and frequency and (b) the PPR.  
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4.3.2. Glutamatergic synapses onto DRN/vlPAG and VTA dopamine neurons 
Both TH-GFP and Pitx3-GFP mice (aged 1-3 months) were used to target DRN/vlPAG and VTA 
dopamine neurons, in coronal and horizontal brain slices, respectively. The mean age for each 
experimental group was 8 weeks (DRN/vlPAG) and 8.1 weeks (VTA). There was no difference in 
any of the measures examined between TH+ and TH- neurons, therefore all GFP+ neurons are 
reported here. A cesium-based solution was used for all recordings with picrotoxin included in 
the aCSF, in order to sample only glutamatergic currents. 
I found that DRN/vlPAG and VTA dopamine neurons differed in their passive properties (Fig. 
10a). Whole-cell capacitance (Cm) was significantly larger in VTA compared to DRN/vlPAG 
dopamine neurons (VTA: 37.18 ± 1.61 pF, n = 107; DRN/vlPAG: 13.60 ± 0.25 pF, n = 449; t554 = 
25.18 p < 0.0001), which is consistent with their generally larger size. In line with this, the Rin of 
VTA dopamine neurons was considerably smaller than DRN/vlPAG dopamine neurons (VTA: 
658.3 ± 88.9 MΩ, n = 32; DRN/vlPAG:  1821.4 ± 72.1 MΩ, n = 192; t222 = 6.45, p < 0.0001), which 
is likely to be related to the difference in cell size. (Note that the Rin here was calculated from a 
10 mV hyperpolarising step at -70 mV, with a cesium-based internal solution, rather than at -50 
mV with a potassium gluconate-based solution, as described in chapter 3). Additionally, I found 
that significantly more negative current was required to hold the cell at -50 mV in the VTA 
compared to DRN/vlPAG dopamine neurons (VTA: -57.08 ± 3.78 pA, n = 96; DRN/vlPAG: -25.04 ± 
0.89 pA, n = 398; t492 = 12.39, p < 00001; Fig. 10a). This again may be a result of the difference in 
cell size, or differences in the intrinsic properties and/or extrinsic inputs to these different 
dopamine populations.  
The PPR of the AMPAR-mediated current was smaller in VTA compared to DRN/vlPAG dopamine 
neurons (VTA: 0.81 ± 0.05, n = 12; DRN/vlPAG: 1.04 ± 0.07, n = 22; t32 = 2.17, p < 0.05; Fig. 10b). 
VTA dopamine neurons generally showed slight paired-pulse depression (consistent with 
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previous reports (e.g., Bonci and Malenka 1999; Lammel et al., 2011), but DRN/vlPAG neurons 
showed a mixture of both slight facilitation and depression in their responses, resulting in an 
average PPR around 1. I recorded AMPAR:NMDAR ratios in VTA dopamine neurons with values 
similar to those previously reported (0.48 ± 0.05, n = 8; e.g. Ungless et al., 2001; Saal et al., 
2003; Argilli et al., 2008, Lammel et al., 2011), but this was significantly smaller than the ratios 
recorded in DRN/vlPAG dopamine neurons (1.23 ± 0.11, n = 13; t19 = 5.07, p < 0.0001; Fig. 10c). 
This higher ratio observed in DRN/vlPAG dopamine neurons could be a result of a larger AMPAR-
mediated component, or a smaller NMDAR-mediated component, or both.  
The decay kinetics of the evoked AMPAR- and NMDAR-mediated current at +40 mV were 
analysed by fitting the decay phase with one and two exponential functions, respectively. I 
observed no difference between the VTA and DRN/vlPAG in the weighted decay time constant 
(τW) of the NMDAR-mediated current (VTA: 132.6 ± 39.4 ms, n = 8; DRN/vlPAG: 110.8 ± 16.7 ms, 
n = 12; t19 = 0.56, p = 0.58; Fig. 10d) or the decay time constant of the AMPAR-mediated current 
(VTA: 3.03 ± 0.53 ms, n = 7; DRN/vlPAG: 3.31 ± 0.22 ms, n = 24; t29 =0.57, p = 0.57; Fig. 10e). To 
further examine the NMDAR current I bath applied 10 µM NMDA for 30 s, while holding the 
neuron at +40 mV (to relieve Mg2+ block of the channel). The opening of NMDARs causes influx 
of Na+, K+ and Ca2+ ions, which depolarises the cell, and so more positive current is required to 
voltage-clamp the cell at +40 mV. The amplitude of the current elicited by NMDA application 
was significantly greater in VTA (258.9 ± 31.2 pA, n = 7) compared to DRN/vlPAG (40.2 ± 9.4 pA, 
n = 7; t12 = 6.70, p < 0.0001; Fig. 10f) dopamine neurons, which may (in part) explain the 
difference in the AMPAR:NMDAR ratio. However, exogenous application of NMDA will 
indiscriminately activate both synaptic and extrasynaptic receptors (Kullmann et al., 1999), 
which can preclude detection of a specific change in synaptic receptors (Mameli and Lüscher, 
2011), and therefore this is crude method for evaluating receptor differences at the synapse. 
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Figure 10. Passive membrane properties and glutamatergic currents in DRN/vlPAG and VTA 
dopamine neurons. (a) Bar charts (mean + SEM) showing membrane capacitance (Cm), holding 
current at -50 mV, and input resistance (Rin) of recorded DRN/vlPAG and VTA dopamine 
neurons. Bar charts and representative examples of (b) the PPR, (c) the AMPAR:NMDAR ratio, 
(d) the weighted decay time constant of NMDAR-mediated current,(e) the decay time constant 
of AMPAR-mediated current, and (f) the response to NMDA application. The red line indicates 
the exponential fit of the decay phase of the current.* indicates p < 0.05. 
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4.4. Conclusion 
I have recorded glutamatergic and GABAergic currents in identified VIP+ and VIP- DRN/vlPAG 
dopamine neurons in order to broaden the synaptic analysis of this population. Spontaneous 
glutamatergic currents in VIP+ neurons displayed smaller amplitude and frequency than in VIP- 
neurons, and showed paired-pulse depression in response to paired stimuli. Contrastingly, there 
was no difference in the PPR of GABAergic current between VIP+ and VIP- neurons, but there 
was a trend for less frequent sIPSCs in VIP- neurons, compared to the greater range of 
frequencies observed in VIP+ neurons. Additionally, there was no difference in the 
AMPAR:NMDAR ratio between VIP+ and VIP- dopamine neurons, suggesting a similar 
contribution by the two glutamatergic receptor-mediated currents at these synapses. Therefore, 
both VIP+ and VIP- neurons within the DRN/vlPAG receive glutamatergic and GABAergic input, 
but their relative proportion of excitatory and inhibitory input may vary. 
I also recorded glutamatergic currents in VTA dopamine neurons in order to compare with the 
DRN/vlPAG population. I found that the two populations differed in their passive membrane 
properties, including Cm, Rin, and holding current, which is likely to be attributable to the larger 
size of VTA dopamine neurons. Additionally, I found that DRN/vlPAG dopamine neurons had a 
larger AMPAR:NMDAR ratio and a higher PPR than VTA dopamine neurons. This suggests that 
glutamatergic synapses may have distinct characteristics in the VTA and DRN/vlPAG, which may 
reflect pre- and postsynaptic differences. It is important to note, however, that there is 
considerable variability in many of these properties in VTA dopamine neurons, which 
corresponds to projection target (Lammel et al., 2008; Lammel et al., 2011). In particular, it has 
been recently demonstrated that there is a significant difference in the AMPAR:NMDAR ratio 
between dopamine neurons projecting to the NAc lateral shell, and those projecting to the NAc 
medial shell or mPFC (Lammel et al., 2011). Therefore a closer inspection of the DRN/vlPAG may 
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reveal differences in the properties of glutamatergic synapses relating to neuronal projection 
target.  
One limitation of this comparison between the VTA and DRN/vlPAG is the use of different 
orientations of slice preparation. Coronal preparations are rarely used for studying synaptic 
physiology in the VTA, since currents are difficult to evoke. However, this is the most 
appropriate orientation for targeting the DRN/vlPAG population. In practice, it was initially 
difficult to evoke adequate-sized synaptic currents in the DRN/vlPAG dopamine neurons, 
particularly the small, periaqueductal population. This may have been due to the orientation of 
the slice preparation and/or the small cell size (as evoking currents in serotonergic neurons was 
not as challenging). With practice, I found that positioning the bipolar stimulating electrode 
ventrolateral to the recorded DRN/vlPAG neuron was the most efficient way of evoking 
currents. However, it is possible that different brain slice orientations may result in a different 
degree of preservation of glutamatergic afferents from different regions, while the position of 
the stimulating electrode may result in stimulation of different glutamatergic afferents. This may 
be the cause of some of the differences noted here, but without neuronal tracing, the origin of 
these fibres cannot be determined with any certainty in either preparation. 
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Chapter 5. Cocaine- and social isolation-induced plasticity in 
DRN/vlPAG dopamine neurons 
 
5.1. Introduction 
In spite of their diverse chemical structures, molecular targets, and associated behavioural and 
psychological effects, addictive drugs converge on the mesolimbic dopamine system to elicit 
their rewarding and reinforcing effects (Wise and Bozarth, 1987; Di Chiara and Imperato, 1988; 
Corrigall et al., 1992; Kalivas, 1995; Wolf, 1998; McBride et al; 1999; Overton et al., 1999; 
Ikemoto and Wise, 2004; Nestler, 2005). One crucial locus of modification following exposure to 
drugs of abuse occurs at excitatory synapses onto dopamine neurons in the VTA. Nearly all 
addictive drugs, including amphetamine, nicotine, morphine, alcohol, and diazepam, are able to 
induce LTP-like potentiation of glutamatergic synapses onto VTA dopamine neurons (Ungless et 
al., 2001; Faleiro et al., 2003; Saal et al., 2003; Heikkinen et al., 2009; Tan et al., 2010). 
Additionally, potentiation at these same synapses can be induced by an aversive stimulus, but 
not by psychoactive, non-addictive substances such as carbamazepine or fluoxetine (Saal et al., 
2003). Cocaine-induced potentiation occurs within a few hours of a single exposure (Faleiro et 
al., 2004; Argilli et al., 2008) and lasts for about a week (Ungless et al., 2001), even following 
multiple noncontingent injections (Borgland et al., 2004).  
Recently, it has been demonstrated that plasticity at these synapses is projection-specific. 
Cocaine-induced potentiation only occurs at synapses onto dopamine neurons projecting to the 
NAc lateral and medial shell, but not dopamine neurons projecting to the mPFC, or SNc neurons 
projecting to the dorsal striatum (Lammel et al., 2011). Contrastingly, an aversive stimulus 
selectively potentiates synapses onto mPFC- and NAc lateral shell-projecting dopamine neurons, 
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without affecting VTA neurons projecting to the NAc medial shell, or SNc neurons projecting to 
the dorsal striatum (Lammel et al., 2011). Therefore dopamine neurons of the VTA are 
functionally heterogeneous in their response to salient stimuli, which is related to their 
projection target. 
5.1.1. Significance of drug-induced plasticity in the VTA 
Synaptic potentiation in the VTA induced by passive cocaine administration was thought to be 
required for the early induction of behavioural sensitization and CPP (Kalivas and Alesdatter, 
1993; Vezina, 1996; Wolf, 1998; Vezina and Queen, 2000; Carlezon and Nestler, 2002; Harris and 
Aston-Jones, 2003; Borgland et al., 2004; Harris et al., 2004; Wolf et al., 2004; Dunn et al., 2005; 
Mead et al., 2005; Borgland et al., 2006; Zweifel et al., 2008). However, this idea was challenged 
by the demonstration that disruption of glutamatergic signalling selectively in dopamine 
neurons, which abolishes cocaine-induced plasticity, does not alter behavioural sensitisation to 
cocaine (Dong et al., 2004) or CPP (Engblom et al., 2008; Luo et al., 2010). Drug-evoked plasticity 
in the VTA has also been implicated in cue- and drug-induced reinstatement during withdrawal 
(Engblom et al., 2008; Mameli et al., 2009), although contradictory results also exist (Zweifel et 
al., 2008). Therefore, establishing a causal relationship between drug-evoked synaptic plasticity 
and behaviour remains a major challenge in the field.  
In addition to possibly mediating some of the behavioural effects of addictive drugs, plasticity in 
VTA dopamine neurons is required for neural adaptations in downstream targets (Mameli et al., 
2009). It was demonstrated that abolishing drug-induced plasticity in the VTA, by inducible 
deletion of the obligatory NR1 subunit of the NMDAR selectively in dopamine neurons (Engblom 
et al., 2008), prevented plasticity in the NAc (Mameli et al., 2009). Furthermore, disrupting 
mGluR1 function selectively in VTA dopamine neurons, which prevents the reversal of cocaine-
induced plasticity in the VTA (Bellone and Lüscher, 2006), is itself sufficient to trigger plasticity in 
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the NAc, even after a single cocaine injection (Mameli et al., 2009). Therefore the increase in 
dopamine neuron firing and dopamine release in target regions, which would be expected to 
accompany an increase in excitatory synaptic strength, is likely to influence activity and 
plasticity in these downstream structures of the reward circuit, resulting in multiple, complex 
neuroadaptations (Hyman and Malenka, 2001; Kalivas and Volkow, 2005). Hence, in spite of its 
transient nature, drug-induced plasticity in VTA dopamine neurons may be important not only 
for the behavioural response to addictive drugs, but also for promoting long-term alterations in 
other regions of the reward circuit. 
Interestingly, the context and mode of drug administration appears to be important in the 
induction of plasticity. For example, the potentiation induced by prolonged self-administration 
(rather than passive injections) can last for around 3 months (Chen et al., 2008), and cues 
predicting a natural reward also potentiate these excitatory synapses following classical 
conditioning (Stuber et al., 2008). This indicates that this plasticity can involve an associative 
learning mechanism, which may be important in determining drug-related behaviour in the 
early development of addiction. 
Given that synaptic plasticity is thought to represent the cellular correlate of learning and 
memory (Hebb, 1949; Eccles 1964; Alkon and Nelson, 1990; Kandel, 1997; Malenka and Bear, 
2004), it is widely considered that addiction represents an aberrant form of learning in neural 
circuits evolutionarily conserved for the processing and reinforcement of natural rewards 
(Kelley, 2004; Kalivas and Volkow, 2005; Hyman et al., 2006; Kauer and Malenka, 2007). This is 
thought to facilitate the development of maladaptive behaviours during chronic drug exposure 
(Robinson and Berridge, 1993; Robinson and Berridge, 2000; Hyman and Malenka, 2001; Kelly 
and Berridge, 2002; Robinson and Berridge, 2003; Kauer, 2004; Vezina, 2004; Kalivas, 2009), 
which ultimately results in compulsive drug consumption, despite negative consequences, which 
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is the hallmark of addiction (Hyman and Malenka, 2001; Ikemoto and Wise, 2004; Jones and 
Bonci, 2005; Nestler, 2005). 
5.1.2. The AMPAR:NMDAR ratio as a measure of synaptic strength 
Cocaine-induced potentiation of glutamatergic synapses onto VTA dopamine neurons was first 
directly demonstrated by measuring the AMPAR:NMDAR ratio following a single dose of cocaine 
in mice (Ungless et al., 2001). The AMPAR:NMDAR ratio is a sensitive measure used to assay 
changes in synaptic strength, defined as the peak AMPAR-mediated current, relative to the peak 
of the NMDAR-mediated current. It conveniently facilitates inter-cell, and inter-brain slice, 
comparison since it is independent of factors such as the relative position of the stimulating and 
recording electrodes, and the number of afferent fibres stimulated within the brain slice, so is 
routinely used to identify changes in synaptic efficacy (Hsia et al., 1998; Kauer and Malenka, 
2007; Thomas et al., 2008). This measure was initially used because cocaine was hypothesised 
to induced synaptic changes that closely resembled those of NMDAR-dependent LTP (Karler et 
al., 1991; Schenk and Snow, 1994; Wolf, 1998; Bonci and Malenka, 1999; Overton et al., 1999). 
This is thought to involve an increase in AMPAR transmission, without a significant change in 
NMDAR transmission (Malenka and Nicoll, 1999), and so the AMPAR:NMDAR ratio was an 
appropriate tool for measuring such a change.   
5.1.3. Does cocaine potentiate synapses onto DRN/vlPAG dopamine neurons? 
Spontaneous and evoked glutamatergic currents can be recorded in DRN/vlPAG dopamine 
neurons in a coronal brain slice preparation ex vivo (Dougalis et al., 2012). Cocaine-induced 
potentiation is present at glutamatergic synapses onto a subset of VTA dopamine neurons, but 
the DRN/vlPAG population have yet to be explored. I therefore assayed the AMPAR:NMDAR 
ratio in these dopamine neurons, following a single dose of cocaine, in the same way as 
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previously reported for the VTA (Ungless et al., 2001). Although there is evidence that the 
DRN/vlPAG population may mediate some of the effects of opiates (Flores et al., 2004; Flores et 
al., 2006; Meyer et al., 2009), drug-induced plasticity in the DRN/vlPAG dopamine neurons has 
not been specifically studied. However, given that these neurons appear to provide a greater 
input to the central amygdala and BNST compared to the VTA (Hasue and Shammah-Lagnado, 
2002; Meloni et al., 2006; Shin et al., 2008), a change in synaptic strength in these neurons 
would have significance for dopamine release and drug-induced changes in different target 
structures and neural circuits. 
5.2. Materials and methods 
5.2.1. Injection protocol  
TH-GFP or Pitx3-GFP mice (1-3 months) received a single dose of cocaine (15 mg/kg), or the 
equivalent volume of 0.9% saline, administered via intraperitoneal (IP) injection at a volume of 
10 ml/kg. Injections were performed at 10.00 am, and the injected mouse was subsequently 
transferred to a clean cage for 24 hours before brain slice preparation. I performed all the 
injections for preliminary experiments, and the majority of the data shown in Fig. 11, but due to 
Central Biomedical Services (CBS) room restrictions all subsequent injections were carried out 
by Piotr Czapski. 
5.2.2. Electrophysiology 
Horizontal or coronal 220 µm brain slices containing the VTA or DRN/vlPAG, respectively, were 
prepared and maintained as described in chapter 3. Whole-cell patch-clamp electrophysiology 
was performed as described in chapter 4, using the cesium-based internal solution (composition 
in mM: CsCH3SO3 130, NaCl 2.8, HEPES 20, EGTA 0.4, TEA-Cl 5, MgATP 2, Li-GTP 0.5, and 0.1% 
neurobiotin; pH 7.3, osmolarity 280-290 mosmol/l) and with 100 µM picrotoxin included in the 
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aCSF. Postsynaptic currents were evoked using a bipolar stimulating electrode (FHC, USA) placed 
100-300 µm ventrolateral recorded neuron. Stimulus intensity was controlled using an ISO-flex 
stimulus isolator (AMPI, Jerusalem, Israel) and adjusted to evoke monosynaptic events, typically 
using a stimulus intensity of 10-40 V, 500 μs duration. AMPAR:NMDAR ratios were recorded in 
voltage-clamp at a holding potential of +40 mV as described in chapter 4. 
5.2.3. Statistics 
Statistical analysis was performed using Prism 5.04 (Graphpad, CA, USA), and values are 
reported as mean ± standard error of the mean (SEM). Two experimental groups were 
compared using an unpaired t-test (non-directional), and three or more groups were compared 
using a one-way ANOVA with Newman-Keuls post-hoc tests. The Pearson’s product-moment 
correlation coefficient was used to analyse correlation between two variables.  
5.2.4. Drugs 
Cocaine hydrochloride (Sigma Aldrich, St Louis, MO, USA) was stored in a safe and dissolved in 
0.9% saline for IP injections. 
5.3. Results 
Two or three brain slices containing the DRN/vlPAG or VTA were obtained per animal, and one 
AMPAR:NMDAR ratio was recorded per slice. Both TH-GFP and Pitx3-GFP mice were used for 
recordings, and no significant difference was found between them in terms of the 
AMPAR:NMDAR ratio in DRN/vlPAG GFP+ neurons (TH-GFP: 1.23 ± 0.14, n = 7; Pitx3-GFP: 1.24 ± 
0.17, n = 6; t11 = 0.009, p = 0.99), or between identified TH+ and TH- cells (TH+: 1.05 ± 0.15, n = 
5; TH-: 0.95 ± 0.38, n = 2; t5 = 0.33, p = 0.75). However, the sample size is too low for accurate 
statistical comparison between TH+ and TH- GFP+ neurons. A lower proportion of recorded 
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neurons were successfully labelled and recovered compared to the experiments described in 
previous chapters, therefore all GFP+ recorded neurons (identified TH+, TH-, VIP+, VIP-, or 
unidentified) have been included, except where stated, to increase the sample size. This may be 
due to the tight seal formed during prolonged recordings of this kind, which made it difficult to 
successfully withdraw the recording electrode without damaging the cell or drawing the cell 
away with it.  
5.3.1. Cocaine-induced potentiation in VTA and DRN/vlPAG dopamine neurons 
In the VTA, a single cocaine injection resulted in a significant increase in the AMPAR:NMDAR 
ratio (0.71 ± 0.09, n = 9; one-way ANOVA: F2,22 = 4.65, p < 0.05) compared to saline-injected 
(0.48 ± 0.04, n = 6; p < 0.05) or naïve animals (0.45 ± 0.05, n = 8; p < 0.05), which were not 
significantly different from each other (p > 0.05; Fig. 11a,b). The range of ratios I recorded was 
similar to those previously reported in mice (e.g., Ungless et al., 2001; Saal et al., 2003; Argilli et 
al., 2008; Lammel et al., 2011). Given the magnitude of the increase in ratio, and the location of 
the cells just medial to the MT, these are likely to be mostly NAc lateral shell-projecting neurons, 
which are mostly frequently targeted in brain slices. Akin to the VTA, in the DRN/vlPAG I found 
that mice which received a single dose of cocaine exhibited a significantly larger AMPAR:NMDAR 
ratio (1.82 ± 0.10, n = 8) than naïve mice (1.12 ± 0.11, n = 12; one-way ANOVA: F2,25 = 9.73, p < 
0.001; naïve vs cocaine p < 0.01; Fig. 11c,d). Unexpectedly, however, I found that mice injected 
with a single dose of saline also displayed a significantly larger AMPAR:NMDAR ratio (2.00 ± 
0.26, n = 8) than naïve mice (p < 0.01), which was not significantly different from cocaine-
treated mice (p > 0.05). This surprising result indicated that an additional factor in both groups 
of injected mice may have been influencing the AMPAR:NMDAR ratio in DRN/vlPAG dopamine 
neurons. Conforming to the method used in Ungless et al., the injection protocol involved 
transferring injected mice to a clean cage, on their own, for 24 hours before brain slice 
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preparation (Fig. 11d). This was in order to minimise possible disruption within the cage, due to 
cocaine-induced hyperactivity in the injected mouse, since the cagemates were to be used in 
other experimental groups. Therefore the two major differences between injected and non-
injected mice were exposure to a novel environment and social isolation for 24 hours before 
recording. I therefore sought to identify whether either of these factors were contributing to the 
synaptic potentiation observed in DRN/vlPAG dopamine neurons.  
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Figure 11. Effect of a single dose of cocaine on the AMPAR:NMDAR ratio. Bar chart (mean + 
SEM) with superimposed scatter plot, and representative examples of the AMPAR:NMDAR ratio 
recorded in (a,b) VTA and (c,d) DRN/vlPAG dopamine neurons in naïve mice or following a single 
dose of saline or cocaine.  The mean age of each experimental group was 5.8 weeks (naive VTA), 
4.8 weeks (saline VTA), 5.2 weeks (cocaine VTA), 8.2 weeks (naive DRN/vlPAG), 6.2 weeks (saline 
DRN/vlPAG), and 6.4 weeks (cocaine DRN/vlPAG).  (e) The injection procedure used in these 
experiments. * indicates p < 0.05. 
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5.3.2. Effect of environmental novelty and/or social isolation on DRN/vlPAG synapses 
Four protocols were tested, in the absence of a saline or cocaine injection, which involved 
environmental novelty and/or social isolation for 24 hours prior to brain slice preparation (Fig. 
12a). Mice in protocol A were naïve group-housed mice, in protocol B they were transferred to a 
clean cage alone, in protocol C they were transferred as a group into a clean cage, and in 
protocol D they were left alone in the original cage. All mice were group-housed in the same 
cage (containing 2-6 mice) for at least 5 days before these protocols were commenced, and the 
manipulations in protocols B-D were performed at 10.00 am, 24 hours before brain slice 
preparation. Additionally, the clean cages were located in the same room, on racks that allowed 
the mice to see, hear, and smell other mice. AMPAR:NMDAR ratios were recorded in each 
condition, which revealed a significantly larger ratio (one-way ANOVA: F3,26 = 6.17, p < 0.01) in 
mice that had been socially isolated with environmental novelty (protocol B: 1.92 ± 0.13, n = 6) 
or without environmental novelty (protocol D: 2.09 ± 0.21, n = 7), compared to either naïve 
group-housed mice (protocol A: 1.25 ± 0.13, n = 8; A vs B: p < 0.05; A vs D: p < 0.01) or mice 
exposed to environmental novelty without isolation (protocol C: 1.45 ± 0.15, n = 9; C vs B: p < 
0.05; C vs D: p < 0.05; Fig. 12b). Furthermore, the AMPAR:NMDAR ratio recorded in mice socially 
isolated with environmental novelty was not significantly different from those socially isolated 
without environmental novelty (B vs D: p > 0.05). Similarly, there was no significant difference 
between the ratio exhibited by naïve mice and those exposed to environmental novelty without 
isolation (A vs C: p > 0.05). This suggested that acute social isolation, but not environmental 
novelty, can potentiate glutamatergic synapses onto DRN/vlPAG dopamine neurons. Pooling 
data from multiple groups confirmed there was no difference in the AMPAR:NMDAR ratio from 
TH-GFP and Pitx3-GFP group-housed mice (TH-GFP: 1.13 ± 0.12, n = 16; Pitx3-GFP: 1.14 ± 0.12, n 
= 14; t28 = 0.14, p = 0.89) or isolated mice (TH-GFP: 1.96 ± 0.09, n = 12; Pitx3-GFP: 2.09 ± 0.29, n 
119 
 
= 8; t18 = 0.48, p = 0.64). There was also no difference in the AMPAR:NMDAR ratio in identified 
TH+ and TH- neurons from group-housed mice (TH+: 1.29 ± 0.09, n = 19; TH-: 1.10 ± 0.21, n =5; 
t22 = 0.94, p = 0.34) or isolated mice (TH+: 2.03 ± 0.13, n = 19 TH-: 1.78 ± 0.14, n = 2; t19 = 0.58, p 
= 0.57).  
Given that there was some variability in the number of animals in each cage (between 2 and 6) 
prior to social isolation, I considered whether this had any bearing on the AMPAR:NMDAR ratio. 
There was no significant correlation between the number of mice per cage and the ratio in 
group-housed mice (Fig. 12c; r2 = 0.0003, p = 0.94, n = 23). For this analysis, ratios were pooled 
from mice which were group-housed in protocols A and C, and also mice which had received a 
single saline injection but remained in the original, group-housed cage (to be reported in 5.3.4.). 
I also observed the same result when I included only ratios from naive mice in protocol A (r2 = 
0.001, p = 0.92, n = 10). However, I found there was significant positive correlation between the 
number of mice per cage, and the AMPAR:NMDAR ratio following 24 hours of social isolation 
(Fig. 12d; r2 = 0.53, p < 0.01, n = 15). In this case, I pooled ratios from mice which were isolated 
in their original cage, in a new cage, or given a single dose of saline before isolation. Equally, 
though, I found a similar positive correlation when I analysed only ratios from mice isolated 
without any injection (i.e., protocols B and D; r2 = 0.61, p < 0.05, n = 9) or isolated in their 
original cage (i.e., protocol D; r2 = 0.70, p < 0.05, n = 6). Additionally, since there was only one 
data point at 6 mice per cage, I also analysed the data without this value, which still resulted in 
significant positive correlation, albeit slightly weaker (r2 = 0.33, p < 0.05, n = 14), therefore it 
would be useful to increase the sample for this cage size. However, these results do suggest that 
social isolation causes a more dramatic increase in the AMPAR:NMDAR ratio when the mouse 
has been isolated from a larger number of cagemates. Therefore, prior social interaction may be 
an important factor in determining the synaptic potentiation following social isolation. 
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Figure 12. Social isolation, but not environmental novelty, potentiates synapses onto 
DRN/vlPAG dopamine neurons. (a) Injection protocol with representative AMPAR:NMDAR 
ratios, and (b) bar chart showing the mean (+ SEM) AMPAR:NMDAR ratio recorded in each 
condition A-D. The mean age for each experimental group was 7.7 weeks (A), 9.3 weeks (B), 6.6 
weeks (C), and 7.8 weeks (D). Scatter graph showing relationship between the number of mice 
per cage and the AMPAR:NMDAR ratio in (c) group-housed and (d) socially isolated mice. This 
revealed significant positive correlation in the socially isolated (r2 = 0.53, p < 0.01), but not the 
group-housed mice (r2 = 0.0003, p = 0.94). * indicates p < 0.05. 
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5.3.3. Effect of social isolation on VTA synapses 
The effect of acute social isolation on glutamatergic synapses onto VTA dopamine neurons has 
not been directly examined in previous studies. However, indirect evidence suggests that social 
isolation does not potentiate synapses in the VTA, because isolated saline-injected mice showed 
no difference in their AMPAR:NMDAR ratio compared to naïve, group-housed mice (present 
observations and Ungless et al., 2001). Nevertheless, I wanted to test directly whether social 
isolation potentiated glutamatergic synapses onto VTA dopamine neurons under the same 
conditions as I had used for examining this in the DRN/vlPAG.  
Mice were socially isolated in their original cage (i.e., protocol D in Fig. 12a) for 24 hours prior to 
brain slice preparation, and AMPAR:NMDAR ratios recorded for comparison with naïve, group-
housed mice (i.e., protocol A). VTA dopamine neurons showed no significant difference in the 
AMPAR:NMDAR ratio recorded in socially isolated mice (0.53 ± 0.04, n = 12) compared to naïve, 
group-housed mice (0.47 ± 0.05, n = 8; t18 = 0.73, p = 0.47; Fig. 13a,b). This suggests that acute 
social isolation does not potentiate glutamatergic synapses onto dopamine neurons in the VTA. 
These recordings were mostly performed in the region just medial to the MT, which has been 
shown to house a considerable proportion of stress-responsive NAc lateral shell-projecting 
neurons (Saal et al., 2003; Lammel et al., 2011). This, therefore, indicates that social isolation is 
unlikely to be an acute aversive or stressful stimulus, as there was no potentiation observed in 
this population. However, the VTA contains a large number of dopamine neurons and, given 
that there appears to be considerable projection-specificity in the midbrain dopamine 
population, it is not impossible that certain smaller subpopulations within the VTA, which do 
respond to social isolation, were not sampled in these experiments.  
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Figure 13. Social isolation does not potentiate synapses onto VTA dopamine neurons. (a) 
Injection protocol with representative examples and (b) bar chart showing the mean (+ SEM) 
AMPAR:NMDAR ratio in group-housed and socially isolated mice. The mean age for each 
experimental group was 5.8 weeks (naive) and 4.6 weeks (isolation). 
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5.3.4. Effect of cocaine, without social isolation, on DRN/vlPAG synapses 
These results suggested that social isolation can increase the AMPAR:NMDAR ratio in 
DRN/vlPAG dopamine neurons after just 24 hours. However, as both saline- and cocaine-
injected mice were isolated in the initial experiment (Fig. 11), the effect of cocaine on these 
synapses had yet to be determined. To investigate this, mice were given single saline or cocaine 
injections, but returned to their original cage, with their original cagemates, for the 24 hours 
prior to brain slice preparation. Under this protocol, I found that saline-injected mice did not 
display a significantly different AMPAR:NMDAR ratio compared to naïve mice (saline: 1.39 ± 
0.20, n = 8; naïve: 1.25 ± 0.14, n = 11; p > 0.05; Fig. 14a,b). However, cocaine-injected mice 
exhibited a significantly larger ratio (1.96 ± 0.22, n = 8; one-way ANOVA: F2,24 = 4.38, p < 0.05) 
than either naïve (p < 0.05) or saline-injected mice (p < 0.05). Therefore, cocaine, in the absence 
of social isolation was able to potentiate glutamatergic synapses onto DRN/vlPAG dopamine 
neurons. It is also noteworthy that the size of the AMPAR:NMDAR ratio following a single dose 
of cocaine given without isolation was no different to that observed following a single dose of 
cocaine with isolation (Fig. 11c,d; t14 = 0.59, p = 0.57), which suggests that social isolation and 
cocaine do not have an additive effect at these synapses. Furthermore, the ratio following 24 
hours of social isolation (Fig. 12a,b) was no different from a single dose of cocaine without 
isolation (t13 = 0.41, p = 0.69) suggesting that both these stimuli can potentiate these synapses 
to a similar extent. Examining the association between the AMPAR:NMDAR ratio and the 
number of mice per cage, pre-injection, did not reveal any significant correlation for the saline-
treated (r2 = 0.22, p = 0.29; Fig. 14c) or cocaine-treated mice (r2 = 0.11, p = 0.42; Fig. 14d). 
However, there is insufficient spread of data points for accurate analysis of correlation in the 
saline-treated group. 
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Figure 14. Cocaine, in the absence of social isolation, potentiates synapses onto DRN/vlPAG 
dopamine neurons. (a) Injection protocol with representative examples, and (b) bar chart 
showing mean (+ SEM) AMPAR:NMDAR ratio in naïve mice, or following a single dose of saline 
or cocaine without social isolation. The mean age for each experimental group was 7.7 (naive), 
7.0 weeks (saline), and 8.1 weeks (cocaine). Scatter graphs showing the relationship between 
the number of mice per cage and the AMPAR:NMDAR ratio found no correlation in either (c) 
saline- or (d) cocaine-treated mice. * indicates p < 0.05. 
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5.3.5. AMPAR:NMDAR ratio in identified VIP+ and VIP- dopamine neurons.  
The VIP projection from the DRN/vlPAG has been shown to exclusively target the dorsolateral 
(dl)BNST (Eiden et al., 1985; Petit et al., 1995; Kozicz et al., 1998). Co-expression of this 
neuropeptide may therefore delineate the dopaminergic projection to this structure, whereas 
VIP- neurons are likely to project to several different targets, including the central amygdala and 
ventral striatum. Given the projection-specificity of cocaine- and aversion-induced plasticity in 
the VTA reported by Lammel et al. (2011), it would be interesting to know whether plasticity in 
the DRN/vlPAG shows a similar organisation. However, I generally found that there was a bias 
towards recording from the large, multipolar, ventrally-located neurons within the DRN/vlPAG 
(which are mostly VIP-) for two reasons. Firstly, due to the ventrolateral positioning of the 
stimulating electrode, recording from the small periaqueductal GFP+ neurons would have 
required placing the electrode on top of many of these ventral GFP+ neurons, and secondly, it 
was usually easier to evoke adequate-sized currents in the large, multipolar neurons compared 
to the small periaqueductal neurons. As mentioned above, a lower proportion of neurons were 
successfully recovered using immunohistochemistry for post-hoc identification, and so I did not 
obtain sufficient numbers of identified VIP+ and VIP- neurons in each experimental condition for 
accurate comparison. 
Nevertheless, for several groups I did record from a sufficient number of VIP- neurons to 
conclude that they showed the same significant changes described for the whole sample. 
Specifically, VIP- neurons in the DRN/vlPAG showed a significantly larger ratio (one-way ANOVA: 
F3,14 = 9.46, p < 0.01) in mice that were socially isolated with (protocol B: 2.1 ± 0.10, n = 4) or 
without (protocol D: 2.3 ± 0.29, n = 4) environmental novelty, compared to naïve mice (protocol 
A: 1.12 ± 0.16, n = 5; A vs B: p < 0.05; A vs D: p < 0.01) or those exposed to a novel environment 
without isolation (protocol C: 1.17 ± 0.21, n = 5; C vs B: p < 0.05; C vs D: p < 0.01; Fig. 15a). 
126 
 
Additionally, similar to the results from sampling the whole population, there was no difference 
in the AMPAR:NMDAR ratio of VIP- neurons from naïve mice compared to those exposed to a 
novel environment without isolation (A vs C: p > 0.05), or from mice socially isolated with or 
without environmental novelty (B vs D: p > 0.05). I also recorded from a sufficient number of 
identified VIP- neurons to confirm the effect of a single dose of cocaine without social isolation 
(Fig. 15b). The AMPAR:NMDAR ratio in VIP- neurons from saline-injected mice (1.30 ± 0.14, n = 
5) was not significantly different from that of naïve mice (1.12 ± 0.16, n = 5; p > 0.05), but ratios 
recorded in cocaine-injected mice (2.05 ± 0.24, n = 6) were significantly larger (one-way ANOVA: 
F2,14 = 4.28, p < 0.05) than those from either saline-injected (p < 0.05) or naïve (p < 0.05) mice. 
When pooling data from multiple groups, I found that VIP+ neurons showed a trend towards 
larger AMPAR:NMDAR ratios following social isolation (1.53 ± 0.07, n = 3) compared to group-
housed mice (1.17 ± 0.19, n = 6; Fig. 15c). However, this difference was not as pronounced as in 
VIP- neurons, and did not reach statistical significance (t7 = 1.30, p = 0.24). This may be due to 
the small sample size, and therefore more data is required to confirm the effect of social 
isolation on the VIP+ population.  
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Figure 15. Effect of social isolation, environmental novelty, and cocaine on identified VIP+ and 
VIP- dopamine neurons. Bar charts showing the mean (+ SEM) AMPAR:NMDAR ratio in 
identified VIP- neurons following (a) social isolation and/or environmental novelty, and (b) a 
single dose of saline or cocaine without social isolation. (c) Bar chart showing the mean (+ SEM) 
AMPAR:NMDAR ratio in identified VIP+ neurons from group-housed and socially isolated mice, 
pooled from multiple experimental groups. * indicates p < 0.05. 
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5.4. Conclusion 
Utilising the AMPAR:NMDAR ratio to assay synaptic strength, I have demonstrated here that 
acute social isolation and/or a single dose of cocaine can potentiate glutamatergic synapses 
onto DRN/vlPAG dopamine neurons. Importantly, this adds to the list of manipulations which 
can potentiate excitatory synapses onto dopamine neurons. The effect of social isolation 
appears to be exclusive to this population as it was not observed in dopamine neurons of the 
VTA. However, given the large number of cells within the VTA, and their multiple projection 
targets, it may be that the whole population was not uniformly sampled in these recordings. 
Therefore this result does not exclude the possibility that there are certain subpopulations 
within the VTA that can also respond to social isolation. Nevertheless, these findings support the 
hypothesis that the DRN/vlPAG dopamine neurons are a distinct functional subpopulation, and 
intriguingly propose another motivationally-relevant cue that may be processed by the 
dopamine system. This result also has relevance to neuropsychiatric disorders for which social 
isolation is frequently used as an animal model, for example depression and schizophrenia (Kim 
and Kirkpatrick, 1996; Jones et al., 2011).  
This potentiation appears to be specific to social isolation, and is not associated with 
environmental novelty, as animals moved to a new cage with the same conspecifics did not 
exhibit a larger AMPAR:NMDAR ratio compared to those which remained in their original cage. 
This is significant, as it has been demonstrated that exposure to a different cage for just 1 hour 
can increase the AMPAR:NMDAR ratio in medium spiny neurons of the NAc shell, measured 
after 24 hours (Rothwell et al., 2011). This was attributed to the novelty of the new cage, and 
disappeared following repeated habituation to the same environment (Rothwell et al., 2011). 
However, the influence of acute social isolation was not considered in this study. It should also 
be noted that ‘environmental novelty’ in Rothwell et al. referred to a different type of cage in a 
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different room, to which the animal had not been previously exposed. However, in my 
experiments the ‘novel environment’ refers to a clean cage which is essentially identical to their 
original cage, and located in the same room near other conspecifics. It is possible that a more 
robust novel stimulus may induce potentiation in certain populations of dopamine neurons, but 
this has not been investigated. The findings of Rothwell et al. and the present results do, 
however, add weight to the idea that more subtle changes in an animal’s environmental 
conditions (which might not be considered strongly rewarding or aversive) may induce synaptic 
adaptations in the mesolimbic dopamine system and its projection targets. This may have 
important consequences for dopamine release in downstream projection sites, and may be 
associated with both short- and long-term changes in behaviour. 
I also found that there was a highly significant positive correlation between the number of mice 
in the cage before isolation, and the AMPAR:NMDAR ratio following 24 hours of social isolation. 
This suggests that the strength of the potentiation is directly related to the loss of previous 
social interaction, and is not an artefact relating to another feature of the social isolation 
procedure. Hence, a mouse which is isolated from just one other cagemate will exhibit a smaller 
increase in the AMPAR:NMDAR ratio compared to a mouse isolated from a larger number of 
cagemates. Therefore the degree of loss in social contact appears to be a strong predictor of 
isolation-induced synaptic potentiation. 
The DRN/vlPAG dopamine neurons have several projection targets, but co-expression of VIP 
may selectively mark the dlBNST projection. It would, therefore, be of interest to determine 
whether this projection is modified by cocaine and/or social isolation. Due to the bias in 
recording from large ventral neurons, the majority of the sample is likely to consist of VIP- 
neurons. Furthermore, recovering recorded, labelled cells with immunohistochemistry was 
more challenging with these longer-duration recordings, and so few successfully identified VIP+ 
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neurons were obtained. I was, however, able to record a sufficient number of identified VIP- 
neurons to conclude that they show the same potentiation as described for the whole 
population. Identified VIP+ neurons also showed the same trend for an increase in the 
AMPAR:NMDAR ratio following social isolation, but this was not statistically significant, and the 
sample size was too small to draw a clear conclusion. An essential part of future work would be 
to increase the sample size of VIP+ neurons in naïve and socially isolated mice in order to 
determine whether social isolation can produce synaptic adaptations in this population.  
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Chapter 6. Characterisation of plasticity in DRN/vlPAG dopamine 
neurons 
 
6.1. Introduction 
Many different types of long-term potentiation (LTP) and long-term depression (LTD) have been 
described, differing in their mechanism of induction and expression (Malenka and Bear, 2004). 
Several of these have been observed in dopamine neurons of the VTA (Bonci and Malenka, 
1999; Jones et al., 2000; Thomas et al., 2000; Bellone and Lüscher, 2005; Liu et al., 2005; Luu 
and Malenka, 2008; Mameli and Lüscher, 2011). One of the best described forms is NMDAR-
dependent LTP, which can be mimicked by high frequency stimulation in brain slices (Bonci and 
Malenka, 1999). The potentiation observed in the VTA following an acute dose of cocaine 
closely resembles that of NMDAR-dependent LTP (Ungless et al., 2001). Cocaine-evoked 
plasticity is reliant on NMDAR activation during induction, and a stimulation protocol used to 
evoke NMDAR-dependent LTP in dopamine neurons is no longer effective following a dose of 
cocaine, suggesting an occlusion of further strengthening at these synapses (Ungless et al., 
2001; Adams and Sweatt, 2002; Argilli et al., 2008; Luu and Malenka, 2008). 
A change in the AMPAR:NMDAR ratio, such as that observed following a single dose of cocaine, 
could reflect an increase in AMPAR transmission, a reduction in NMDAR transmission, or a 
concomitant change in both receptors. This usually results from postsynaptic modifications at 
the synapse, but could also be due to presynaptic changes in the probability of glutamate 
release, although this is likely to impact equally on the synaptic response of both types of 
receptor (Malenka and Nicoll, 1999).  
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6.1.1. Cocaine-induced plasticity: presynaptic expression 
In order to assay a change in the relative probability of presynaptic neurotransmitter release 
(Pr), paired-pulse stimulation in brain slices is frequently employed, and changes in the PPR are 
usually attributed to changes in presynaptic function (Zucker, 1989; Dobrunz and Stevens, 1997; 
Zucker and Regehr, 2002). Consistent with the view that cocaine induces a postsynaptic, but not 
presynaptic, change, there is no difference in the PPR following a single dose of cocaine 
compared to saline, suggesting that the probability of glutamate release is unaltered (Ungless et 
al., 2001).  
6.1.2. Cocaine-induced plasticity: postsynaptic expression 
The cocaine-induced increase in the AMPAR:NMDAR ratio in VTA dopamine neurons was 
originally attributed to a strengthening of AMPAR transmission, as bath application of 
exogenous AMPA, but not NMDA, resulted in an increase in receptor current following cocaine 
(Ungless et al., 2001). Additional evidence for an upregulation of AMPARs was provided through 
recording miniature (m)EPSCs in VTA dopamine neurons, which increased in both the amplitude 
and frequency following a single cocaine, but not saline injection (Ungless et al., 2001). 
Measurement of mEPSCs, which arise from spontaneous exocytosis of presynaptic vesicles of 
glutamate, is a standard method used to determine the locus of a synaptic change. A change in 
mEPSC amplitude is generally attributed to a postsynaptic change in receptor number and/or 
function, whereas a change in frequency could reflect a change in the Pr, or a change in the 
receptor number due to the uncovering of ‘silent’ synapses (Isaac et al., 1995; Malenka and 
Nicoll, 1999). An increase in frequency could also result from an increase in the amplitude of 
events, as the detection threshold is often very close to the mean, so an increase in amplitude 
would improve detection of smaller events. 
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6.1.2.1. Switch in AMPAR subunit composition 
It has subsequently been demonstrated that the increase in AMPAR current is associated with a 
change in subunit composition of the postsynaptic AMPARs, from GluR2-containing to high-
conductance GluR2-lacking receptors (Bellone and Lüscher, 2006). AMPARs are heterotetramer 
assemblies of four types of subunit, GluR1-4, with the presence of the GluR2 subunit dictating 
the cation-permeability of the AMPAR (Keinanen et al., 1990; Hollmann et al., 1991; Wisden and 
Seeburg, 1993; Hollmann and Heinemann, 1994; Mano and Teichberg, 1998; Rosenmund et al., 
1998; Mayer, 2005; Isaac et al., 2007). GluR2-containing receptors are permeable mostly only to 
Na+ and K+ ions, but the absence of this subunit creates an AMPAR that is permeable to both 
Ca2+ and Zn2+ , and also exhibits higher single channel conductance (Jonas and Burnashev, 1995; 
Kamboj et al., 1995; Liu and Zukin, 2007). GluR2-lacking receptors are susceptible to voltage-
dependent block by intracellular polyamines (e.g., spermine), which inhibit the AMPAR current 
at positive potentials, resulting in a characteristic inwardly-rectifying I-V curve (Verdoorn et al., 
1991; Bowie and Mayer, 1995; Jonas and Burnashev, 1995; Kamboj et al., 1995; Koh et al., 1995; 
Washburn et al., 1997; Pellegrini-Giampietro, 2003). This rectification can be quantified in brain 
slices by recording the AMPAR current at positive and negative potentials, and calculating the 
rectification index (RI: typically the peak amplitude at -70 mV relative to the peak amplitude at 
+40 mV; e.g., Mameli et al., 2007; Mameli et al., 2009).  
The incorporation of GluR2-lacking AMPARs was first demonstrated in very young mice which 
showed a significant increase in the AMPAR RI, and a sensitivity to polyamines following a single 
dose of cocaine but not saline (Bellone and Lüscher, 2006). This has subsequently been 
confirmed in older mice (Mameli et al., 2009) and rats (Argilli et al., 2008; Good and Lupica, 
2010). Furthermore, the redistribution of the GluR2 subunit from synaptic regions to 
intracellular compartments has been revealed through the use of electron microscopy (Mameli 
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et al., 2007; Brown et al., 2010), and the increased single channel conductance of the AMPARs 
demonstrated through nonstationary ﬂuctuation analysis (Mameli et al., 2007). 
The incorporation of AMPARs with a specific subunit composition is reminiscent of LTP in other 
brain regions such as the hippocampus, in which GluR2-containing AMPARs are transiently 
replaced by GluR2-lacking AMPARs following LTP induction (Shi et al., 1999; Hayashi et al., 2000; 
Liu and Cull-Candy, 2000; Malinow and Malenka, 2002; Song and Huganir, 2002; Bredt and 
Nicoll, 2003; Malenka and Bear, 2004; Plant et al., 2006). Some studies, however, have failed to 
detect this change in AMPAR rectification following cocaine (e.g., Dong et al., 2004; Faleiro et 
al., 2004), which may be due to technical differences in experimental conditions (Kauer and 
Malenka, 2007). However, there is also controversy over whether a switch in subunit 
composition of AMPARs is required for NMDAR-dependent LTP in other regions (Adesnik and 
Nicoll, 2007; Kopec et al., 2007). 
6.1.2.2. NMDAR transmission 
One limitation to the hypothesis that cocaine-evoked potentiation involves a partial exchange of 
GluR2-containing for rectifying GluR2-lacking AMPARs, is that given that these AMPARs pass 
minimal current at positive potentials, this would not account for the increase observed in the 
AMPAR:NMDAR ratio measured at +40 mV (even in the presence of spermine; Mameli et al., 
2007; Mameli et al., 2009; Good and Lupica, 2010; Lammel et al., 2011; Mameli et al., 2011). 
However, a solution to this conundrum was recently provided through the demonstration that 
cocaine-evoked plasticity is also associated with a reduction in NMDAR transmission (Mameli et 
al., 2011). This was shown by activating single synapses using 2-photon laser photolysis of caged 
glutamate, which revealed a reduction in NMDAR current at the same synapses that showed 
strong-rectification of the AMPAR current, suggesting synapse-specific modification by cocaine 
(Mameli et al., 2011). This change in NMDAR transmission had not been previously identified 
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using conventional methods of bath application of exogenous NMDA (Ungless et al., 2001; 
Borgland et al., 2004), probably due to its non-specific action on both synaptic and extrasynaptic 
NMDARs, which precluded detection of a selective change in the synaptic population of 
receptors (Kullmann et al., 1999; Mameli et al., 2011). 
6.1.3. Plasticity induced by other addictive drugs 
A switch in the subunit composition of AMPARs, and a reduction in NMDAR current, is thought 
to be integral to the expression of cocaine-induced synaptic plasticity in VTA dopamine neurons. 
However, in spite of the observation that many different classes of addictive drug can induce 
this increase in the AMPAR:NMDAR ratio (Saal et al., 2003), there are both similarities and 
differences in their mechanism of induction and expression. For example, benzodiazepines have 
been shown to increase the RI of the AMPAR current (Tan et al., 2010), but increase the 
frequency of mEPSCs rather than the amplitude (Heikkinen et al., 2009), while nicotine-induced 
potentiation is associated with a change in the probability of glutamate release, as shown by a 
reduction in the PPR (Gao et al., 2010). Additionally, potentiation induced by self-administration 
of cocaine, or a natural reward, is associated with an increase in the frequency, but not 
amplitude of mEPSCs (Chen et al., 2008). Furthermore, stress-induced potentiation of excitatory 
synapses in the VTA is NMDAR-dependent but, unlike cocaine-evoked potentiation, it can be 
blocked by a glucocorticoid receptor antagonist, but not by a D1-receptor antagonist (Saal et al., 
2003; Dong et al., 2004), suggestive of a different induction mechanism.  
6.1.4. Expression of plasticity in DRN/vlPAG dopamine neurons 
Given that cocaine-induced plasticity in VTA dopamine neurons has been well characterised, I 
considered whether the potentiation observed in DRN/vlPAG dopamine neurons would exhibit a 
similar mechanism of expression. As discussed, there are a variety of electrophysiological 
136 
 
protocols which are frequently employed to assay presynaptic and postsynaptic changes at 
synapses. I have utilized three of these, namely the PPR, RI, and mEPSCs, in order to examine 
AMPAR transmission in DRN/vlPAG dopamine neurons. I have recorded these measures in mice 
which have been group-housed, socially isolated, or received a single injection of saline or 
cocaine (without isolation) 24 hours before brain slice preparation. In this way, I have compared 
the characteristics of both cocaine-induced and social isolation-induced potentiation at these 
synapses.  
6.2. Materials and methods 
6.2.1. Injection and social isolation protocol 
TH-GFP or Pitx3-GFP mice (1-4 months) received a single dose of cocaine (15 mg/kg), or the 
equivalent volume of 0.9% saline, administered via intraperitoneal (IP) injection at a volume of 
10 ml/kg. Injections were performed at 10.00 am, and the injected mouse was subsequently 
either transferred to a clean cage alone for 24 hours, or returned to the original cage, before 
brain slice preparation. For social isolation, all cagemates were removed at 10.00 am to leave a 
single mouse alone in its original cage for 24 hours before brain slice preparation.  All injections 
were carried out by Piotr Czapski. 
6.2.2. Electrophysiology 
Coronal or horizontal 220 µm brain slices containing the DRN/vlPAG or VTA, respectively, were 
prepared and maintained  as described in chapter 3. Whole-cell patch-clamp recordings were 
performed as described in chapter 4, using the cesium-based internal (composition in mM: 
CsCH3SO3 130, NaCl 2.8, HEPES 20, EGTA 0.4, TEA-Cl 5, MgATP 2, Li-GTP 0.5, and 0.1% 
neurobiotin; pH 7.3, osmolarity 280-290 mosmol/l), and with 100 µM picrotoxin in the aCSF 
throughout the experiments. EPSCs were evoked using a bipolar stimulating electrode (FHC, 
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USA) placed 100-300 µm ventrolateral recorded neuron. Stimulus intensity was controlled using 
an ISO-flex stimulus isolator (AMPI, Jerusalem, Israel) and adjusted to evoke monosynaptic 
events, typically using a stimulus intensity of 10-40 V, 500 μs duration. To measure the PPR, two 
afferent stimuli were delivered with an inter-stimulus interval of 50 ms while holding the cell at -
70 mV in voltage-clamp. The PPR was calculated by dividing the average peak amplitude of the 
EPSC generated by the second stimulus by the average peak amplitude generated by the first. 
When recording rectification indices (RIs) 0.1 mM spermine was included in the internal 
solution. To calculate the RI, 50 µM AP5 was added to the aCSF, and the AMPAR current 
recorded while holding the neuron at -70 mV, 0 mV, and +40 mV. The RI was calculated by 
dividing the average peak of the AMPAR current recorded at -70 mV by the average peak 
recorded at +40 mV.  AMPAR:NMDAR ratios were recorded at +40 mV as described in chapter 4. 
The decay kinetics of the AMPAR-mediated and NMDAR-mediated current recorded at +40 mV 
were determined by fitting the decay phase of the current with an exponential curve using Spike 
2 (Cambridge Electronic Design, UK). The AMPAR current was fitted with a single exponential 
function and the NMDAR-mediated current was fitted with a double exponential function. 
Miniature (m)EPSCs were recorded for at least 3 min while holding the neuron at -70 mV, in the 
presence of 1 µM tetradotoxin citrate (TTX). MiniAnalysis 6.0.7 (Synaptosoft, Fort Lee, NJ) was 
used to detect and analyse mEPSCs with the threshold set at 7 pA, and events subsequently 
verified by eye to confirm fast rise (<3 ms) and exponential decay kinetics. 
6.2.3. Statistics 
Statistical analysis was performed using Prism 5.04 (Graphpad, CA, USA) and values are reported 
as mean ± standard error of the mean (SEM). PPRs, RIs, and mean values for mEPSCs were 
compared using a one-way ANOVA with Newman-Keuls multiple comparison tests, and 
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cumulative frequency distributions of mEPSCs were compared using a two-way ANOVA, with 
Newman-Keuls multiple comparison tests. 
6.3. Results 
As in chapter 5, data collected from all GFP+ neurons in TH-GFP and Pitx3-GFP mice has been 
pooled, unless otherwise stated. The mean age for each experimental group in the DRN/vlPAG 
was 8.4 weeks (naive), 6.9 weeks (socially isolated), 7.4 weeks (saline), 9.4 weeks (cocaine), and 
6.4 weeks (cocaine with isolation). 
6.3.1. Paired-pulse ratio (PPR) 
I calculated the PPR from the peak of the AMPAR current response to paired-pulse stimulation 
at -70 mV, in the presence of picrotoxin. Individual PPRs in the DRN/vlPAG tended towards 
either slight depression or slight facilitation, and so the mean was generally around 1. I found no 
significant difference in the PPR between naïve (1.06 ± 0.09, n = 15), socially isolated (1.35 ± 
0.21, n = 6), saline-treated (0.908 ± 0.15, n = 11) or cocaine-treated mice (1.07 ± 0.08, n = 13; 
one-way ANOVA: F13,43 = 1.81, p = 0.16; Fig. 16). This suggests that the probability of glutamate 
release is similar in all four groups.  
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Figure 16. AMPAR PPR in DRN/vlPAG dopamine neurons is unchanged following social isolation 
or a single dose of cocaine. (a) Bar chart (mean + SEM) and (b) representative examples of the 
PPR in naïve, socially isolated, saline-, and cocaine-treated mice. 
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6.3.2. AMPAR currents recorded in the presence of spermine 
AMPAR-mediated current was evoked at holding potentials of -70 mV, 0 mV, and +40 mV, in 
order to calculate the RI. The RI values recorded in DRN/vlPAG GFP+ neurons in naïve mice were 
generally slightly lower (1.61 ± 0.26, n = 9) than previously reported values for the VTA (∼2; 
Bellone and Lüscher 2006; Mameli et al., 2009; Tan et al., 2010). This suggests that perhaps the 
basal subunit composition of the AMPARs in the DRN/vlPAG may differ slightly from the VTA, or 
this may be a result of the coronal (as opposed to horizontal) slice preparation and the 
stimulation of different afferent inputs. Following a dose of cocaine in the VTA, the RI has been 
shown to increase to around 3.0-3.5 in mice (Bellone and Lüscher, 2006; Mameli et al., 2009). I 
found that either a single dose of cocaine (2.5 ± 0.13, n = 8), or 24 hours of social isolation (2.2 ± 
0.19, n = 10) caused a significant increase in the RI (one-way ANOVA: F3,31 = 6.05, p < 0.01), 
compared to either naïve mice (1.61 ± 0.26, n = 9; naïve vs cocaine: p < 0.01; naïve vs isolation: p 
< 0.05) or those which had received a single dose of saline (1.55 ± 0.07, n = 8; saline vs cocaine: 
p < 0.01; saline vs isolation: p < 0.05; Fig. 17a,b). This is suggestive of an increased presence of 
GluR2-lacking receptors, which are inhibited by intracellular polyamines at positive potentials, 
resulting in positive rectification. Furthermore, there was no significant difference between the 
RI in naïve and saline-injected mice (p > 0.05) or between socially isolated and cocaine-treated 
mice (p > 0.05), suggesting that both social isolation and cocaine induce similar modifications to 
the AMPAR subunit composition. 
Interestingly, although the PPR is routinely used to indicate a presynaptic change at a synapse, 
under certain conditions it can also indicate a postsynaptic change. In particular, the 
postsynaptic expression of the GluR2 subunit of the AMPAR can influence the degree of paired-
pulse facilitation (Rozov and Burnashev, 1999). This is because intracellular polyamines can 
partially block GluR2-lacking AMPARs at resting membrane potentials (Bowie and Mayer, 1995). 
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However, opening of the receptor (i.e. stimulation-evoked synaptic current) can temporarily 
relieve this blockade, which results in a greater response to subsequent stimulation (Rozov et 
al., 1998; Rozov and Burnashev, 1999; Armstrong and MacVicar 2001; Bagal et al., 2005). This, 
therefore, affects short-term plasticity at the synapse, by promoting paired-pulse facilitation at 
GluR2-lacking but not GluR2-containing synapses (Liu and Zukin, 2007; Savtchouk and Liu, 2011). 
I therefore analysed PPRs recorded in the presence of spermine, and found a non-significant 
trend (one-way ANOVA: F3,43 = 2.05, p = 0.12) towards an increase in the ratio following either a 
single dose of cocaine (1.50 ± 0.21, n = 11), or 24 hours of social isolation (1.38 ± 0.16, n = 13), 
compared to either saline-injected (1.09 ± 0.10, n = 16) or naïve mice (0.99 ± 0.13, n = 7; Fig. 
17c,d). Although this was not statistically significant, the direction of the trend is consistent with 
what would be expected at synapses where there has been a switch from GluR2-containing to 
GluR2-lacking receptors (Rozov and Burnashev, 1999). It is likely that utilising a smaller inter-
stimulus interval of, for example 10 ms (Savtchouk and Liu, 2011), may be more suitable to 
reveal this difference, as there would be less time for intracellular polyamines to re-establish 
their blockade of the receptors. Additionally, the difference may be small and harder to detect 
than a change in rectification, but increasing the sample size for this protocol would be an 
important part of future work. 
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Figure 17. AMPAR rectification index (RI) is increased, and the PPR measured with polyamine 
blockade shows a trend towards facilitation, following social isolation or a single dose of 
cocaine. Bar chart (mean + SEM) and representative examples of (a,b) AMPAR RI and (c,d) the 
PPR in naïve, socially isolated, saline-, and cocaine-treated mice. * indicates p < 0.05. 
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6.3.3. Decay kinetics of evoked AMPAR and NMDAR current 
I next examined the decay kinetics of the AMPAR current at +40 mV and -70 mV, and the 
NMDAR current at +40 mV, by fitting the decay to one or two exponentials for the AMPAR-
mediated and NMDAR-mediated current, respectively. There was no significant difference in the 
weighted time constant (τW) of the NMDAR decay (one-way ANOVA: F3,30 = 0.52, p = 0.67) 
between the four groups (naïve: 110.8 ± 16.7 ms, n = 12; isolation: 86.67 ± 15.0 ms, n = 6; saline: 
122.9 ± 13.8 ms, n = 8; cocaine: 110.0 ± 27.3 ms, n = 8; Fig. 18a), or the AMPAR decay time 
constant measured at -70 mV (naïve: 2.53 ± 0.16 ms, n = 9; isolation: 3.08 ± 0.31 ms, n = 10; 
saline: 3.00 ± 0.32 ms, n = 9; cocaine: 2.92 ± 0.31 ms, n = 8; : F3,32 = 0.74, p = 0.54; Fig. 18b). 
Additionally there was no difference in the decay time constant of the AMPAR current at +40 
mV measured either with spermine (naïve: 3.60 ± 0.37 ms, n = 9; isolation: 3.71 ± 0.22ms, n = 9; 
saline: 4.27 ± 0.50 ms, n = 9; cocaine: 3.34 ± 0.23 ms, n = 8; F3,31 = 1.20, p = 0.33; Fig. 18c) or 
without (naïve: 3.14 ± 0.27 ms, n = 15; isolation: 2.84 ± 0.42 ms, n = 7; saline: 2.65 ± 0.25 ms, n = 
8; cocaine: 2.72 ± 0.35ms, n = 8; F3,34 = 0.58, p = 0.64; Fig. 18d). 
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Figure 18. Decay kinetics of NMDAR and AMPAR current in DRN/vlPAG dopamine neurons 
following social isolation or a single dose of cocaine revealed no major differences. Bar charts 
(mean + SEM) and example traces with exponential fit (red line) showing the weighted decay 
time constant (τW) of the NMDAR current at +40 mV, (b) the decay time constant (τ) of the 
AMPAR current at -70 mV, and (c) the AMPAR current at +40 mV with spermine and (d) without 
spermine.  
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6.3.4. mEPSC amplitude and frequency 
AMPAR-mediated mEPSCs were recorded for typically 3-5 min at -70 mV in the presence of TTX, 
and events ≥7 pA detected for inclusion in the analysis. For each experimental group the mean 
amplitude and frequency is reported in bar charts (using an average from each recorded cell), 
and also the distribution of the events in a cumulative frequency graph. There was considerable 
variability in the frequency of recorded mEPSCs, from 0.023 Hz to 7.068 Hz, and so using all the 
recorded events to produce the cumulative frequency distribution would have caused 
significant bias towards cells with high event frequency. Equally, randomly selecting, for 
example 50 events per cell, may not have accurately represented the sample of events in these 
cells. Therefore to evaluate mEPSCs in the most accurate and unbiased manner, I calculated a 
cumulative frequency distribution for each recorded cell, and averaged these to give the final 
distribution of events. 
6.3.4.1. Effect of cocaine on mEPSCs in the VTA 
In the VTA, I observed a trend towards an increase in mEPSC amplitude following a single dose 
of cocaine (15.29 ± 1.25 pA, n = 13) compared to saline (13.13 ± 0.59 pA, n = 14; Fig. 19a), 
similar to previous reports (Ungless et al., 2001). This did not reach statistical significance using 
a t-test on the mean amplitudes (t25 = 1.62, p = 0.12; Fig. 19b), but the cumulative distribution of 
mEPSC amplitude showed a clear shift to the right (Fig. 19c), indicative of a greater proportion 
of larger amplitude events. A two-way ANOVA revealed a significant main effect of treatment 
(interaction between treatment and bin amplitude, F22,575 = 1.41, p = 0.10; main effect of 
treatment, F1,575 = 12.45, p < 0.0005; main effect of bin amplitude, F22,575 = 540.99, p < 0.0001) 
with a significant difference between 5-15 pA events (p < 0.001). Additionally, I found no 
significant difference in the frequency of mEPSCs between cocaine-treated (1.15 ± 0.43 Hz, n = 
13) and saline-treated (1.09 ± 0.25 Hz) mice (t25 = 0.13, p = 0.90; Fig. 19d,e). This contrasts to the 
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finding in Ungless et al. that both amplitude and frequency increase following a dose of cocaine, 
but this may have been a result of the high sucrose used for recording these events in this study. 
These recordings in the VTA, however, are indicative of an increase in the amplitude of AMPAR-
mediated events, without a change in presynaptic glutamate release, which is consistent with an 
increase in AMPAR transmission (Lüscher and Malenka, 2011). 
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Figure 19. Increase in mEPSC amplitude, but not frequency, in VTA dopamine neurons following 
a single dose of cocaine. (a) Representative examples of mEPSCs from a saline-treated and a 
cocaine-treated mouse. (c,d) Bar charts (mean + SEM) and (e,f) cumulative frequency graphs 
showing mEPSC amplitude, frequency, and inter-event interval (IEI). A two-way ANOVA revealed 
a significant main effect of treatment on mEPSC amplitude (p < 0.05). The mean age for each 
experimental group was 4.5 weeks (saline) and 4.5 weeks (cocaine). 
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6.3.4.2. Effect of social isolation or cocaine on mEPSCs in the DRN/vlPAG 
In the DRN/vlPAG, I found that there was no significant difference in the mean amplitude of 
mEPSCs in the four experimental groups (naïve: 19.17 ± 1.11 pA, n = 21; isolated: 22.13 ± 1.60 
pA, n = 18; saline: 19.86 ± 0.80 pA, n = 12; cocaine: 21.69 ± 1.06 pA, n = 17; F3,64 = 1.40, p = 0.25; 
Fig. 20a,b), but again a clear shift towards larger amplitude events was revealed in the 
cumulative frequency distribution for both mice which had been socially isolated for 24 hours 
and those which had received a single dose of cocaine (Fig. 20c). A two-way ANOVA found a 
significant effect of group (interaction between treatment and bin amplitude, F102,2275 = 1.12, p = 
0.19; main effect of treatment, F3,2275 = 9.84, p < 0.0001; main effect of bin amplitude, F34,2275 = 
739.80, p < 0.0001), with post-hoc tests revealing a significant difference between cocaine-
injected and naïve mice at 10-25 pA events (p < 0.05) and between cocaine-injected and saline-
injected mice at 5-20 pA events (p < 0.05). Similarly there was a significant difference between 
socially isolated and naïve mice at 10-25 pA events (p < 0.05) and socially isolated and saline-
injected mice at 5-20 pA events (p < 0.05). However, there was no significant difference 
between naïve and saline-injected mice, or between cocaine-injected and socially isolated mice, 
at any amplitude level. This shift in mEPSC amplitude distribution indicates an increase in 
AMPAR number or function, which may result from an increase in receptor conductance, as 
suggested by the RI data.  
Interestingly, there was a significant difference in the mean frequency of mEPSCs (F3,64 = 3.02, p 
< 0.05), which reached statistical significance in post-hoc comparisons between naïve (0.83 ± 
0.26 Hz, n = 21) and cocaine-treated mice (2.31 ± 0.56 Hz, n = 17, p < 0.05), but not for saline-
treated (0.91 ± 0.30 Hz, n = 12, p > 0.05), or socially isolated mice (1.17 ± 0.39 Hz, n = 18, p > 
0.05; Fig. 20d). The cumulative frequency distribution of inter-event intervals (IEIs) showed a 
clear shift towards smaller IEIs in cocaine-treated mice, with saline-treated and socially isolated 
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mice displaying an intermediate distribution between naïve and cocaine-treated mice (Fig. 20e). 
This suggests that a single dose of cocaine or social isolation appear to affect the amplitude of 
mEPSCs to a similar extent, but only cocaine has a robust effect on event frequency.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
150 
 
 
Figure 20. Social isolation or a single dose of cocaine increases mEPSC amplitude in DRN/vlPAG 
dopamine neurons, but only cocaine increases the frequency. (a) Representative examples of 
mEPSCs, (b,d) bar charts (mean + SEM), and (c,e) cumulative frequency graphs showing mEPSC 
amplitude, frequency, and IEI, in naïve, socially isolated, saline-, and cocaine-treated mice. A 
two-way ANOVA revealed a significant main effect of treatment on mEPSC amplitude (p < 0.05). 
* indicates p < 0.05. 
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6.3.4.3. Cocaine in the presence or absence of social isolation 
I also examined mEPSCs in mice which received cocaine with social isolation, and mice which 
received cocaine without social isolation. I found no difference in the mean mEPSC amplitude 
(cocaine with isolation: 23.49 ± 2.84 pA, n = 12; cocaine without isolation: 21.69 ± 1.06 pA, n = 
17, t27 = 0.67, p = 0.51; Fig. 21a) or the cumulative distribution of events (interaction between 
treatment and bin amplitude, F27,756 = 0.18, p = 1.00; main effect of treatment, F1,756 = 3.84, p = 
0.06; main effect of bin amplitude, F27,756 = 211.40, p < 0.0001; Fig. 21b). There was also no 
difference in mEPSC frequency (cocaine with isolation: 1.86 ± 0.40 Hz, n = 12; cocaine without 
isolation: 2.32 ± 0.56 Hz, n = 17; t26 = 0.59, p = 0.56; Fig. 21c,d) between these two groups. This 
suggests (consistent with the AMPAR:NMDAR ratios) that there is no additive effect of cocaine 
and social isolation at these synapses.  
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Figure 21. Cocaine with social isolation has the same effect on mEPSC amplitude and frequency 
as cocaine without social isolation. (a,b) Bar charts (mean + SEM) and (c,d) cumulative frequency 
graphs showing mEPSC amplitude, frequency, and IEI. 
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6.3.5. Characteristics of AMPAR current in identified VIP+ and VIP- neurons 
Similar to the recordings in chapter 5, I found a general bias towards recording from VIP- 
neurons, and the longer-duration recordings often precluded post-hoc identification of recorded 
neurons. However, for many of the protocols I recorded from a sufficient number of identified 
neurons to confirm the characteristics of VIP- neurons, and in some cases (using pooled data) 
also VIP+ neurons.  
6.3.5.1. PPR 
Interestingly, under these recording conditions (cesium-based internal and picrotoxin in the 
aCSF, compared to potassium gluconate-based internal and the absence of picrotoxin in chapter 
4) I found no difference in the PPR between VIP+ and VIP- neurons (VIP+: 1.10 ± 0.17, n = 5; VIP-: 
1.11 ± 0.15, n = 7; t10 = 0.03, p = 0.98). This suggests that perhaps this reflected differences in 
GABAAR-mediated modulation of AMPAR transmission or glutamate release. There was also no 
difference in the PPR in VIP- neurons between naïve (1.11 ± 0.15, n = 7), socially isolated (1.40 ± 
0.33, n = 4), saline-treated (0.90 ± 0.16, n = 10) or cocaine-treated mice (1.03 ± 0.16, n = 6; F3,23 = 
1.06, p = 0.39; Fig. 22a), indicating that there is no change in presynaptic glutamate release in 
the VIP- subpopulation.  
6.3.5.2. AMPAR current in the presence of spermine  
The RI in identified VIP- neurons displayed a similar trend to the whole population sample, with 
an increase following social isolation (2.18 ± 0.15, n = 7) or a single dose of cocaine (2.60 ± 0.15, 
n = 3), compared to naïve (1.49 ± 0.26, n = 7) or saline-treated mice (1.41 ± 0.12, n = 3; one-way 
ANOVA: F3,16 = 5.31, p < 0.01; Fig. 22b), but this only reached statistical significance for the post-
hoc comparison between cocaine-treated mice and naive (p < 0.05) or saline-treated mice (p < 
0.05). Furthermore, the same trend towards paired-pulse facilitation was displayed by cocaine-
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injected (1.34 ± 0.29, n = 4) and socially isolated mice (1.41 ± 0.32, n = 6) in identified VIP- 
neurons, when recorded in the presence of spermine, in comparison to naïve (0.92 ± 0.06, n = 4) 
or saline-treated mice (0.97 ± 0.22, n = 6; Fig. 22c). However, as with the result from all 
recorded GFP+ cells, this was not overall statistically significant (F3,16 = 0.91, p = 0.46). Some of 
these groups are only made up of a few cells for these protocols, therefore increasing the 
sample size may provide a more conclusive result. 
 
 
 
 
 
 
 
 
 
 
 
 
 
155 
 
 
Figure 22. AMPAR current in identified VIP- neurons following social isolation or a single dose of 
cocaine. Bar charts (mean + SEM) showing (a) PPR, (b) RI, and (c) PPR with polyamine block in 
naïve, socially isolated, saline-, and cocaine-treated mice. * indicates p < 0.05. 
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6.3.5.3. Decay kinetics of evoked AMPAR and NMDAR current 
The τW of the NMDAR current decay did not differ significantly in VIP- neurons between the four 
experimental groups (naïve: 76.54 ± 37.24 ms, n = 4; social isolation: 66.83 ± 12.22 ms, n = 4; 
saline: 104.92 ± 16.31 ms, n = 5; cocaine: 79.00 ± 18.69 ms, n = 7; F3,16 = 0.52, p = 0.68; Fig. 23a), 
similar to results for the whole population. Additionally, identified VIP- neurons showed no 
significant difference in the AMPAR current decay measured at +40 mV with spermine (naïve: 
3.63 ± 0.55 ms, n = 6; social isolation: 3.99 ± 0.24 ms, n = 6; saline: 2.65 ± 0.34 ms, n = 6; 
cocaine: 2.78 ± 0.40 ms, n = 7; F3,14  = 0.30, p = 0.82; Fig. 23c) or without (naïve: 3.69 ± 0.52 ms, n 
= 5; social isolation: 2.31 ± 0.29 ms, n = 4; saline: 3.33 ± 0.74 ms, n = 3; cocaine: 3.55 ± 0.50 ms, 
n = 3; F3,18 = 1.77, p = 0.19; Fig. 23d), or measured at -70 mV (naïve: 2.47 ± 0.19 ms, n = 7; social 
isolation: 3.28 ± 0.38 ms, n = 7; saline: 2.76 ± 0.57 ms, n = 3; cocaine: 2.50ms ± 0.35 ms, n = 3; 
F3,16. = 1.39,  p = 0.28; Fig. 23b).  
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Figure 23. NMDAR and AMPAR current decay in identified VIP- neurons revealed no significant 
changes following social isolation or a single dose of cocaine. (a) Weighted decay time constant 
(τW) of the NMDAR current at +40 mV, (b) the decay time constant (τ) of the AMPAR current at -
70 mV, and (c) the AMPAR current at +40 mV with spermine and (d) without spermine. 
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6.3.5.4. mEPSC amplitude and frequency 
I pooled mEPSCs from all groups of socially isolated and group-housed mice in order to compare 
VIP+ and VIP- neurons in these two conditions. I found that in socially isolated mice both VIP+ 
and VIP- neurons showed a strong trend towards larger mEPSC amplitudes (VIP+: 22.99 ± 2.12 
pA, n =  12; VIP-: 22.16 ± 0.88 pA, n = 20; Fig. 24a,c) and higher frequency (VIP+: 1.43 ± 0.39 Hz, 
n = 12; VIP-: 2.07 ± 0.44 Hz, n = 20; Fig 24b,d), in comparison to group-housed mice (amplitude – 
VIP+: 19.48 ± 1.03 pA, n = 19, t29 = 1.66, p = 0.11; VIP-: 18.87 ± 1.39 pA, n = 11, t29 = 2.10, p < 
0.05; frequency – VIP+: 0.62 ± 0.23Hz, n = 19, t29 = 1.94, p = 0.06; VIP-: 1.28 ± 0.46Hz, n = 11, t29 = 
1.16, p = 0.26), but this was only statistically significant for the amplitude in VIP- neurons. This 
suggests that social isolation may potentiate the AMPAR-mediated current in both neuronal 
subtypes, but perhaps to a greater extent in VIP- neurons. Additionally, I did not observe a 
significant difference in either amplitude or frequency of mEPSCs between VIP+ and VIP- 
neurons for either the pooled group-housed mice (amplitude: t28 = 0.35, p = 0.73; frequency: t28 
= 1.45, p = 0.16), or solely the naïve mice (amplitude: t13 = 0.35 p = 0.73; frequency: t13 = 0.83, p 
= 0.42). Similar to the PPR, it appears that under these conditions, as opposed to those in 
chapter 4, there are no detectable differences in glutamatergic currents between VIP+ and VIP- 
neurons.  
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Figure 24. Social isolation increases mEPSC amplitude in VIP- neurons. Bar charts (mean + SEM) 
showing (a,b) mEPSC amplitude and (c,d) frequency in identified VIP+ and VIP- neurons. * 
indicates p < 0.05. 
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6.4. Conclusion 
I have utilised several electrophysiological protocols to examine different properties of AMPAR 
and NMDAR transmission in DRN/vlPAG dopamine neurons. These measures can be used to 
determine the locus of a change in synaptic efficacy, such as that observed in these neurons 
following a single dose of cocaine or social isolation. I therefore focused mainly on examining 
these measures of synaptic strength in four groups of mice: naïve, socially isolated, saline-
treated, and cocaine-treated.  
Overall, these results indicate that cocaine and social isolation induce similar changes at these 
excitatory synapses, which, importantly, also resemble the changes seen following cocaine in 
the VTA. Specifically, I observed an increase in the RI of the AMPAR current, without a change in 
the PPR, suggesting a postsynaptic, rather than presynaptic, modification at the synapse. 
Additionally, the PPR in the presence of spermine, showed a trend towards paired-pulse 
facilitation, only in cocaine-treated and socially isolated mice, which supports the notion that 
there is an increased insertion of GluR2-lacking receptors at these synapses. Although mEPSCs 
did not yield a clear result, they tended towards larger amplitudes in cocaine-treated and 
socially isolated mice, which is consistent with what would be expected from this change in 
AMPAR subunit composition.   
It has been noted that a large number of cells are often required to reveal differences in the 
characteristics of mEPSCs, and the lack of robust differences observed here may be due to the 
relatively small sample size. Indeed in the VTA, a considerable increase in the AMPAR:NMDAR 
ratio is observed following cocaine, but this is accompanied by a change of only a few pA in the 
mEPSC amplitude (Ungless et al., 2011). Therefore mEPSCs may not be the most appropriate or 
sensitive measure to use when examining this form of synaptic plasticity. Conversely, it could be 
that the observed increase in the AMPAR:NMDAR ratio is not a result of a substantial change in 
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AMPAR number or function, but instead may be mediated by a reduction in NMDAR 
transmission. This is more difficult to assay in brain slices, and may require analysis at the single 
synapse resolution, as in Mameli et al. (2011), which could be usefully investigated in future 
studies.   
The AMPAR and NMDAR current decay kinetics can be used to demonstrate changes in the 
receptor subunit composition, as incorporation of certain subunits can confer different 
properties on the receptor. No significant difference was found between any of the groups 
examined in terms of the decay time constant of these currents, suggesting that perhaps there 
is no change in kinetics of the current through these receptors. However, equally, this may not 
be the most sensitive method for detecting a clear change. Furthermore, the NMDAR current 
was produced by digitally subtracting the AMPAR current from the mixed response, but 
analysing the pure recorded current might yield a more reliable result.  
The basal AMPAR RI in DRN/vlPAG dopamine neurons was generally lower than previously 
reported values in the VTA, which could be related to a specific feature of the slice preparation, 
or may indicate a difference in the basal subunit composition of the AMPARs on these two 
dopamine neuron subpopulations. There is some evidence for the latter interpretation, for 
example, in the macaque GluR1 and GluR2 are the most abundantly expressed transcripts in 
both the VTA and DRN/vlPAG, but there is a higher proportion of GluR1 in the midbrain reticular 
formation (housing the VTA) compared to the DRN/vlPAG, while the DRN/vlPAG also expresses 
the GluR3-4 subunits (Beneyto and Meador-Woodruff, 2004). Although this is not specific to the 
dopamine population, it indicates that perhaps a different composition of AMPARs could 
underlie the difference in rectification observed in DRN/vlPAG compared to VTA dopamine 
neurons. 
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Due to the general bias in recording from VIP- neurons, and the difficulty in recovering high 
numbers of labelled, recorded neurons, I was not able to determine every feature of AMPAR 
and NMDAR transmission in both VIP+ and VIP- neurons. However, I was able to confirm that 
the RI, PPR, and current decay showed the same result for both cocaine and social isolation 
when only identified VIP- neurons were included in the analysis. Additionally, using pooled 
mEPSC data, I found that both VIP+ and VIP- neurons appeared to show a trend towards a 
greater amplitude and frequency of events in socially isolated mice, although perhaps to a lesser 
extent in VIP+ neurons. Furthermore, under these recording conditions, I did not observe a 
difference between VIP+ and VIP- neurons in terms of the PPR or mEPSC characteristics, 
suggesting that perhaps the differences I observed in chapter 4 were mediated by a GABAA-
receptor mechanism, or were a result of the different internal solution. It would be interesting 
to confirm the effect of social isolation and cocaine on VIP+ neurons, as these neurons are likely 
to be providing a significant dopaminergic (and VIPergic) input to the dlBNST. Furthermore, the 
type of postsynaptic change that my results suggest is likely to have consequences for the 
excitability of these dopamine neurons, and the processing of synaptic inputs, which would 
ultimately impact on the output of this neuronal circuit (Liu and Savtchouk, 2011). 
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Chapter 7. Is the synaptic potentiation in DRN/vlPAG dopamine 
neurons anxiety-induced? 
 
7.1. Introduction 
7.1.1. Consequences of social isolation 
Studies on socially isolated animals have revealed multiple behavioural abnormalities, including 
hyperreactivity to a novel environment (Sahakian et al., 1977; Gentsch et al., 1981; Gentsch  et 
al., 1982; Domeney and Feldon, 1998; Varty et al., 2000; Del Arco et al., 2004), increased 
aggression and poor social interaction (Harlow et al., 1965; Valzelli, 1973; Wongwitdecha and 
Marsden, 1996), enhanced response to psychomotor stimulants (Sahakian et al., 1975), and a 
range of cognitive deficits (Schrijver and Würbel, 2001; Bianchi et al., 2006). Social isolation is 
therefore frequently used as an animal model for several neuropsychiatric disorders including 
schizophrenia and depression (Ehlers et al., 1993; Geyer et al., 1993; Jaffe et al., 1993; Myhrer, 
1998; Whitaker-Azmitia et al., 2000; Lapiz et al., 2003; Heim et al., 2004; Fone and Porkess, 
2008; Wilkinson et al., 2009; Fabricius et al., 2011; Fischer et al., 2012; Moller et al., 2012). 
Furthermore, a wealth of evidence implicates the dopamine system in mediating these 
isolation-induced behavioural changes (Guisado et al., 1980; Bean and Lee, 1991; Jones et al., 
1992; Rilke et al., 1995; Hall et al., 1998a; Heidbreder et al., 2000; Peters and O’Donnell, 2005; 
Djouma et al., 2006; Wallace et al., 2009; Fabricius et al., 2010; Han et al., 2011; Han et al., 
2012). 
7.1.1.1. Response to addictive drugs 
One interesting observation is that the psychostimulant effects of cocaine, amphetamine, and 
ethanol are increased by prior social isolation (Jones et al., 1990a,b; Fowler et al., 1993; Ahmed 
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et al., 1995; Smith et al., 1997; Hall et al., 1998b; Michel and Tirelli, 2002; Lu et al. 2003). 
Animals exhibit an increased propensity to self-administer cocaine (Matthews et al., 1999; 
Howes et al., 2000; Kosten et al., 2000; Zhang et al., 2005), suggestive of enhanced impulsivity 
or motivation for cocaine (Schenk et al., 1987), and more frequently infuse the drug, suggesting 
that social isolation also reduces its reinforcing properties (Schenk et al., 1986; LeSage et al., 
1999; Ding et al., 2005), similar to other addictive drugs (Alexander et al., 1978; Hadaway et al., 
1979; Schenk et al., 1986; Phillips et al., 1994; Wongwitdecha and Marsden, 1995; 
Wongwitdecha and Marsden, 1996). It has also been hypothesised that isolation rearing may 
interact with dopamine-dependent mechanisms to modify the response to addictive drugs 
(Jones et al., 1990b; Broseta et al., 2005; Estelles et al., 2005). 
7.1.1.2. Behavioural changes 
Isolation rearing has been shown to increase anxiety levels measured, for example, using the 
elevated-plus maze and open field tests (Hatch et al., 1965; Koch and Arnold, 1972; Sahakian et 
al., 1977; Morinan and Parker, 1985; Parker and Morinan, 1986; Wright et al., 1991; Bickerdike 
et al., 1993; Fone et al., 1996; Da Silva et al., 1996; Hellemans et al., 2004; Weiss et al., 2004; 
Chourbaji et al., 2005; Kwak et al., 2009; Conrad et al., 2011), and causes a greater physiological 
reaction to stress (Baldwin et al., 1995; Ruis et al., 1999). Furthermore, it has been noted that, in 
contrast to group-housed animals, socially isolated animals spend significantly less time 
engaging in social behaviours (when subsequently re-introduced to conspecifics), and display 
higher levels of aggression (Estelles et al., 2004). 
Although social stimuli are innately rewarding (Krach et al., 2010), the lack of social interaction is 
not the only factor that would be important in determining the emotional and physiological 
state of an isolated animal. For example, social isolation would also involve an increase in 
metabolic activity to maintain body temperature, a reduction in the complexity of the 
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surrounding environment, loss of tactile stimulation, and decreased visual, auditory, gustatory 
and olfactory stimulation (Bates et al., 1985; Kim and Kirkpatrick 1996). Therefore both social 
and non-social factors are likely to contribute to the neurobiological repercussions of social 
isolation. 
7.1.1.3. Acute social isolation 
The majority of these studies typically isolate animals in the neonatal or adolescent period, for 
around 2-12 weeks, but the effects of a short period of social isolation in adulthood have not 
been extensively investigated, with only a handful of studies examining the effect of just 24 
hours of social isolation. Furthermore, it has been suggested that the effects of isolation in 
adulthood can be distinct from isolation during childhood or adolescence (King et al., 2009). For 
example, isolation in adulthood is not thought to affect the self-administration of cocaine 
(Bozarth et al., 1989), or ethanol (Schenk et al., 1990), and conversely increases social 
interaction (Lister and Hilakivi 1988; Ferdman et al., 2007). However, along with the duration of 
isolation, many other methodological variations are likely to affect the outcome of these 
isolation studies, including animal species, strain, age, and the frequency of handling (Lapiz et 
al., 2003; Fone and Porkess, 2008). Therefore contradictory results are common in these types 
of investigations.  
The few studies that have investigated short-term social isolation in adulthood, in a similar 
manner to this investigation, have revealed interesting deficits. For example, Conrad et al. 
(2011) report a trend for increased anxiety levels (in the open field test and elevated-plus 
maze), along with blunting of LTP in the dorsolateral (dl)BNST, following just 24 hours of social 
isolation. Additionally, it has been reported that 24 hours of isolation produces a significant 
decrease in striatal dopamine D2 receptor density, indicating increased synaptic dopamine 
concentration in this region (Rilke et al., 1995). Therefore even a short period of isolation in 
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adulthood is likely to have consequences for behaviour, synaptic plasticity, and dopaminergic 
transmission. 
7.1.2. Effect of cocaine on social behaviour and anxiety 
Cocaine administration exerts complex actions on many aspects of social behaviour. Although 
mixed results have been reported with regard to the effect of cocaine on aggressive behaviours 
in both animals (Miczek and O’Donnell, 1978; Miczek, 1979; Hadfield et al., 1982; Emley and 
Hutchinson, 1983; Filibeck et al., 1988; Long et al., 1996; Estelles et al., 2004) and humans 
(Miller et al., 1991; McCormick and Smith, 1995; Bukstein, 1996; Gordon et al., 1996; Denison et 
al., 1997; Moeller et al., 1997; Dhossche, 1999; LeSage et al., 1999), many studies have noted a 
reduction in social contacts with conspecifics following cocaine administration (Darmani et al., 
1990; Rademacher et al., 2002; Estelles et al., 2004; Estelles et al., 2007). Furthermore, isolation-
induced reduction in social contact is further impaired by an acute dose of cocaine, leading to 
almost a complete absence of social investigation (Estelles et al., 2004). Interestingly, both the 
dopamine and glutamate systems have been implicated in the effect of cocaine on social 
behaviour (Lluch et al., 2005). Furthermore, there is general agreement that cocaine increases 
flight and avoidance (i.e., defensive behaviours), which is specifically expressed in the presence 
of other conspecifics (Blanchard and Blanchard, 1999; Estelles et al., 2004), and can also elicit an 
anxiogenic response in various behavioural assays of anxiety (Costall et al., 1989; Rogerio and 
Takahashi, 1992a,b; Yang et al., 1992; Paine et al., 2002). This can be observed following just a 
single dose of cocaine, or after chronic exposure during withdrawal (Paine et al., 2002; Hayase 
et al., 2005). 
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7.1.3. Is synaptic potentiation in DRN/vlPAG dopamine neurons induced by acute anxiety? 
Previous work indicates that cocaine administration and social isolation have in common that 
they induce a reduction in social interaction and an increase in anxiogenic behaviour. This 
suggests that these factors may be integral to the effects observed here. I therefore 
hypothesised that the synaptic potentiation in DRN/vlPAG dopamine neurons was induced by 
acute anxiety, resulting from either social isolation or a single dose of cocaine. However, 
previous studies have been performed over varying timescales and examined animals of 
different ages, with different cocaine dose ranges, and behavioural assays. Therefore as a first 
step to investigate this hypothesis, the open field test was used to assess anxiety-like behaviour, 
under the same conditions used for electrophysiological recordings. Secondly, I investigated the 
effect of a single dose of diazepam on the AMPAR:NMDAR ratio at synapses onto DRN/vlPAG 
dopamine neurons. Diazepam is an addictive drug, which has been shown to potentiate 
excitatory synapses onto VTA dopamine neurons following a single dose, in a similar way to 
cocaine (Heikkinen et al., 2009; Tan et al., 2010). However, diazepam is an anxiolytic compound, 
and therefore elicits a different behavioural profile to cocaine administration. Thirdly, I tested 
whether the potentiation observed following social isolation could be prevented by two 
different compounds: diazepam and ketamine. Diazepam and other benzodiazepines are widely 
prescribed to treat anxiety disorders (Woods et al., 1992; Gallager and Primus, 1993; Carlini, 
2003). Ketamine has more recently been suggested to have anxiolytic and antidepressant-like 
effects (Berman et al., 2000; Zarate et al., 2006; Machado-Vieira et al., 2009; Li et al., 2010; 
Vollenweider and Kometer, 2010; Murrough, 2011), and is an NMDAR antagonist (Harrison and 
Simmonds, 1985). The potentiation observed in DRN/vPAG dopamine neurons bears a certain 
resemblance to cocaine-induced plasticity in the VTA, which is blocked by systemic 
administration of an NMDAR antagonist (Ungless et al., 2001). It would also, therefore, be 
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interesting to determine whether NMDAR blockade can prevent social isolation-induced 
plasticity.  
7.2. Materials and methods 
7.2.1. Open field test 
The open field arena consisted of a wooden chamber 45 cm x 45 cm, with 30 cm walls, under 
constant illumination in a sound-attenuated room, which was separate from the room in which 
the mice were housed. Mice were acclimatised to the new surroundings for at least 20 min, in 
their own cage, before being placed in the centre of the open field arena. Their activity was 
recorded using a video camera suspended above the arena, interfaced with a computerised 
tracking system (HVS Image 2100, Hampton, UK). For analysis, the arena was divided into a grid 
of 36 squares (7.5 cm x 7.5 cm), and the time spent in each square, the total number of entries 
into new squares, the % time spent moving, and the total distance travelled were calculated 
using the HVS Image 2100 software. Subsequent analysis was performed in Excel, and the level 
of anxiety quantified by calculating the proportion of time spent in the periphery (outer 1125 
cm2) of the arena. 
7.2.2. Injection protocol  
Diazepam (5 mg/kg), ketamine hydrochloride (10 mg/kg), or the equivalent volume of vehicle, 
was administered via IP injection in a volume of 10 ml/kg. Mice were injected at 10.00 am and 
either returned to their original cage, with their cagemates, or moved to a clean cage on their 
own for 24 hours before brain slice preparation.  
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7.2.3. Electrophysiology 
Coronal 220 µm brain slices containing the DRN/vlPAG were prepared, and whole-cell 
electrophysiology was used to record AMPAR:NMDAR ratios as described in chapter 4. The 
cesium-based internal solution (composition in mM: CsCH3SO3 130, NaCl 2.8, HEPES 20, EGTA 
0.4, TEA-Cl 5, MgATP 2, Li-GTP 0.5, and 0.1% neurobiotin; pH 7.3, osmolarity 280-290 mosmol/l) 
was used for all recordings and 100 µM picrotoxin was included in the aCSF. 
7.2.4. Drugs 
Diazepam (Sigma, UK) was dissolved by sonication in 0.9% saline with 0.3% Tween-80, and 
ketamine hydrochloride (Fort Dodge Animal Health, US) was dissolved in 0.9% saline. 
7.2.5. Statistics 
Statistical analysis was performed using Prism 5.04 (Graphpad, CA, USA) and values are reported 
as mean ± standard error of the mean (SEM). Behaviour in the open field test was analysed 
using a one-way ANOVA with Newman-Keuls post-hoc tests, and the Pearson’s product-moment 
correlation coefficient. AMPAR:NMDAR ratios from diazepam or ketamine-treated mice were 
compared using an unpaired t-test (non-directional).  
7.3. Results 
7.3.1. Open field test 
Mice were socially isolated, or received a single injection of saline or cocaine at 10.00 am, and 
their behaviour was monitored in the open field test between 9.00 – 11.00 am the following 
day. I collected around half of the data in the naïve and socially isolated groups, and the 
remainder was collected by Rebecca Davis. The open field test has been extensively used to 
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study general anxiety-like behaviour, by exploiting the natural aversion of mice to open spaces 
(Carola et al., 2002). Mice therefore tend to spend more time near the edges of the arena, and 
less time in the centre. I quantified the level of anxiety by the percentage of time spent in the 
periphery of the open field over the first 5 min of the trial (Fig. 25a,b). This revealed that mice 
which were socially isolated (78.13 ± 1.50%, n = 13) or received a single dose of cocaine (80.81 ± 
2.12%, n = 8) spent a greater proportion of time in the periphery compared to naïve (73.60 ± 
1.55%, n = 12) or saline-treated mice (76.09 ± 1.97%, n = 7), but this was more pronounced for 
cocaine, and so only the comparison between the naïve and cocaine-treated groups was 
significant in post-hoc tests (F3,36 = 3.08 , p < 0.05;  naïve vs cocaine p < 0.05; Fig. 25b). There 
was, however, no difference in the total distance travelled over this same time period (naïve: 
51.85 ± 5.30 m, n = 12; socially isolated: 51.21 ± 5.90 m, n = 13; saline: 54.07 ± 4.24 m, n = 7; 
cocaine: 54.31 ± 6.92 m, n = 8; F3,36 = 0.07, p = 0.98; Fig. 25c), indicating that there is no change 
in general locomotor activity. This suggests that a single dose of cocaine and, perhaps to a lesser 
extent, social isolation can increase general anxiety levels in mice. The mean time spent in the 
periphery for saline-treated mice was slightly higher than the naïve group, which may have been 
due to the stress related to the injection and handling. Increasing the sample size for this 
experiment may reveal a more clear separation between these four groups. However, it has 
already been noted that the effect of 24 hours of social isolation on anxiety levels is subtle 
(Conrad et al., 2011).  
Interestingly, I noticed a trend for positive correlation between the number of mice in the cage 
pre-isolation, and the time spent in the periphery after 24 hours of isolation (Fig. 25e). This did 
not quite reach statistical significance (r2 = 0.17, p = 0.16), which may be because there was 
limited spread of the data points, since the majority of mice had been in a cage of 3 before 
isolation. However, this is similar to the relationship that I had observed between the number of 
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mice per cage pre-isolation and the AMPAR:NMDAR ratio post-isolation, suggesting that both 
the AMPAR:NMDAR ratio and anxiety levels are both directly related to the previous social 
interaction of the animal. Additionally, similar to the AMPAR:NMDAR ratio, I found no 
correlation between the number of mice per cage and the time spent in the periphery for the 
naive mice (r2 = 0.0005, p = 0.94; Fig 25d). Contrastingly, however, I found negative correlation 
between the number of mice per cage and the time spent in the periphery following a cocaine 
injection (r2 = 0.61, p < 0.05; Fig 25f). This indicates that perhaps greater social contact reduces 
the anxiogenic effects of cocaine. However, there is limited spread of the data points in these 
three groups, and therefore more data is required for accurate statistical analysis. 
 
 
 
 
172 
 
 
Figure 25. A single dose of cocaine increases anxiety measured in the open field test. (a) 
Representative path examples and bar charts (mean + SEM) showing (b) % time spent in the 
periphery of the open field and (c) total distance travelled in naïve, socially isolated, saline-, and 
cocaine-treated mice. The mean age for each experimental group was 12 weeks (naive), 10.6 
weeks (socially isolated), 13.3 weeks (saline), and 11.6 weeks (cocaine). Scatter graphs showing 
the relationship between the number of mice per cage and the % time spent in the periphery in 
(d) naïve, (e) socially isolated, and (f) cocaine-treated mice. This revealed significant negative 
correlation in cocaine-treated mice (r2 = 0.61, p < 0.05), but no correlation in naïve or socially 
isolated mice. * indicates p < 0.05. 
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7.3.2. Effect of a single dose of diazepam 
Mice received a single injection of 5 mg/kg diazepam, or vehicle, at 10.00 am and were 
subsequently returned to their original cage, with their cagemates, before brain slice 
preparation 24 hours later.  This dose of diazepam has been shown to not only induce an 
anxiolytic effect on behaviour (Chaouloff et al., 1997; Griebel et al., 1998), but also potentiate 
excitatory synapses onto VTA dopamine neurons after just 24 hours (Heikkinen et al., 2009; Tan 
et al., 2010). I found that the AMPAR:NMDAR ratio in DRN/vlPAG dopamine neurons was not 
significantly different following a single dose of diazepam (1.55 ± 0.09, n = 7) compared to 
vehicle (1.40 ± 1.61, n = 6, t11 = 0.83, p = 0.42; Fig. 26). This indicates that, unlike VTA dopamine 
neurons, excitatory synapses onto DRN/vlPAG dopamine neurons are not potentiated by 
diazepam. 
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Figure 26. Diazepam does not potentiate synapses onto DRN/vlPAG dopamine neurons. (a) 
Injection protocol with representative examples and (b) bar chart showing mean (+ SEM) 
AMPAR:NMDAR ratio in mice given a single dose of diazepam or vehicle. The mean age for each 
experimental group was 5 weeks (vehicle) and 5.6 weeks (diazepam). 
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7.3.3. Effect of diazepam or ketamine on social isolation-induced potentiation 
In order to investigate whether the synaptic potentiation induced by social isolation could be 
prevented by alleviating anxiety, I administered diazepam, ketamine, or vehicle before socially 
isolating the mouse. The effect of an acute dose of diazepam was compared to administration of 
the equivalent volume of vehicle, whereas the effect of ketamine was compared to the saline-
injected and isolated group from an earlier experiment (chapter 5, Fig. 11c). I found that there 
was no significant difference in the AMPAR:NMDAR ratio in mice isolated with a single injection 
of diazepam (1.77 ± 0.19, n = 6) compared to vehicle (1.71 ± 0.1, n = 6; t10 = 0.24, p = 0.81; Fig. 
27a,b), or a single injection of ketamine (1.59 ± 0.31, n = 7) compared to saline (2.00 ± 0.26, n = 
8; t13 = 1.02, p = 0.33; Fig. 27c,d), although there was a small trend for lower ratios following 
ketamine with isolation. This suggests that neither of these compounds is effective in reducing 
the potentiation induced by social isolation. However, this could be due to a number of reasons. 
For example anxiety levels were not assayed, and therefore these two compounds may or may 
not have produced a measurable effect on anxiety after isolation for 24 hours. Equally the acute 
effect of the drug would have worn off after a few hours, but the mouse would have remained 
isolated for the ensuing 24 hours. Therefore, it is difficult to accurately evaluate the effect of 
these compounds on the induction of plasticity in these neurons.   
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Figure 27. Neither diazepam nor ketamine prevent social isolation-induced potentiation in 
DRN/vlPAG dopamine neurons. (a,c) Injection protocol with representative examples and (b,d) 
bar charts showing the mean (+ SEM) AMPAR:NMDAR ratio following a single dose of diazepam 
or ketamine with social isolation. The mean age for each experimental group was 5.5 weeks 
(vehicle with isolation), 6.3 weeks (diazepam with isolation), 6.2 weeks (saline with isolation) 
and 5.8 weeks (ketamine with isolation). 
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7.4. Conclusion 
In this chapter I have tested the hypothesis that cocaine- and social isolation-induced 
potentiation in DRN/vlPAG dopamine neurons is a result of acute anxiety. I found that there was 
a trend for increased anxiety measured in the open field test in both these groups of animals, in 
comparison to group-housed or saline-treated controls. However, this was only statistically 
significant for cocaine, with a more subtle effect observed following social isolation, in line with 
previous work (Conrad et al., 2011). Furthermore, an acute dose of diazepam did not increase 
the AMPAR:NMDAR ratio in DRN/vlPAG dopamine neurons (unlike in the VTA; Heikkinen et al., 
2009), suggesting that it may be the anxiogenic quality of cocaine, rather than its addictive 
properties, which is important for the induction of plasticity in this region. I also investigated the 
ability of diazepam or ketamine to prevent the potentiation induced by social isolation. While I 
noted a trend for smaller AMPAR:NMDAR ratios following isolation with ketamine, neither of 
these compounds produced a significantly smaller ratio compared to administration of vehicle 
or saline. However, this result is difficult to interpret because the isolation will still be in play 
even after the acute effect of the drug has worn off. If the time course for this plasticity was 
known, these compounds could be tested during a critical period of induction, which may be 
more appropriate. Additionally, the dependence of plasticity on NMDAR transmission could be 
evaluated using mice with selective disruption of NMDAR signalling in dopamine neurons 
(Engblom et al., 2008; Zweifel et al., 2008). 
The observation that social isolation only exhibited a trend towards higher anxiety levels in the 
open field test, and a trend towards correlation of anxiety with prior social interaction, could be 
due to the relatively small sample size and/or the limited sensitivity of this behavioural assay for 
detecting a difference in anxiety levels. Indeed, Conrad et al. (2011) note that under more 
anxiogenic testing conditions the trend they observed for an increase in anxiety-like behaviour 
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may become more apparent. In contrast, however, it may be that social isolation does not have 
a robust effect on general anxiety levels, and the synaptic potentiation observed may be instead 
more directly related to the lack of social contact, rather than an increase in general anxiety. 
This would also be one explanation for why the anxiolytic compounds had no effect on isolation-
induced potentiation. This idea is also supported by the correlation observed between the 
AMPAR:NMDAR ratio following isolation and the number of mice per cage, suggesting that the 
extent of prior social interaction is directly associated with isolation-induced synaptic 
potentiation. However, conversely, cocaine-treated mice showed negative correlation between 
anxiety-like behaviour and the number of mice per cage, suggesting that perhaps social 
interaction can alleviate the anxiogenic effects induced by cocaine. 
An alternative hypothesis could be that social isolation-induced plasticity is a result of stress.  
However, whereas chronic social isolation is considered a stressful experience for adult mice 
(Cabib et al., 2002; Avitsur et al., 2003), acute isolation is suggested to be anxiogenic, without 
effecting depressive-like behaviour (Kwak et al., 2009) or stress (Hilakivi et al., 1989). 
Furthermore, if 24 hours of social isolation was acutely stressful for the animals, I would have 
expected an increase in the AMPAR:NMDAR ratio in the VTA (Saal et al., 2003; Lammel et al., 
2011), but this was not the case in this study, or in others (Ungless et al., 2001).  
The behavioural and neurochemical alterations arising from long-term isolation rearing have 
been extensively examined, but acute social isolation has received considerably less attention. 
Furthermore, even though multiple lines of evidence suggest that modifications to the 
dopamine system result from social isolation, the precise nature of these changes is not clear 
(Fone and Porkess, 2008). Using this simple, acute manipulation in adult mice, however, I have 
observed that social isolation can induce changes to excitatory synapses, at a particular subset 
of dopamine neurons, which supports the involvement of the dopamine system in the response 
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to isolation. The two experimental conditions which induce potentiation in DRN/vlPAG 
dopamine neurons have in common that they are both thought to increase general anxiety and 
reduce social interaction. While these effects are brought on by the drug in cocaine-treated 
mice, enforced isolation directly abolishes social contact. Therefore even though the emotional 
state of the animals is generated in different ways, the resulting behaviour (and synaptic 
alterations) does have similarities. My results suggest the possibility that this potentiation may 
be related to acute anxiety, but it would be interesting to see whether a manipulation that 
increases anxiety, but does not alter social interaction per se, would cause synaptic potentiation 
in DRN/vlPAG dopamine neurons. 
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Chapter 8. Discussion and future work 
 
8.1. Introduction and summary 
Psychostimulant addiction represents a serious medical and social problem for which no 
effective treatment currently exists (McLellan et al., 2000; Gorelick et al., 2004; Vocci and Ling, 
2005; Kalivas, 2007; Karila et al., 2008). Cocaine dependence is particularly common, with an 
estimated 1.5 million dependent users in the US (Substance Abuse and Mental Health Services 
Administration, 2011). Chronic exposure to psychostimulants, such as cocaine, provokes 
profound structural and neurochemical alterations in neural circuitry conserved for motivation 
and natural rewards (Hyman and Malenka, 2001; Jones and Bonci, 2005; Hyman et al., 2006). 
This is thought to underlie the enduring drug craving and drug-seeking behaviour apparent even 
after long periods of withdrawal, which are defining features of addiction (Robinson and 
Berridge, 1993; Robinson and Berridge, 2000; Hyman and Malenka, 2001; Kelly and Berridge, 
2002; Robinson and Berridge, 2003; Kauer, 2004; Vezina, 2004; Kalivas, 2009). A key component 
of this neural circuit mediating the effects of addictive drugs is the midbrain dopamine system, 
which consists of dopamine neurons projecting to, and receiving input from, a variety of limbic 
and cortical structures (Bjӧrklund and Dunnett, 2007a). Excitatory synapses onto these 
dopamine neurons are a critical site of drug-induced neuroadaptation, exhibiting potentiation 
within just a few hours of a single drug exposure (Ungless et al., 2001; Argilli et al., 2008). This 
transient LTP-like plasticity is thought to be involved in the early induction of behavioural 
sensitisation and conditioned place preference (CPP; Kalivas and Alesdatter, 1993; Vezina, 1996; 
Wolf, 1998; Vezina and Queen, 2000; Carlezon and Nestler, 2002; Harris and Aston-Jones, 2003; 
Borgland et al., 2004; Harris et al., 2004; Wolf et al., 2004; Dunn et al., 2005; Mead et al., 2005; 
Borgland et al., 2006; Zweifel et al., 2008), and is also essential for longer-term synaptic changes 
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in downstream structures following continued drug exposure (Mameli et al., 2009). Additionally, 
potentiation at these synapses is thought to contribute to cue- and drug-induced reinstatement 
during withdrawal (Engblom et al., 2008; Mameli et al., 2009), which highlights the importance 
of this plasticity at different stages in the addiction process.  
However, while the dopamine system is traditionally associated with reward, several studies in 
the last few years have added weight to the hypothesis that dopamine neurons also respond to 
aversive stimuli (Horvitz, 2000; Di Chiara, 2002; Pezze and Feldon, 2004; Redgrave and Gurney, 
2006; Brischoux et al., 2009; Lammel et al., 2011). This supports the emerging evidence that the 
midbrain dopamine neurons are a heterogeneous population, with distinct molecular, 
electrophysiological, and functional properties (Neuhoff et al., 2002; Ford et al., 2006; Margolis 
et al., 2006a,b; Lammel et al., 2008; Margolis et al., 2008; Brischoux et al., 2009; Lammel et al., 
2011). Aversion-responsive dopamine neurons had previously been overlooked, as they display 
‘unconventional’ electrophysiological properties (Lammel et al., 2008) and are located more 
medially within the VTA, so they have rarely been targeted in brain slices or in vivo (Brischoux et 
al., 2009). Another understudied subset of midbrain dopamine neurons is located in the 
DRN/vlPAG (Lindvall and Björklund, 1974; Hӧkfelt et al., 1976; Ochi and Shimizu, 1978; Hӧkfelt 
et al., 1984; Trulson et al., 1985; Descarries et al., 1986; Oades and Halliday, 1987; Arsenault et 
al., 1988; Stratford and Wirtshafter, 1990; Charara and Parent, 1998), which has received 
substantially less attention than dopamine neurons residing in the VTA. This is likely to be a 
result of their relatively small size and number, and the fact that they are in the minority in this 
region (Descarries et al., 1986). Therefore although numerous studies have targeted this region, 
there is only one report of a single recorded dopamine neuron in vivo (Schweimer and Ungless, 
2010), and no accounts of ex vivo electrophysiology. Furthermore, in spite of the observation 
that these neurons provide the majority of the dopamine input to the central amygdala and 
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BNST (Hasue and Shammah-Lagnado, 2002; Meloni et al., 2006; Shin et al., 2008), and selective 
lesioning has hinted at their role both in the sleep-wake cycle (Lu et al., 2006) and mediating the 
effects of opiates (Flores et al., 2004; Flores et al., 2006; Meyer et al., 2009), no clear function 
has been ascribed to the DRN/vlPAG dopamine neurons.  
I have studied this dopaminergic subpopulation using immunohistochemistry and 
electrophysiology ex vivo, in combination with drug administration, environmental 
manipulations, and behavioural analysis. In chapters 2-4, I assessed the suitability of transgenic 
mice for targeting these dopamine neurons, and characterised their basal neurochemical and 
electrophysiological properties. They generally expressed the same dopaminergic markers, and 
exhibited similar properties to ‘unconventional’ VTA dopamine neurons (Lammel et al., 2008), 
including their response to depolarisation and hyperpolarisation. Additionally, around half of 
these dopamine neurons co-expressed the neuropeptide VIP. These VIP+ neurons displayed 
more irregular firing, lower maximal firing frequencies, and a larger Ih than VIP- neurons. In 
chapter 5, I examined the ability of cocaine to induce potentiation at excitatory synapses onto 
these neurons, in order to determine if drug-evoked neural modifications were a key feature of 
this population, similar to the VTA. I found that not only could cocaine potentiate the 
glutamatergic synapses onto DRN/vlPAG dopamine neurons, but this was also observed 
following 24 hours of social isolation. This acute environmental manipulation caused a similar 
magnitude increase in the AMPAR:NMDAR ratio compared to a single dose of cocaine. Further 
characterisation in chapter 6 revealed that this plasticity was associated with a change in 
AMPAR transmission, indicative of a switch from GluR2-containing to GluR2-lacking receptors, 
which resembles that of cocaine-induced plasticity in the VTA. Contrastingly, however, I found 
that social isolation did not potentiate glutamatergic synapses onto VTA dopamine neurons. In 
chapter 7, I hypothesised that this potentiation was related to the acute anxiety induced by 
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either 24 hours of social isolation or a single dose of cocaine. Only cocaine-treated animals 
showed a statistically significant increase in anxiety measured using the open field test, but the 
addictive, anxiolytic drug diazepam was not able to potentiate these synapses, as it has been 
reported to do so in the VTA (Heikkinen et al., 2009; Tan et al., 2010). It is not clear whether 
general anxiety levels are increased by social isolation, but interestingly the AMPAR:NMDAR 
ratio measured following social isolation directly correlated with the number of mice housed 
together in the cage before isolation, suggesting that the loss of social interaction may be a key 
factor contributing to this potentiation. However, conversely, the number of mice per cage was 
negatively correlated with the anxiety levels following cocaine, suggesting that perhaps social 
interaction is able to counteract the anxiogenic effects of this drug.  
My findings provide an initial immunohistochemical and electrophysiological description of this 
understudied population of dopamine neurons, on which future studies can build. This includes 
not only identifying potential caveats with GFP mouse models used to target this population, 
but also proposing use of the neuropeptide VIP to delineate the two subsets of dopamine 
neuron in this region. The observation that both cocaine and social isolation can induce 
potentiation at glutamatergic synapses implicates the DRN/vlPAG neurons as an important 
component of the midbrain dopamine population, which can respond to a different type of 
salient cue. These results are discussed in relation to the functional properties of other midbrain 
dopamine neurons, the possible implications for downstream targets of this dopamine 
subpopulation, and the potential clinical relevance of these findings.  
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8.2. Immunohistochemical and electrophysiological characterisation 
8.2.1. Suitability of GFP mouse models 
An initial step towards characterising the functional properties of the DRN/vlPAG population 
involved confirming the suitability of transgenic GFP mice for targeting this population in brain 
slices. Utilising both TH-GFP and Pitx3-GFP mice, I found that while the majority of GFP+ 
neurons in the DRN/vlPAG were TH+, the proportion was slightly lower than previously reported 
in the VTA (Matsushita et al., 2002; Zhao et al., 2004). GFP expression in TH-GFP mice was 
stronger, more efficient, and more uniformly distributed throughout the TH+ population in this 
region, compared to Pitx3-GFP mice. In particular, Pitx3-directed GFP expression appeared 
stronger in the small periaqueductal neurons compared to the larger, multipolar, and more 
ventrally located neurons, in which it was often weak or absent. The reason for this is unclear, 
as in the VTA and SNc, there is near complete overlap between GFP and TH in Pitx3-GFP mice 
(Zhao et al., 2004). However, it has been noted that although Pitx3 is expressed in all midbrain 
dopamine neurons, there appears to be a differential reliance on this transcription factor in 
different dopamine subpopulations (van den Munckhof et al., 2003). The majority of SNc and 
about half of VTA dopamine neurons fail to develop in Pitx3-/- mice, but a subset of VTA 
dopamine neurons are unaffected, suggesting potential differences in Pitx3 expression and 
function (Nunes et al., 2003; van den Munckhof et al., 2003; Smidt et al., 2004; Maxwell et al., 
2005). The DRN/vlPAG population may also exhibit differential dependence on Pitx3 for 
development and maintenance, which could result in the variable Pitx3-directed GFP expression 
pattern seen here.  
Interestingly, GFP+/TH- neurons generally corresponded to the small, periaqueductal neurons, 
even in TH-GFP mice, suggesting that perhaps these cells are dopaminergic, but that TH is 
expressed at low levels in these cells, which has been previously suggested (Hӧkfelt et al., 1976; 
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Rogers, 1992). One reason for this could be that TH is transported to the terminals of these 
neurons, as is suggested to occur in some dopaminergic neurons (Frain and Leviel, 1998), 
rendering somatodendritic TH undetectable using immunohistochemistry. A second reason 
could be the location of these neurons, just ventral to the aqueduct of Sylvius. It has been noted 
using glutaraldehyde fixation, that there is particularly intense autofluoresence in this region 
(Hasue and Shammah-Lagnado, 2002), which may impair immunohistochemical detection of TH. 
One method of improving the strength of TH staining could be to use colchicine. This prevents 
axonal transport, which results in accumulation of proteins in the soma. Restricted injection of 
colchicine into the striatum has been successfully used to confirm the presence of TH+ neurons 
in this region, which express low levels of TH but are GFP+ in a TH-GFP mouse (Ibáñez-Sandoval 
et al., 2010). Therefore, in the same way, this method could be used to confirm the presence of 
TH in the small periaqueductal GFP+ neurons.  
The enzyme AADC colocalised with a similar proportion of GFP+ neurons as TH, confirming that 
these neurons are enzymatically capable of producing dopamine, while the dopamine 
transporter (DAT) was mostly expressed by the large, ventral GFP+ neurons. The absence of DAT 
in some of these neurons does not necessarily indicate a non-dopaminergic phenotype, because 
different subtypes of VTA dopamine neuron have been shown to express variable levels of DAT, 
or even lack detectable expression (Lammel et al., 2008). Mice expressing GFP under the control 
of AADC or DAT could act as alternatives for targeting this dopamine population. However, 
these are likely to be less suitable, as AADC is also expressed by the 5-HT neurons in the 
DRN/vlPAG, and DAT shows variable expression both in the DRN/vlPAG and the VTA dopamine 
populations (Lammel et al., 2008).  
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8.2.2. VIP distinguishes between two subsets of DRN/vlPAG dopamine neuron 
Two subsets of dopamine neuron in the DRN/vlPAG have been described, based on their size, 
morphology, and anatomical location (Hӧkfelt et al., 1976; Stratford and Wirtshafter, 1990; 
Charara and Parent, 1998; Flores et al., 2004). I found that expression of the neuropeptide VIP 
could distinguish between these two subtypes, as it was co-expressed by the small 
periaqueductal dopamine neurons, but not by the large, multipolar more ventrolaterally located 
neurons. The functional relevance of these two subpopulations remains to be established. 
However, most of the functions so far attributed to the DRN/vlPAG dopamine neurons relate to 
the large, ventral subtype, since these appear to be selectively affected by 6-OHDA lesion 
(Flores et al., 2004; Flores et al., 2006; Lu et al., 2006). Consistent with this, I noted that DAT was 
expressed in the large ventral neurons, but not generally in the small periaqueductal neurons, 
suggesting that this may prevent uptake of the neurotoxin in this dopaminergic subtype. The 
low, and often absent expression of DAT, resembles that described for VTA dopamine neurons 
projecting to the NAc core, NAc medial shell, mPFC, and BLA, which are generally found more 
medially (Lammel et al., 2008).  
Apart from 6-OHDA, DRN/vlPAG dopamine neurons have also been shown to display differential 
vulnerability to the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), with more 
extensive dopaminergic cell loss noted in the ventral DRN than the dorsal part (Unguez and 
Schneider, 1988). Furthermore, the ventral DRN has been suggested to house striatal-projecting 
dopamine neurons (Descarries et al., 1986), whereas the dorsal DRN is thought to contain more 
neurons projecting to the extended amygdala (Hasue and Shammah-Lagnado, 2002), suggesting 
that selective vulnerability may also relate to projection target. This is consistent with the more 
dorsal location of the VIP+ neurons, and their projection to the dlBNST (Petit et al., 1995; Kozicz 
et al., 1998). Interestingly, even though there have so far been no reports linking VIP to 
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dopaminergic function, many studies have demonstrated a robust neuroprotective role for VIP 
following exposure of dopaminergic neurons to neurotoxins including 6-OHDA and MPTP (Offen 
et al., 2000; Delgado and Ganea, 2003). Consequently, VIP may serve as a neuroprotective agent 
in these dopamine neurons, limiting their vulnerability to neurodegeneration. Therefore the 
existence of different subtypes of dopamine neuron within this nucleus may have implications 
for the vulnerability of these neurons to different toxic agents.  
8.2.3. VIP population of the DRN/vlPAG 
Sparse co-expression of PHI/VIP with TH+ neurons in the periventricular region has been 
previously reported (Seroogy et al., 1988a), but the findings here suggest that all VIP+ neurons 
in the DRN/vlPAG may be dopaminergic. Presumably, therefore, dopamine and VIP are co-
released, which may have functional significance for the downstream targets of this neuronal 
subpopulation. Indeed it has been shown that VIP is able to modulate synaptic transmission 
(e.g. Ciranna and Cavallaro, 2003; Itri and Colwell, 2003) and intrinsic membrane currents (Wang 
and Aghajanian, 1990; Haug and Storm, 2000; Sun et al., 2003; Pakhotin et al., 2006), implying 
that its release from these dopamine neurons may be functionally important in regulating 
neural activity. The VIP projection from this region appears to be restricted to the dlBNST (Petit 
et al., 1995; Kozicz et al., 1998), which has also been described as a major target of DRN/vlPAG 
dopamine neurons (Hasue and Shammah-Lagnado, 2002; Meloni et al., 2006). This suggests that 
co-expression of VIP in the DRN/vlPAG may selectively mark the dopaminergic projection to the 
dlBNST.  
Very little is known about the VIP population in the DRN/vlPAG, although its presence has been 
noted in several species (Sims et al., 1980; Moss and Basbaum, 1983; Eiden et al., 1985; 
Antonopoulos et al., 1987; El Kafi et al., 1994; Smith et al., 1994; Petit et al., 1995). There is 
evidence from electron microscopy that these VIP neurons make local excitatory contacts onto 
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inhibitory interneurons within the PAG to form a local circuit (Paspalas et al., 2000). 
Furthermore, it has been hypothesised that VIP signalling may also occur via the CSF of the 
aqueduct of Sylvius, as VIP neurons and processes appear to extend into the aqueduct (Paspalas 
et al., 2000). While this could be a sectioning artefact, the existence of ‘liquor-contact’ neurons 
and fibres, which form a supraependymal system, has been proposed (Leonhardt and 
Lindemann, 1973). Therefore the influence of VIP (and possibly dopamine) release may occur via 
different means in this neuronal subpopulation.  
My findings suggest that VIP is expressed in a significant proportion of this dopaminergic 
population, but this does not preclude the possibility that other neuropeptides and/or 
neuromodulators are also co-expressed. Indeed, multiple neuropeptides have been described in 
the DRN/vlPAG (Fu et al., 2010), and there is evidence for co-expression of cholecystokinin (CCK) 
in some dopamine neurons in this region (van der Kooy et al., 1981; Seroogy et al., 1988a; 
Seroogy and Fallon, 1989) as well as CCK and neurotensin in some VTA dopamine neurons 
(Hökfelt et al., 1984; Seroogy et al., 1987; Seroogy et al., 1988a,b). However, the functional 
significance of this co-expression remains to be established. 
8.2.4. Electrophysiological characterisation 
Utilising TH-GFP and Pitx3-GFP mice to record from the DRN/vlPAG dopamine neurons in brain 
slices ex vivo revealed that they generally exhibit similar electrophysiological properties to VTA 
dopamine neurons. Specifically, they best resemble ‘unconventional’ dopamine neurons (i.e. 
those projecting to the NAc core, NAc medial shell, BLA, and mPFC) but not ‘conventional’ 
dopamine neurons (i.e. those projecting to the dorsal striatum or NAc lateral shell; Neuhoff et 
al., 2002; Ford et al., 2006; Lammel et al., 2008; Lammel et al., 2011). This was based on their 
average firing rate, action potential width, high frequency firing in response to depolarisation, 
and small Ih following hyperpolarisation.  
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8.2.4.1. Identified TH+ and TH- GFP+ neurons 
Post-hoc immunohistochemical identification of recorded GFP+ neurons revealed no differences 
between TH+ and TH- neurons in terms of any electrophysiological measures assayed. This 
supports the suggestion that GFP+/TH- neurons may be dopaminergic, but with very low TH 
levels. Moreover, previous work has demonstrated that the electrophysiological properties of 
these dopamine neurons are distinct from those of putative serotonergic (Dougalis et al., 2012), 
and putative GABA (Dougalis, unpublished) neurons in the DRN/vlPAG, suggesting that they may 
be distinguishable based on these properties alone. However, this does not overcome the initial 
difficulty in locating these dopamine neurons, being the minority in this nucleus.  
8.2.4.2. Identified VIP+ and VIP- GFP+ neurons 
I compared the electrophysiological characteristics of identified VIP+ and VIP- GFP+ neurons. 
The slightly higher proportion of GFP+/VIP+ neurons I had observed in Pitx3-GFP mice, 
compared to TH-GFP mice, translated to recordings, in which just under and just over half of 
recorded GFP+ neurons were VIP+ in TH-GFP and Pitx3-GFP mice, respectively. This 
demonstrated that both neuronal subtypes can be targeted in each GFP mouse model, but with 
a slight bias towards VIP+ neurons in Pitx3-GFP mice. However, due to the pattern of expression 
of these two subtypes, it is possible (to some degree) to attempt to visually target small 
periaqueductal neurons or large ventrolateral neurons for a greater likelihood of recording a 
VIP+ or VIP- neuron, respectively.  
Identified VIP+ and VIP- neurons generally exhibited very similar electrophysiological properties, 
but they did differ in terms of their whole-cell capacitance, action potential firing pattern, 
maximal firing frequency in response to depolarisation, and Ih amplitude. A difference in the Ih 
may be due to differences in the expression or function of the hyperpolarization-activated cyclic 
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nucleotide-gated (HCN) channels, which mediate this current (Santoro and Tibbs, 1999). 
However, a difference in firing pattern may reflect differences in the intrinsic properties of the 
neurons (Person and Kudina, 1972; Overton & Clark, 1997; Bennett and Wilson, 1999; Powers 
and Binder, 2000), for example SK3 channel expression (Wolfart et al., 2001), and/or differences 
in the temporal and spatial properties of their synaptic input (Calvin and Stevens, 1968; Stevens 
and Zador, 1998; Gonzalez-Forero et al., 2001). Support for the latter interpretation was 
provided by the observation that certain features of the glutamatergic and GABAergic input 
differed between VIP+ and VIP- neurons. Hence a difference in the ratio of excitatory to 
inhibitory input may contribute to the variation observed in firing regularity. However, the 
differences in the properties of glutamatergic synapses were not apparent in the presence of 
picrotoxin and a cesium-based internal solution. This indicates that perhaps differences in the 
GABAAR-mediated influence over the glutamatergic currents may underlie the differences 
observed.  
Interestingly, a high CV-ISI, such as that observed in VIP+ neurons, is generally associated with a 
greater probability of burst firing in vivo (Brischoux et al., 2009). An important part of future 
work would be to assess the characteristics of these neurons in vivo. However, targeting these 
dopamine neurons would be challenging since they are the minority in the DRN/vlPAG. An 
optogenetic approach may overcome this difficulty, by expressing a light-activated channel 
selectively in dopamine neurons, and using the response to brief illumination to confirm 
dopaminergic identity (Lima et al., 2009), which has been successfully employed in the VTA 
(Cohen et al., 2012).  
While it has been shown that the Ih can contribute to the firing frequency in a subpopulation of 
SNc dopamine neurons (with the largest Ih amplitudes; Luthi and McCormick, 1998; Neuhoff et 
al., 2002), it is not thought to influence the basal firing of VTA dopamine neurons, which 
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generally exhibit smaller Ih amplitudes (Neuhoff et al., 2002; Appel et al., 2003). It would follow, 
therefore, that the small Ih observed in DRN/vlPAG dopamine neurons is unlikely to influence 
the firing properties of these neurons at rest, although this remains to be determined, and may 
differ between VIP+ and VIP- neurons due to the difference in the average size of their Ih. 
Another widely used hallmark of dopamine neurons is hyperpolarisation by a D2-receptor 
agonist (Lacey et al., 1989), which is important in dopamine-mediated feedback inhibition to 
regulate neuronal excitability (Beckstead et al., 2004). However, this is only characteristic of a 
subpopulation of VTA dopamine neurons (Johnson and North, 1992a; Ford et al., 2006; Lammel 
et al., 2008; Margolis et al., 2008), and therefore an important future experiment to conduct 
would be to determine the response of the DRN/vlPAG dopamine population to a D2 agonist.  
8.2.5. Immunohistochemical and electrophysiological characterisation: conclusion 
DRN/vlPAG dopamine neurons resemble the ‘unconventional’, generally more medially-located, 
VTA dopamine neurons (Lammel et al., 2008) in terms of their molecular and 
electrophysiological properties. Interestingly, a subset of VTA dopamine neurons have been 
found to co-express the vesicular glutamate transporter, VGLUT2 (Kawano et al., 2006; 
Yamaguchi et al., 2011), and shown to co-release glutamate in the NAc shell (Hnasko et al., 
2010; Stuber et al., 2010; Tecuapetla et al., 2010). These dopamine neurons are generally found 
in more medial and caudal regions of the VTA, particularly the interfascicular nucleus, rostral 
linear nucleus, and rostral part of the caudal linear nucleus (Kawano et al., 2006; Yamaguchi et 
al., 2011). Additionally, it is noted by Kawano et al. that a small proportion of A10dc 
(DRN/vlPAG) dopamine neurons co-express VGLUT2. It would therefore be intriguing to examine 
the possibility of co-release of glutamate in this population, as it may have important functional 
consequences for neural activity in projection targets. 
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The differences observed between VIP+ and VIP- dopamine neurons, while reasonably subtle, 
may have implications for the neuronal response to synaptic input, and the pattern of dopamine 
release in target regions. Given that the VIP+ dopamine neurons may project more exclusively to 
the dlBNST, this hints at projection-specific properties, which is a feature of VTA dopamine 
neurons (Lammel et al., 2008). Indeed, differences in maximal firing frequency and Ih amplitude 
have been associated with VTA dopamine neurons projecting to different targets (Lammel et al., 
2008), which is also suggested by these results. Future work could therefore include analysing 
the neurochemical and electrophysiological characteristics of the DRN/vlPAG dopamine neurons 
in a projection-specific manner, possibly utilising retrogradely-transported fluorescent beads, as 
has been done for several major projection targets of the VTA (Lammel et al., 2008). Specifically, 
the vlBNST, dlBNST, and centromedial and centrolateral subregions of the central amygdala 
would be intriguing targets to examine. 
8.3. Cocaine- and social isolation-induced plasticity 
8.3.1. Characterisation of plasticity in the DRN/vlPAG 
An acute dose of an addictive drug (Ungless et al., 2001; Saal et al., 2003), an aversive stimulus 
(Saal et al., 2003; Lammel et al., 2011), or a reward-predicting cue (Stuber et al., 2011) have all 
been shown to strengthen excitatory synapses onto VTA dopamine neurons. Here, I have 
demonstrated that an additional type of salient stimulus – social isolation – can potentiate 
excitatory synapses onto DRN/vlPAG dopamine neurons. Either 24 hours of social isolation or a 
single dose of cocaine resulted in an increase in the AMPAR:NMDAR ratio measured in 
DRN/vlPAG dopamine neurons, but social isolation appeared ineffective at potentiating these 
synapses in the VTA. Further electrophysiological analysis suggested that both social isolation- 
and cocaine-induced plasticity in the DRN/vlPAG are associated with a postsynaptic change in 
AMPAR subunit composition, which is also a feature of cocaine-induced potentiation in the VTA 
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(Bellone and Lüscher, 2006). Specifically, the AMPAR rectification index and AMPAR-mediated 
mEPSC amplitude were significantly increased following either social isolation or a single dose of 
cocaine, while the AMPAR PPR (in the presence of polyamine block) showed a trend in the same 
direction. This indicates that both types of stimuli induce a similar potentiation of AMPAR 
transmission, characterised by a switch from GluR2-containing to GluR2-lacking receptors. 
Additionally, however, cocaine (in the presence or absence of social isolation) caused an 
increase in the frequency of AMPAR-mediated mEPSCs, which was not observed following 
purely social isolation. Therefore a distinct property of this psychostimulant may induce 
additional changes at these glutamatergic synapses. Importantly, however, cocaine 
administered with isolation did not have an additive effect on synaptic strength, in terms of the 
AMPAR:NMDAR ratio, or mEPSC amplitude and frequency. This again suggests that the 
mechanism of expression of plasticity resulting from these two stimuli may be similar. It is also 
reminiscent of the effect of cocaine and an aversive stimulus on the AMPAR:NMDAR ratio in the 
VTA, which also does not exert an additive effect at these synapses (Dong et al., 2004). 
8.3.2. Potentiation following social isolation correlates with prior social contact 
The AMPAR:NMDAR ratio following social isolation was positively correlated with the number of 
mice housed together prior to isolation. However, no relationship was observed between these 
two variables in naïve or cocaine-treated mice. This suggests that the greater the prior social 
interaction, the stronger the potentiation following removal of that interaction. In the VTA, 
cocaine-induced plasticity is proposed to involve a ‘switch-like’ mechanism at excitatory 
synapses, whereby the synapses are maximally potentiated following a single injection, and 
cannot be further potentiated by chronic exposure (Ungless et al., 2001; Borgland et al., 2004; 
Mameli et al., 2009). However, several studies have associated variability in this synaptic 
enhancement with measures of cocaine-induced behaviour. For example, in drug-naïve rats the 
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magnitude of cocaine-induced locomotor activity, following a single dose of cocaine, was 
positively correlated with the increase in the AMPAR:NMDAR ratio (Borgland et al., 2004). Given 
that no correlation was observed between locomotor activity and the ratio in saline-treated 
rats, this suggests that the locomotor activity itself does not drive the increase in synaptic 
strength (Borgland et al., 2004). Therefore in the same way here, social contact in naïve mice 
may not itself determine synaptic strength, but the magnitude of the social change imposed by 
isolation may dictate the strength of the potentiation.  
Furthermore, in mice trained to lever press for intravenous cocaine administration, the 
rectification index of the AMPAR current correlated with the number of active lever presses 
when tested during withdrawal, suggesting that greater synaptic strength is associated with 
more intense drug craving (Mameli et al., 2009). Additionally, an intense stress experience 
induces robust potentiation in a subset of VTA dopamine neurons (Saal et al., 2003; Lammel et 
al., 2011). However, it is frequently noted that the AMPAR:NMDAR ratio is generally slightly 
higher in saline-injected compared to naïve mice, which is routinely attributed to the stress of 
the injection. Hence, this mildly stressful stimulus may have a small effect at these synapses (or 
only affect a certain subset of synapses) to result in a small, but noteworthy increase. Therefore, 
the isolation-induced increase in the AMPAR:NMDAR ratio may be dependent on the degree of 
change in social contact, i.e. separation from a large social group represents a more intense, 
motivationally salient, stimulus, which results in greater synaptic potentiation. Indeed, it has 
been suggested that the magnitude of cocaine-induced locomotor activity reflects the degree of 
motivational significance of the drug (Borgland et al., 2004).  
8.3.3. Time course of plasticity 
The time course of cocaine-induced plasticity in the VTA has been well-studied, and is thought 
to be expressed within a few hours (Argilli et al., 2008), and lasts for around a week following a 
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single exposure (Ungless et al., 2001). It would be interesting to know whether the potentiation 
in DRN/vlPAG dopamine neurons exhibits the same time course as the VTA, and whether this is 
similar for both cocaine- and social isolation-induced plasticity. It is conceivable that these two 
stimuli may be distinct in terms of the time required to induce the potentiation, since the effect 
of social isolation may not progress as quickly as the rapid actions of cocaine within the brain. 
Furthermore, it has been shown that seven daily injections of cocaine increased the 
AMPAR:NMDAR ratio in the VTA to the same extent as a single dose, and still only remained for 
around a week following the final exposure (Borgland et al., 2004). This would be harder to test 
with social isolation, as it could involve either leaving the mouse in social isolation for a week, or 
repeatedly returning the animal to its cagemates for a fixed period of time between daily 
isolations.  
Interestingly, even though addictive drugs, aversive stimuli, and rewarding-predicting cues are 
the only identified stimuli which can potentiate excitatory synapses onto VTA dopamine 
neurons, other salient stimuli have been shown to induce plasticity in other parts of the reward 
circuitry. One notable example is the potentiation observed in NAc medium spiny neurons 24 
hours after exposure to a novel environment (Rothwell et al., 2011). This supports the notion 
that a more subtle, but salient, environmental change can potentiate excitatory synapses within 
24 hours. Interestingly, physiological responses and plasticity induced by mild forms of stress 
(e.g. environmental novelty or physical restraint), but not intense forms of stress (e.g. forced 
swim or social defeat), have been shown to habituate with repeated exposure (Covington and 
Miczek, 2005; Grissom and Bhatnagar, 2009; Kreibich et al., 2009; Rothwell et al., 2011). 
Therefore, in the same way, social isolation-induced potentiation may reverse with repeated 
exposure, as long as the animals are intermittently returned to their cagemates. However, 
continued isolation may represent a more intense form of stress, which may not exhibit 
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habituation. Indeed, multiple lines of evidence indicate that chronic social isolation induces 
significant neurochemical changes in the brain (e.g. Heidbreder et al., 2000, Lapiz et al., 2003; 
Fone and Porkess, 2008; Koike et al., 2009; Fabricius et al., 2010). Therefore even if the plasticity 
observed here is only transient, it may promote longer-term changes in downstream regions of 
the neural circuit, in a similar way to cocaine-induced plasticity in the VTA (Mameli et al., 2009). 
Intriguingly, both acute and chronic social isolation have been shown to alter LTP in the dlBNST 
(Conrad et al., 2011), which is one target of this population (discussed in 8.4.2). 
Reversal of cocaine-induced potentiation in the VTA requires mGluR-LTD, which resets the 
synapses back to their basal GluR2-containing state (Bellone and Lüscher, 2006; Mameli et al., 
2007). Given that potentiation in DRN/vlPAG dopamine neurons also appears to involve a switch 
in AMPAR subunit composition, it would be interesting to test whether mGluR-LTD is necessary 
and/or sufficient to reverse the potentiation observed following cocaine or social isolation in the 
DRN/vlPAG. 
8.3.4. What is the underlying cause of this potentiation? 
One key similarity between social isolation and acute cocaine is that they are both proposed to 
be anxiogenic. Consequently, one interpretation of my results is that excitatory synapses onto 
DRN/vlPAG dopamine neurons are strengthened by acute anxiety. To test this hypothesis I 
assayed behaviour in the open field test and also examined whether an acute dose of diazepam 
could increase the AMPAR:NMDAR ratio at these synapses. Anxiety-like behaviour (quantified 
by the time spent in periphery of the open field) was significantly increased 24 hours after a 
single dose of cocaine, with a (non-significant) increase also observed following 24 hours of 
social isolation. Additionally, a single dose of the addictive, but anxiolytic, drug diazepam did not 
increase the AMPAR:NMDAR ratio in DRN/vlPAG dopamine neurons, suggesting that it may not 
be the addictive quality of cocaine which is important for inducing potentiation in DRN/vlPAG 
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dopamine neurons, as it is in the VTA. I also tested the ability of diazepam, or the NMDAR 
antagonist ketamine, to prevent the potentiation following social isolation. Diazepam 
administration with social isolation had no effect on the AMPAR:NMDAR ratio compared to 
social isolation with vehicle, and ketamine administered with social isolation caused a modest 
reduction in the AMPAR:NMDAR ratio, although this was not statistically significant. 
8.3.4.1. Is the potentiation purely anxiety-induced? 
There was a significant difference across the four experimental groups in the time spent in the 
periphery of the open field, which revealed a difference between naïve and cocaine-treated 
mice in post-hoc tests following a one-way ANOVA. A trend for increased anxiety levels was also 
observed in socially isolated mice, but this was not significantly different from naïve, saline- or 
cocaine-treated mice. However, this was consistent with the non-significant trend for increased 
anxiety found following 24 hours of social isolation in a previous study (Conrad et al., 2011), 
suggesting that this period of isolation may only have a mild effect on general anxiety. 
Increasing the sample size of the four groups may reveal whether or not social isolation does 
have a clear effect on anxiety levels. Alternatively, using a more sensitive behavioural assay, 
such as the elevated plus-maze (Lister, 1987), may clarify this result. Indeed, different 
behavioural tests are likely to reflect different underlying features of anxiety, and so may be 
modelling different components of this emotional state (File, 1992; Belzung and Le Pape, 1994; 
Ramos et al., 1997; Flaherty et al., 1998; Cheeta et al., 2001). It may, therefore, be useful to 
employ multiple behavioural assays to evaluate the behavioural state of the animal. In order to 
strengthen the relationship between anxiety levels and synaptic potentiation it would also be 
useful to assay anxiety-like behaviour prior to recording from these dopamine neurons, in 
group-housed, socially isolated, saline-, and cocaine-treated mice, in order to determine 
whether anxiety levels correlate with synaptic strength. However, one caveat of this approach 
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could be that the behavioural assay itself has an acute stress-like effect, which may produce 
synaptic alterations in these neurons.  
Another possible approach to testing the hypothesis that this potentiation is anxiety-induced 
could be to administer an acute dose of an anxiogenic pharmacological agent. A corticotrophin-
releasing factor receptor 1 (CRFR1) agonist, for example, has been shown to increase anxiety 
levels measured in the open field or elevated-plus maze (Sutton et al., 1982; Koob et al., 1985; 
Moreau et al., 1997; Momose et al., 1999; Valdez et al., 2002; Bakshi et al., 2002; Zorrilla et al., 
2002). A single dose of corticosterone has also been shown to increase anxiety-like behaviour, 
although this is only apparent 12 days, and not 24 hours, after exposure, suggesting a delayed 
anxiogenic effect (Mitra and Sapolsky, 2008). However, similar to the effect of acute social 
isolation, there is a modest effect of corticosterone after just 24 hours on anxiety in the 
elevated zero-maze (Conrad et al., 2011), suggesting perhaps, that subtle responses are 
beginning to emerge after 24 hours, but are not fully apparent. Other well established 
anxiogenic pharmacological agents that could be tested are yohimbine (Handley and Mithani, 
1984; Pellow et al., 1985; Baldwin et al., 1989; Johnston and File, 1989; Cole et al., 1995; 
Redfern and Williams, 1995) and meta-chlorophenylpiperazine (mCPP; Mueller et al., 1985; 
Kennett et al., 1989; Benjamin, 1990; Kahn et al., 1990; Rodgers et al., 1992). 
Equally, it would also be interesting to examine whether acute social isolation increases 
circulating levels of corticosterone, or CRF, which may indicate an acute stress response. Indeed 
other environmental manipulations, e.g. exposure to a novel environment, have been shown to 
increase levels of this stress hormone (Badiani et al., 1998; Piazza et al., 1991). However, this 
would not confirm whether this is a cause or consequence of the synaptic potentiation 
observed, or simply an additional side-effect. 
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8.3.4.2. The importance of prior social interaction 
Regardless of whether social isolation causes an increase in anxiety or not, it clearly abolishes 
social interaction. It is intriguing, therefore, that an acute dose of cocaine is reported to reduce 
social interaction (Darmani et al., 1990; Rademacher et al., 2002; Estelles et al., 2004; Estelles et 
al., 2007), which presents a second similarity between these two stimuli. Synaptic strength 
following social isolation appears to be directly correlated with the extent of social contact prior 
to isolation. However, it remains to be determined whether this potentiation results from: (1) 
anxiety directly resulting from the loss of social interaction, or (2) loss of social interaction alone 
(i.e. independent of anxiety). However, any manipulation which increases anxiety is likely to also 
reduce social interaction (e.g., Dunn and File, 1987; Mele et al., 1987; Kennett et al., 1989; 
Elkabir et al., 1990), therefore teasing apart the relative importance of (and relationship 
between) anxiety and social interaction, is a considerable challenge.  
I also found there was a trend for a positive correlation between the number of mice per cage 
prior to isolation, and the time spent in the periphery of the open field post-isolation, hinting 
that possibly higher anxiety levels result from a greater loss of social contact (i.e. in support of 
hypothesis 1). However, this correlation was not significant, probably because the majority of 
mice were isolated from a cage of three, with only one mouse isolated from a cage of two, and 
one from a cage of four. This limited sample range is not sufficient to reveal the relationship 
between prior social interaction and the anxiety response to social isolation. It would, therefore, 
be important to establish whether anxiety levels are directly related to the loss of social contact 
by increasing the sample size of isolated mice from different sized social groups. Given that I 
also observed strong positive correlation between the number of mice per cage prior to 
isolation, and the AMPAR:NMDAR ratio post-isolation, a positive relationship between cage size 
and anxiety would suggest that this potentiation may be related to the anxiety induced by the 
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loss of social contact (although it would not be sufficient to demonstrate a direct causal link 
between the two). However, if increasing loss of social contact does not predict higher anxiety 
levels, it may be that another feature resulting from the loss of social interaction is important in 
inducing this potentiation (hypothesis 2).  
It was also observed that cocaine-treated mice housed with a larger number of cagemates 
exhibited lower anxiety levels in the open field test, suggesting that social interaction may be 
able to counteract the anxiogenic effect of cocaine. This suggests that anxiety and social 
interaction are intimately connected, and under certain conditions, an increase in social 
interaction may be able to reduce anxiety. Indeed, social interaction is often used as a 
behavioural test for anxiety, and increased interaction is interpreted as reduced anxiety levels. 
However, the AMPAR:NMDAR ratio following a single dose of cocaine did not correlate with the 
number of cagemates, suggesting that perhaps cocaine-induced potentiation is independent of 
social interaction. 
Whereas there are a few potential experiments which could be used to test whether an 
anxiogenic stimulus (regardless of a change in social interaction) can induce potentiation 
(described in 8.3.4.1), assessing the reverse is much harder, because any manipulation which 
alters social housing conditions is likely to have an impact on anxiety. One possible approach 
would be to examine the social hierarchy within a group of mice. Interestingly it has been 
shown, using the tube-test for social dominance in mice, that social rank correlates with 
synaptic strength in the mPFC (Wang et al., 2011). Furthermore, increasing or decreasing this 
synaptic efficacy causes an upwards or downwards movement, respectively, in the social rank of 
the mouse (Wang et al., 2011). This study also speculates that downstream targets of the mPFC, 
including the VTA, DRN, hypothalamus, and amygdala, are likely to be important in setting this 
social dominance hierarchy, and mediating different features of its behavioural expression 
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(Wang et al., 2011). Therefore the association observed here, between synaptic strength in 
DRN/vlPAG dopamine neurons and loss of social interaction, hints at the involvement of this 
system in social behaviour. 
8.3.4.3. Can social isolation-induced potentiation be prevented? 
Neither the anxiolytic drug diazepam, nor the NMDAR antagonist ketamine, prevented the 
social isolation-induced increase in the AMPAR:NMDAR ratio. This could be evidence in support 
of hypothesis 2, that the potentiation is independent of anxiety levels. However, the 
ineffectiveness of diazepam could be due to the acute effect of the drug compared to the longer 
period of social isolation. It has also been noted that single-housed rats are less sensitive to the 
anxiolytic effects of diazepam compared to pair-housed rats (Gardner and Guy, 1984), which 
may also have contributed to its lack of effectiveness. Another way to examine this could be to 
assay anxiety-like behaviour after social isolation with administration of diazepam, to ascertain 
whether this acute dose has any effect on anxiety levels after 24 hours. If it does reduce anxiety 
levels (but the potentiation is still evident) then this would suggest that the plasticity is 
independent of anxiety.  
Furthermore, the result obtained with ketamine administration is also open to interpretation, as 
(although a trend towards smaller ratios was observed) the negative result does not necessarily 
indicate that the plasticity is NMDAR-independent. It could simply be that the time frame within 
which the ketamine is acting does not correspond to the time-scale over which isolation-
induced changes are taking place. Although it is not an established anxiolytic like diazepam 
(O’Brien, 2005), ketamine has been reported to have therapeutic potential in the treatment of 
anxiety-related disorders (Vollenweider and Kometer, 2010). Another method to assess whether 
this plasticity is NMDAR-dependent would be to abolish NMDAR signalling, by selective deletion 
of the obligatory NR1 subunit in dopamine neurons. This has been shown to prevent cocaine-
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induced plasticity in the VTA (Engblom et al., 2008; Zweifel et al., 2008), and so may reveal the 
necessity of NMDAR transmission for the induction of plasticity in the DRN/vlPAG.  
8.3.5. Alternative hypotheses and considerations 
8.3.5.1. Stress 
An alternative hypothesis is that this potentiation is stress-induced. However, several lines of 
evidence caution against this interpretation. Firstly, excitatory synapses onto VTA dopamine 
neurons are potentiated by an acutely stressful experience (Saal et al., 2003; Lammel et al., 
2011), and therefore I would have expected to observe an increase in the AMPAR:NMDAR ratio 
in the VTA following social isolation. However, this was not the case in this study, or following 
social isolation with a saline injection in Ungless et al. (2001). Secondly, it has been suggested 
that acute social isolation is anxiogenic, but not stressful per se (Morinan and Leonard, 1980) or 
associated with a depression-like phenotype (Kwak et al., 2009). However, distinguishing 
between an ‘anxiogenic’ and a ‘stressful’ stimulus is also difficult, as there may be considerable 
inter-animal variability in the emotional result of such a manipulation. Interestingly, even 
though natural rewards, addictive drugs, and stress all increase circulating levels of 
glucocorticoids, and increase dopamine release in the NAc (Kalivas and Duffy, 1995; Piazza et al., 
1996; Piazza and Le Moal, 1997), only stress-induced, but not cocaine-induced, potentiation in 
the VTA is glucocorticoid-dependent (Saal et al., 2003). It would therefore be interesting to 
examine whether cocaine- and/or social isolation-induced plasticity in the DRN/vlPAG is 
dependent on glucocorticoid receptor activation.  
These findings are consistent with the idea that neuroadaptations can be triggered by mild 
forms of stress (Grissom and Bhatnagar, 2009; Rothwell et al., 2011). Even the relatively mild 
injection stress has been suggested to contribute to synaptic changes in the dopamine system 
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(Barrot et al., 2000; Argilli et al., 2008). Therefore, aside from the functional implications of 
social isolation-induced synaptic plasticity, these results also highlight the importance of 
controlling environmental factors in studies of this kind.  
8.3.5.2. Sleep deprivation 
The DRN/vlPAG dopamine neurons have been proposed to promote arousal in the sleep-wake 
cycle, and their c-Fos expression is correlated with wakefulness (Lu et al., 2006). Therefore 
another hypothesis is that this potentiation is related to the sleep deprivation induced by either 
acute social isolation or a single dose of cocaine. 
However, sleep deprivation and anxiety are closely related, therefore separating the 
contribution of these two factors is difficult. Chronic sleep deprivation in humans has been 
reported to lead to pathological anxiety (Peeke et al., 1980; Dinges et al., 1980; Roy-Byrne et al., 
1986; Sagaspe et al., 2005), while the majority of people suffering from anxiety disorders are 
also sleep deprived (Wyatt et al., 1971). Moreover, animal models of sleep deprivation suggest a 
strong association with anxiety. However, although many of these studies report that sleep 
deprivation is anxiogenic (Pokk and Zharkovsky, 1995; Silva et al., 2004; Kumar and Garg, 2009; 
Kumar and Singh, 2009; Xu et al., 2010), others suggest that it is anxiolytic (Van Hulzen and 
Coenen, 1981; Pokk et al., 1996; Pokk and Zharkovsky, 1997; Pokk and Zharkovsky, 1998; 
Suchecki et al., 2002). This implies that the type of sleep deprivation protocol used, and the 
anxiety-like measure employed, is likely to heavily impact on the interpretation of the results. To 
investigate the relative contribution of sleep deprivation to potentiation at these synapses, a 
minimally-stressful protocol could be used, in group-housed mice, to see if sleep deprivation 
without a loss of social interaction can induce potentiation. 
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Interestingly, it has recently been shown that socially isolated mice display impaired recovery 
from sleep deprivation compared to paired mice (Ramesh et al., 2012). Furthermore, social 
interaction has been shown to not only reduce fear-conditioned responses (Harlow and Harlow, 
1965; Davitz and Mason, 1955; Hake and Laws, 1967; Kikusui et al., 2006; Kiyokawa et al., 2007), 
but also to reduce the REM sleep fragmentation induced by conditioned fear, compared to 
socially isolated animals (DaSilva et al., 2011). Therefore social isolation may also induce 
neuroadaptations in the neural circuitry controlling sleep.  
It has also been proposed that drug addiction is associated with dysfunction in regions of the 
brain that regulate sleep (Brower and Perron, 2009), and several studies have demonstrated an 
association between sleep disturbances in childhood (particularly insomnia) and early-onset 
drug abuse (Wong et al., 2009). REM sleep-deprived rats display hypersensitivity of post-
synaptic dopamine receptors (Tufik et al., 1978) and subsensitivity of pre-synaptic DATs (Tufik et 
al., 1987). Furthermore, D2 receptors appear to be directly involved in many of the behavioural 
effects induced by REM sleep deprivation (Nunes Junior et al., 1994; Andersen et al., 2003) since 
D2 blockade suppresses REM sleep (Lima et al., 2008). This is an interesting observation, since a 
link has been proposed between reduced D2-receptor expression and vulnerability to drug 
abuse (Dalley et al., 2007). Furthermore, repeated amphetamine administration leads to 
considerable disruption of the sleep-wake cycle, marked by a clear reduction in REM sleep and 
an increased latency to REM and non-REM sleep (Andersen et al., 2008). It has also been 
proposed that sleep disturbance is a universal risk factor for relapse in addiction to all 
psychoactive drugs (Brower and Perron, 2009), and it is a symptom reported in all substance-
related withdrawal syndromes (American Psychiatric Association [DSM-IV], 2000). Both cocaine 
and social isolation, therefore, have an important impact on sleep regulation. 
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8.4. Importance of plasticity for downstream targets: central amygdala and BNST 
An enhancement of excitatory synaptic strength in dopamine neurons increases the likelihood 
of burst firing, and subsequent dopamine release, which is crucial in dopamine-dependent 
plasticity observed in projection regions (Montague et al., 2004; Wickens et al., 2007; Kreitzer 
and Malenka, 2008; Surmeier et al., 2009; Maia and Frank, 2011). This is thought to be a 
particularly important mechanism by which addictive drugs promote learned associations with 
drug-related stimuli, thereby promoting drug-seeking behaviour (Hyman et al., 2006). In the 
same way that chronic cocaine exposure leads to persistent alterations of neural function in the 
reward circuitry that ultimately leads to addiction, it is thought that chronic anxiety-like 
stressors may result in maladaptive neural changes, which could underlie the anxiety 
component of chronic neuropsychiatric disorders (Vyas et al., 2002; Rainnie et al., 2004; de 
Kloet et al., 2005; Shekhar et al., 2005; McEwen, 2007). Therefore it is tempting to speculate 
that just as cocaine-induced potentiation in the VTA is required for subsequent induction of 
plasticity in the NAc (Mameli et al., 2009), acute anxiety-induced potentiation at synapses onto 
dopamine neurons of the DRN/vlPAG may be essential for synaptic changes in downstream 
structures. Interestingly, the central amygdala and BNST have been suggested to receive a major 
dopaminergic input from the DRN/vlPAG neurons (Hasue and Shammah-Lagnado, 2002; Meloni 
et al., 2006; Shin et al., 2008).  
The amygdala is a complex, highly interconnected structure, which has a well-established role in 
regulating emotional behaviour, including the response to stress, fear and anxiety (Phillips and 
LeDoux, 1992; Davis et al., 1994; Pitkanen et al., 1997; LeDoux, 2000; Davis and Whalen, 2001; 
Everitt et al., 2003; Millan, 2003; Alvarez et al., 2008; Engin and Treit, 2008; Pérez de la Mora et 
al., 2008; Ehrlich et al., 2009; Herry et al., 2010). Learning to recognise and respond to negative 
cues is evolutionary conserved to facilitate survival (Cho and Fudge, 2010). There is also strong 
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evidence implicating the amygdala in social behaviours, as lesioning in nonhuman primates 
causes profound deficits in social interaction (Kling, 1968; Dicks et al., 1969; Kling et al., 1970; 
Kling and Cornell, 1971; Kling and Steklis, 1976). 
The central amygdala and BNST (part of the extended amygdala) are both heavily implicated in 
mediating anxiety-like behaviour (Inoue et al., 1994; Walker et al., 2003; Kalin et al., 2004) and 
their dopaminergic input has been suggested to play an important role in modulating the 
response to aversive stimuli (Asan 1997; Guarraci and Kapp, 1999; Inglis and Moghaddam, 1999; 
Pezze and Feldon, 2004; Engin and Treit, 2008; de la Mora et al., 2010). Dopamine release in the 
amygdala has also been shown to facilitate LTP (Bissiere et al., 2003; Kash et al., 2008; Tye et al., 
2010), which may underlie long-lasting changes in behaviour, and is likely to be responsible for 
maladaptive behaviours which manifest in neuropsychiatric disorders. 
8.4.1. Central amygdala (CeA) 
The CeA has been heavily implicated in attention and motivation in response to both rewarding 
and aversive events (Holland and Gallagher, 1999; Baxter and Murray, 2002; Merali et al., 2003; 
Balleine and Killcross, 2006). Along with other subnuclei of the amygdala, neurons of the CeA 
have been proposed to signal motivational salience, and their activity is correlated with 
behavioural measures of arousal (Nishijo et al., 1988; Belova et al., 2007; Shabel and Janak, 
2009). The CeA serves as the major output of the amygdala, and participates in the control of 
physiological and behavioural defensive responses to both conditioned and unconditioned 
aversive stimuli (Kapp et al., 1979; Hitchcock and Davis, 1986; Beaulieu et al., 1987; Iwata et al., 
1987; LeDoux et al., 1988; Roozendaal et al., 1990; Davis, 1992; Davis et al., 1994; Campeau and 
Davis, 1995; Walker and Davis, 1997; LeDoux, 2000; Kalin et al., 2004; Gozzi et al., 2010). 
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There is a strong dopaminergic input to the CeA (Fuxe, 1965a,b; Asan, 1993; Freedman and 
Cassell, 1994; Eliava et al., 2003; Fuxe et al., 2003), which is considered to play an important role 
in the modulation of fear and anxiety (Pezze and Feldon, 2004; Engin and Treit, 2008; de la Mora 
et al., 2010). Dopamine is reportedly released in the amygdala under stressful conditions 
(Abercrombie et al., 1989; Coco et al., 1992; Young and Rees, 1998; Inglis and Moghaddam, 
1999; Yokoyama et al., 2005), and while there is a high density of both D1 and D2 dopamine 
receptors in this region (Boyson et al., 1986; Dawson et al., 1986; Scibilia et al., 1992; Maltais et 
al., 2000; Fuxe et al., 2003), D1 receptors have been implicated in promoting anxiogenic 
behaviours (Lamont and Kokkinidis, 1998; Guarraci et al., 1999a,b; Nader and LeDoux, 1999; de 
la Mora et al., 2005). The role of D2-receptors appears more complex, with contradictory 
findings likely to be a result of antagonist infusion into different subregions of the amygdala, 
and the type of behavioural assay employed (Nader and LeDoux, 1999; Greba et al., 2001; de 
Oliveira et al., 2011; Guarraci et al., 2000; Perez de la Mora et al., 2012). Nevertheless, there is 
strong evidence of a modulatory role for dopamine within the CeA. 
8.4.2. BNST 
The BNST plays an established role in mediate stress- and anxiety-like responses to diffuse or 
unpredictable stimuli (Davis, 1998; Walker et al., 2003). Anxiogenic compounds or experiences 
increase neuronal activation within the BNST (Singewald et al., 2003; Straube et al., 2007), 
stimulation of the BNST elicits an anxiety-like physiological response (Casada and Dafny, 1991; 
Kalin et al., 2005), and inactivation of the BNST blocks many anxiogenic behaviours (Davis et al., 
1997; Fendt et al., 2003; Hammack et al., 2004; Sullivan et al., 2004; Waddell et al., 2006). The 
BNST has been particularly associated with mediating long-term ‘tonic’ anxiety-like behavioural 
responses to sustained, diffuse and/or unpredictable threats (Walker et al., 2003; Waddell et al., 
2006; Walker and Davis, 2008; Walker et al., 2009; Davis et al., 2010), as opposed to the CeA 
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which is thought to be more important in the rapid, acute response to anxiety-like stressors 
(Walker et al., 2003; Kalin et al., 2005; Davis et al., 2010). Consistent with this, chronic stress 
promotes maladaptive plasticity and remodelling within the BNST, which is associated with 
pathological anxiety-like behaviour (Schulkin et al., 1998; Vyas et al., 2002; Vyas et al., 2003; 
Pego et al., 2008). Therefore, stress-induced alterations in neuronal function and synaptic 
plasticity within this region are thought to underlie anxiety disorders in humans (Straube et al., 
2007). The BNST also contains a high density of D1- and D2-receptors, and receives a strong 
dopaminergic input, which is thought to contribute to BNST-mediated behaviours and synaptic 
plasticity (Wamsley et al., 1989; Phelix et al., 1992; Epping-Jordan et al., 1998; Hurd et al., 2001; 
Eiler et al., 2003; Kash et al., 2008). 
It is of particular interest to note that one of the very few studies to have investigated 24 hours 
of social isolation found that this acute manipulation resulted in blunting of NMDAR-dependent 
LTP in the dlBNST (Conrad et al., 2011). This was also observed following chronic social isolation 
(6 weeks) or chronic corticosterone administration, both of which (unlike acute social isolation) 
significantly increased anxiety measured in the open field test and elevated-zero maze (Conrad 
et al., 2011). This supports the notion that acute social isolation can induce alterations in 
synaptic strength after just 24 hours, and implicates the DRN/vlPAG dopamine neurons as a key 
participant in this neural response. It was also hypothesized by Conrad et al. (similar to the 
speculation discussed here) that these acute changes may have significance for long-term 
neuroadaptations. They suggest that the chronic isolation-induced state of enhanced anxiety, 
driven in part by synaptic changes in the dlBNST, was only beginning to develop after 24 hours 
(Conrad et al., 2011). Interestingly, chronic social isolation is thought to be associated with 
multiple changes to dopamine neurotransmission, including that within the amygdala (Guisado 
et al., 1980; Bardo and Hammer, 1991; Jones et al., 1992; Phillips et al., 1994; Smith et al., 1997; 
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Fulford and Marsden, 1998; Hall et al., 1998a; Heidbreder et al., 2000; Howes et al., 2000; Del 
Arco et al., 2004; Peters and O’Donnell, 2005; Djouma et al., 2006). However, the precise role of 
dopamine and the amygdala in mediating the effects of social isolation remains unknown.  
8.4.3. Significance of projection target  
Increasingly, evidence is accumulating that the projection target (Lammel et al., 2011) and the 
source of afferent input (Good and Lupica, 2010) are crucial determinants of the functional 
output of a dopamine neuron. The demonstration that only a particular subset of synapses are 
potentiated by cocaine, or an aversive event, dependent on their projection target (Lammel et 
al., 2011), suggests that these salient stimuli influence dopaminergic activity in restricted neural 
circuits. Therefore, although this presents a greater technical challenge, determining the 
connections of a neuron prior to recording allows changes to be interpreted in terms of distinct 
neural circuits, rather than generalised neurotransmitter release. Therefore, one key future 
experiment would be to assess cocaine- and social isolation-induced plasticity in a projection-
specific manner. This could be achieved by employing the same retrograde labelling technique 
as Lammel et al. (2008, 2011), which involves injection of fluorescently-tagged retrobeads into 
specific target sites, followed by recording from identified dopaminergic neurons. Specifically, 
the dlBNST and central amygdala would be intriguing projection targets to examine, given their 
proposed roles in anxiety-like behaviour. While this would be an important aspect of future 
work, its absence does not detract from the importance of these findings. More, these results 
provide a useful guide as to the role of this understudied subset of dopamine neurons, 
proposing a new type of salient stimulus processed by dopamine neurons, and possibly 
including a considerable number of mesoamygdaloid neurons, which are sparsely distributed, 
and therefore rarely recorded from, in the VTA. 
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Indirectly, the use of VIP expression in the DRN/vlPAG dopamine neurons could be used as an 
indicator of projection target, as these neurons appear to project selectively to the dlBNST (Petit 
et al., 1995; Kozicz et al., 1998). However, for long duration recordings involving evoked synaptic 
currents, I found that not only were less neurons successfully recovered with 
immunohistochemistry, but there was a bias towards recording from the larger, more ventrally-
located VIP- neurons. This was mainly due to the relative position of the stimulating electrode, 
and the difficulty in evoking currents in the small, periaqueductal VIP+ neurons. Therefore, while 
I was able to confirm the majority of my electrophysiological findings in identified VIP- neurons, 
I did not have a sufficient number of identified VIP+ neurons to also confirm the synaptic 
response of this subpopulation. When pooling data from multiple groups, VIP+ neurons 
appeared to show a trend towards higher AMPAR:NMDAR ratios following social isolation, 
suggesting that perhaps this acute manipulation does affect the dlBNST-projecting dopamine 
neurons. However, the sample size was not sufficient for a conclusive result, therefore future 
work would involve collecting more data from the VIP+ population to determine the effect of 
social isolation or cocaine on this subpopulation.   
One approach to testing a causal role for the DRN/vlPAG dopaminergic projection to the 
amygdala in anxiety-like and social behaviour would be to exploit the spatial and temporal 
precision offered by optogenetics (Boyden et al., 2005; Tye and Deisseroth, 2012), in order to 
selectively control a specific dopaminergic projection. Optogenetic stimulation of VTA dopamine 
neurons has already demonstrated their requirement in reward-seeking behaviour (Tsai et al., 
2009), while studies in the amygdala have demonstrated the capacity to modify anxiety-like 
behaviour by optogenetically controlling a specific set of synapses (Tye et al., 2011). Specifically, 
mice expressing channelrhodopsin-2 (ChR2; a light-activated cation channel for neural 
activation; Boyden et al., 2005) or halorhodopsin (eNpHR3.0; a light-activated chloride pump for 
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neural inhibition; Gradinaru et al., 2010), selectively in DRN/vlPAG dopamine neurons, could be 
examined in behavioural assays for general anxiety or social interaction. This could be combined 
with selective optogenetic control over the dopaminergic terminals within a specific target 
structure, for example the central amygdala or dlBNST, in order to reveal the role of these 
dopaminergic projections in specific aspects of behaviour.  Additionally, combining optogenetic 
activation of the dlBNST projection, with infusion of vasoactive intestinal polypeptide receptor 
(VPAC) antagonists into this region, could indicate the requirement for co-release of VIP. 
Alternatively, VIP-Cre mice (Song et al., 2012) could be used to selectively control the VIP+ 
population. This could be combined with fast scan cyclic voltammetry to determine dopamine 
release, and VPAC or dopamine receptor antagonists to uncover the necessity of each 
neurotransmitter for a particular function.  
8.4.4. Functional role of VIP 
Although VIP expression within the central nervous system is limited, one major group of VIP 
neurons reside within the suprachiasmatic nucleus (SCN; Welsh et al., 1995; Romijn et al., 1997; 
Guillaumond et al., 2007). VIP release from these neurons, acting through the VPAC2 receptor, 
is thought to be critical in promoting circadian rhythmicity and behaviour, and maintaining 
synchrony between intrinsically rhythmic SCN neurons (Shen et al., 2000; Harmar et al., 2002; 
Colwell et al., 2003; Aton et al., 2005; Brown et al., 2006). However, interestingly, the VIP 
population within the DRN/vlPAG has also been implicated in the regulation of sleep and 
wakefulness, possibly exerting their effects via local inhibition of the serotonergic system 
(Bourgin et al., 1997; Simon-Arceo et al., 2003; Ahnaou et al., 2006). Given that it has also been 
suggested that the dopaminergic neurons in this region participate in regulating the sleep-wake 
cycle (Lu et al., 2006), it is likely that both dopamine and VIP release from these neurons is 
important in this function. VIP has also been implicated in pain sensitivity and analgesia (Sullivan 
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and Pert, 1981; Mácsai et al., 1998), which is another function attributed to the DRN/vlPAG 
dopamine neurons (Flores et al., 2004; Meyer et al., 2009), again suggesting a functional 
significance for the co-expression of these neurotransmitters. 
Interestingly, VIP has also been implicated in anxiety and social behaviour. Blockade of VIP 
signalling during a critical period of embryogenesis disrupts development and causes a 
permanent change in brain neurochemistry (Gozes et al., 1989; Gressens et al., 1993; Hill et al., 
1994; Wu et al., 1997; Glazner et al., 1999; Hill et al., 1999; Servoss et al., 2001; Hill et al., 
2007a,b). This results in impaired learning, increased anxiety-like behaviour, and deficits in 
social behaviour in adulthood, which is proposed to bear similarities to autism-like social deficits 
(Hill et al., 2007a,b). It has also been shown that disruption of VIP signalling is associated with 
cognitive, and memory and learning deficits (Cottrell et al., 1984; Flood et al., 1990; Glowa et al., 
1992, Gozes et al., 1993; Takashima et al., 1993a,b; Itoh et al., 1994; Chaudhury et al., 2008), 
which are functions routinely ascribed to the dopaminergic system. Reduced plasma 
concentrations of VIP have been found in patients with anxiety and depressive disorders, as well 
as reduced levels in the cerebrospinal fluid of patients with depression, which suggests a 
possible role for this neuropeptide in the neurobiological mechanisms of affective disorders 
(Gjerris et al., 1984; Rafaelsen and Gjerris, 1985; Gjerris, 1988; Saiz Ruiz et al., 1992). 
Furthermore, duplications in the VIP receptor gene, VIPR2, have been associated with an 
increased risk for schizophrenia (Vacic et al., 2011). Given that this has predominantly been 
viewed as a disorder of dopamine dysfunction, this represents another potential functional link 
between these two neurotransmitter systems. Consistent with this, it has been noted that the 
orphan nuclear receptor, Nurr1, which is essential for the formation of midbrain dopamine 
neurons during development (Zetterstrom et al., 1997), can directly regulate VIP transcription, 
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and activate its expression (Luo et al., 2007). These studies point towards a functional 
association between VIP and dopamine, which would be intriguing to examine further. 
8.5. Clinical relevance of these findings 
The results presented here implicate the DRN/vlPAG dopamine neurons in the response to social 
isolation, and possibly anxiogenic stimuli, in contrast to the rewarding stimuli processing by the 
VTA. The DRN/vlPAG provides a substantial dopaminergic input to the central amygdala and 
BNST (Hasue and Shammah-Lagnado, 2002; Meloni et al., 2006; Shin et al., 2008), and therefore 
synaptic changes in this population may have functional implications for dopamine release and 
neuroadaptations, particularly in these structures. The findings reported here are of relevance 
not only to anxiety-related disorders, but also to those with a social dysfunction component, such 
as autism, which have all been associated with the amygdala in humans. Dopamine has also been 
linked to many neuropsychiatric disorders with anxiety-like and social impairments, including 
schizophrenia (Swerdlow and Koob, 1987; Davis et al., 1991; Lodge and Grace, 2011), depression 
(Dailly et al., 2004; Nestler and Carlezon, 2006), ADHD (Swanson et al., 1998; Swanson et al., 
2000; Tye et al., 2010), and autism (Lake et al., 1977; Ernst et al., 1997; Baron-Cohen, et al., 2000; 
Robinson et al., 2001; Gadow et al., 2008; Nakasato et al., 2008). Additionally, chronic social 
isolation is frequently used as an animal model of schizophrenia and depression, since many of 
the behavioural manifestations bear similarities to those characterising these disorders (Ehlers et 
al., 1993; Geyer et al., 1993; Jaffe et al., 1993; Myhrer, 1998; Lapiz et al., 2003; Heim et al., 2004; 
Fone and Porkess, 2008; Wilkinson et al., 2009; Fischer et al., 2012; Moller et al., 2012).  
8.5.1. Anxiety disorders 
Anxiety disorders span a range of diagnoses including panic disorder, agoraphobia, post-
traumatic stress disorder, social anxiety disorder/social phobia, generalized anxiety disorder, 
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and obsessive-compulsive disorder (American Psychiatric Association [DSM-IV], 2000). Anxiety 
disorders have the highest prevalence of all psychiatric diseases, both in the US (Kessler et al., 
2005) and in many European countries (Alonso and Lepine, 2007), and show high co-morbidity 
with other neuropsychiatric diseases including addiction and major depression (de Graaf et al., 
2002; Ressler and Mayberg, 2007). Furthermore, these disorders are associated with a huge 
socioeconomic burden (François et al., 2010), with the direct cost of anxiety disorders estimated 
at $63.1 billion in the US in 1998 (Greenberg et al., 1999). Current treatments, however, are 
limited in their efficacy and consistency. For example, selective serotonin reuptake inhibitors are 
associated with undesirable side-effects including headaches, nausea and insomnia, while 
benzodiazepines carry the risk of dependence and cognitive impairments (Woods et al., 1992; 
Stein, 2004). This highlights the need for more effective therapeutic interventions, which first 
requires a comprehensive understanding of the neural circuits underlying anxiety.  
Aside from the wealth of animal evidence which implicates the amygdala in anxiety-like 
behaviour, hypersensitivity in the amygdala has been associated with depression and related 
disorders in humans (Sheline et al., 2001; Siegle et al., 2002). This is proposed to result from 
misinterpretation of, and an exaggerated response to, negative cues (Wenzlaff et al., 1988; 
Oaksford and Stenning, 1992; Cho and Fudge, 2010). Furthermore it has been shown in humans 
that increased dopamine release potentiates amygdala function (Hariri et al., 2002; Tessitore et 
al., 2002), suggesting that variability in dopamine signalling may underlie the individual variability 
in amygdala function and emotional behaviours. Consistent with this, it was demonstrated that 
amygdala dopamine storage capacity is correlated with amygdala activation in response to an 
aversive stimulus (Kienast et al., 2008). It has therefore been hypothesised that differences in 
amygdala dopamine contribute to individual differences in trait anxiety (Kienast et al., 2008).  
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8.5.2. Autism and social interaction 
Autism Spectrum Disorders (ASDs) are characterised by abnormal social behaviour, in addition to 
deficits in communication, repetitive behaviours, and narrowly focused interests (Howlin and 
Moore, 1997; Schultz, 2005; White and Roberson-Nay, 2009; Landrigan, 2010). Furthermore, up 
to 74% of autistic persons have generalized anxiety disorder (Fombonne, 1992; Kim et al., 2000; 
Gillott et al., 2001; Hill and Furniss, 2006). Despite tremendous research efforts aimed at 
identifying the cause of autism, no singular cause has emerged, and available medications are 
‘off-label’ therapies that are typically prescribed for other conditions (Happe et al., 2006; Filipek 
et al., 2006; Oswald and Sonenklar, 2007). 
In humans, the amygdala has been linked to a number of processes directly relevant to the core 
symptoms of autism, including social anxiety (Amaral, 2003; Etkin et al., 2004; Killgore and 
Yurgelun-Todd, 2005; Phan et al., 2006), the recognition of emotional facial expressions (Morris 
et al., 1996; Schultz 2005; Ashwin et al., 2007), the size of our social networks (Bickart et al., 
2011) and even the concept of personal space (Kennedy et al., 2009). Amygdala lesions in 
animals produce some autism-like behaviours (Hetzler and Grifﬁn, 1981), while in patients this 
results in errors in social judgement (Adolphs et al., 1994; Young et al., 1996). Additionally, fMRI 
has revealed altered amygdala volume (Abell et al., 1999; Sparks et al., 2002; Schumann et al., 
2004) and reduced activation (Baron-Cohen et al., 1999) in individuals with autism, while signs 
of neuropathology have been observed in the amygdala of post-mortem autistic brains (Bauman 
and Kemper, 1985; Abell et al., 1999; Aylward et al., 1999; Howard et al., 2000; Pierce et al., 
2001; Schumann and Amaral, 2006). This has led to the hypothesis that dysfunction of the 
amygdala may be partly responsible for the deficits in social behaviour seen in autism (Baron-
Cohen et al., 2000).  
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Interestingly, hyperactivation of the dopamine system has been hypothesized to play a role in 
autism (Nakasato et al., 2008), based on evidence that risperidone, which blocks postsynaptic 
dopamine receptors, is effective in treating many symptoms and stereotyped behaviours of 
individuals with autism (McCracken et al., 2002; McDougle et al., 2005). In addition, of relevance 
to the findings here, it is also interesting to note that increased VIP levels have been reported in 
newborns with autism (Nelson et al., 2001), implicating this neuropeptide in the 
pathophysiology of this neurodevelopmental disorder. 
8.6. Conclusion 
The results presented here are relevant to several neuropsychiatric disease states, which are 
currently limited in their understanding and available treatments. Given that the DRN/vlPAG 
dopamine population is tightly integrated into the neural circuit which mediates many of the 
maladaptive behaviours associated with these disorders, it is likely to play a crucial regulatory 
role in the expression of these responses. Finally, and most importantly, the amygdala (Sander 
et al., 2003) and the dopamine system (Pani and Gessa, 1997) display remarkable conservation 
throughout evolution, suggesting that findings in animals will be relevant to humans, and thus 
have considerable translational potential. These results are therefore of interest to disease 
states modelled by social isolation, and disorders of anxiety, as well as to the rapidly evolving 
field of social neuroscience (Eisenberger and Cole, 2012).  
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